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Abstract 
Osteoarthritis (OA) is a highly prevalent, debilitating disease affecting many joints 
including the knee. Despite the involvement of several tissues, it is believed that the 
articular cartilage is the primary site of pathogenesis in humans.  
Within this study, a new scoring system of OA was devised, incorporating the articular 
cartilage and underlying bone, aimed at providing a more comprehensive means of grading 
the severity of tissue damage. We examined changes progressively from mild to severe 
and were able to deduce from the scoring system that bone changes may precede those of 
the overlying cartilage.  
Immunohistochemistry was used to assess stem cell marker expression, proliferation and 
progressive changes within the extracellular matrix of sectioned osteochondral plugs, 
however no distinct pattern of change could be extrapolated, highlighting the variable 
nature of this taxing disease. 
Previous studies have demonstrated the presence of a sub-population of chondroprogenitor 
cells present in normal hyaline cartilage. We demonstrated in this study that a similar 
group of cells reside in osteoarthritic articular cartilage. We were able to isolate and 
expand clonally derived primary cell lines to beyond 50 population doublings whilst 
maintaining a chondrogenic phenotype, and demonstrated the tri-lineage potential of these 
cells. That said, a significant amount of variation was observed and it was, therefore, 
postulated that there may be a smaller cohort of viable cells within this sub-population 
isolated from osteoarthritic cartilage.  
A preliminary study was also carried out comparing chondroprogenitors from normal 
articular cartilage to those isolated from OA tissue. Heterogeneity was again encountered, 
suggesting that there was a group of OA chondroprogenitors with similar characteristics to 
the normal cells, which differed from the other less metabolically active cells. This finding 
was agreeable with the aforementioned postulation. Data from our preliminary integration 
study was promising as we demonstrated the potential for using these chondroprogenitor 
cells in combination with other cells whilst achieving successful integration. However, 
further work is necessary to distinguish between the cell lines with the potential for 
integration from those that lacked this ability, thereby eliminating the heterogeneity.  
The presence of viable chondroprogenitor cells in OA tissue challenges the dogma that the 
tissue is irrecoverable, and opens the scope for regenerative medicine using resident 
progenitor cells. This is an exciting prospect that could significantly contribute to articular 
cartilage repair.  
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Chapter 1: 
General Introduction 
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1.1. Joints  
 
A joint refers to the structural arrangement at the union between two or more parts of the 
skeleton. There are several different bases of classification of joints including structural 
classification and functional classification (figure 1.1) (Tortora and Anagnostakos, 1990). 
Synovial joints (otherwise known as diarthroses) are the most evolved and consequently 
the most mobile type of joint in the vertebrate. They comprise a joint cavity enclosed by a 
fibrous capsule linking skeletal elements including bone, ligament, meniscus and 
synovium. Within the capsule, a synovial membrane lines the surface and secretes a vital, 
lubricating fluid known as the synovial fluid. A thin layer of hyaline cartilage covers the 
surface of the articulating bones and this is commonly referred to as the articular cartilage. 
The structure of normal synovial joints enables high tensile strengths to be absorbed whilst 
providing a surface with low levels of friction permitting smooth, pain free movement. 
Synovial joints can withstand loads of up to ten times the body weight with a very low 
friction coefficient (Ratcliffe and Mow, 1996).   
 
 
 
Figure 1.1. Diagrammatic presentation of joint classifications.  
Synovial joints fall under the structural classification of joints. 
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Figure 1.2. Diagram of a synovial joint.  
Articular cartilage covers the opposing surfaces of the skeletal elements. (Figure kindly 
donated by Dr. Kirsty Richardson). 
 
 
1.2. Development of cartilage 
 
The development of the skeleton is a crucial process beginning early in embryogenesis, 
initiated by the formation of cartilage. Undifferentiated mesenchymal cells from the 
paraxial mesoderm give rise to somites; short segments of bead-like elevations that appear 
along the dorsolateral surface of the embryo and later differentiate into the axial and 
appendicular skeleton (Moore and Persaud, 2003). Cartilage develops from cells within the 
limb bud condensing to form a cartilaginous model of bone through a sequence of 
synchronised steps. This involves commitment and proliferation of cells into 
chondrogenesis, followed by the acquisition of a chondrogenic phenotype; events which 
are not only controlled by the chondrocytes themselves, but also by the local environment. 
An important transcription factor involved during chondrogenic condensation is Sox9, 
which is known to precede the expression of early cartilage marker collagen type IIa 
(Akiyama et al., 2002). 
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The process by which the cartilage anlagen develops into skeletally mature bone is called 
endochondral ossification. This process involves chondrocyte proliferation, chondrocyte 
hypertrophy and matrix production, followed by the invasion of blood vessels. Apoptosis 
or transdifferentiation of hypertrophic chondrocytes into osteoprogenitor cells occurs 
which leads to the establishment of primary ossification centres in the diaphyses. At these 
sites mineralisation occurs, through which the cartilaginous anlagen is replaced by bone. In 
humans at birth, secondary ossification centres are established at either ends of diaphyseal 
shafts. Between the secondary centres and the developing diaphyseal bone is an area 
known as the epiphyseal growth plate (Stevens et al., 1992). Many similarities exist 
between chondrocytes of the growth plate, articular cartilage and permanent cartilage 
including metabolism and markers such as collagens, however there also many 
biochemical and physiological differences due to local surroundings. Understanding the 
different mechanisms involved in chondrocyte fate remains to be fully elucidated. 
 
1.3. Development of synovial joints 
 
Synovial joints arise from mesenchymal condensations at specified sites through a process 
mediated by cell adhesion molecules and matrix receptors. Following the early stages of 
development in which the condensations chondrify, there is a secondary phase of 
remodelling. During this phase a region of cells at the presumptive joint flatten and 
become non-chondrogenic; at which point the region is known as the interzone (Archer et 
al., 2003, Craig et al., 1987). It is believed that the joint tissues are derived and develop 
from the cells of the interzone (Mitrovic, 1977), which in humans is seen as a thin layer of 
two to three flattened cells (Edwards et al., 1994).  
 
There is a plethora of data to suggest a defined pattern is involved in specification of 
developing joints. Positioning and patterning of limbs involve cellular interactions 
between the mesenchymal cells that form the core of the limb bud and surrounding 
ectoderm (Khan et al., 2007). This process is controlled by three main signalling centres, 
which drive patterned limb growth along each of the three axes of the limb; namely 
proximal-distal, anterior-posterior and dorsal-ventral (Niswander, 2002). During the initial 
phases of joint specification, Noggin and Chordin, secreted bone morphogenetic protein 
(BMP) antagonists are expressed throughout the mesenchymal condensation and 
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presumptive joint space, and are crucial during joint development (Brunet et al., 1998). 
Growth and differentiation factor (GDF) -5, a member of transforming growth factor-β 
(TGF-β) superfamily is known to be heavily involved in the formation of the joint 
interzone, despite being from a chondrogenesis-promoting family (Archer et al., 2003, 
Storm et al., 1994). It is believed that GDF-5 was the first recognised gene marker in the 
developing joint and, therefore, much work has been focused on analysing its role during 
joint specification (Archer et al., 2003). Mutations to the GDF-5 gene disrupts normal 
skeletal development and results in abnormal joint development (Francis-West et al., 1999, 
Storm and Kingsley, 1999). 
 
Despite its involvement in joint development, it has been found that GDF-5 is not directly 
involved in specifying joint type and it is believed that synovial joints are specified and 
controlled by an upstream activator of GDF-5 from the Wnt family of genes (Hartmann 
and Tabin, 2001). Wnt14 specifically has been identified as a key factor in the 
development of synovial joints, and localised production of Wnt14 induces the expression 
of GDF-5 (Khan et al., 2007). Convincing data by Hartmann and Tabin (2001) 
demonstrate how Wnt14 is sufficient to direct joint development in the chick, based on its 
ability to induce and/or maintain relevant gene markers for joint development including 
chordin, CD44 and GDF-5.  
 
Several studies have also focussed on Hox genes, homeodomain-containing transcription 
factors which have been shown to be critical for the specification and patterning of 
vertebrate embryo (Nowicki and Burke, 2000). Having stated that, the extent to which 
these genes are in fact critical for joint patterning and determination is unknown as little 
work has been followed up to confirm and/or extend from the initial proposals (Pacifici et 
al., 2005).  
 
The next phase of development is joint cavitation at which point there is a significant 
reduction of chondrogenic marker expression, namely sox9 and collagen type II. As 
described by Khan et al., 2007, ‘the process of cavitation involves the generation of a 
cavity between two cartilaginous elements that are growing against each other through 
forces largely generated by hypertrophy and matrix secretion’. This process is achieved 
through upregulation of mechanically induced hyaluronan (HA) synthesis by cells of the 
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interzone, articular surface and synovium. There are several other factors which have been 
postulated to be involved in the formation of the synovial cavity including cell death, 
enzymatic degradation, differential matrix synthesis and mechanical stimulation. 
 
1.4. Articular cartilage 
 
Articular cartilage is a thin layer of hyaline cartilage that covers the surface of bones at 
large articulating diarthrodial joints. It is renowned for being avascular and aneural, and 
for being a tissue with a poor reparative capacity. The function of articular cartilage is to 
provide a wear-resistant surface with low frictional properties, whilst having the ability to 
bear high tensile strengths; withstanding compression and shear (Benjamin, 1999).   
 
The characteristic properties of articular cartilage are achieved through its highly 
structured organisation. Its uniquely dense extracellular matrix (ECM) is produced and 
maintained by a single specialised cell; the chondrocyte, whose relative numbers are low 
and make up less than 5% of the tissues total volume (Bora and Miller, 1987) . The ECM 
is abundant in collagens (10-30% of wet weight) that provide a network in which 
proteoglycans (5-10% of wet weight) and other molecules can embed. The negatively 
charged proteoglycans are responsible for a high osmotic swelling pressure, resulting in a 
large proportion of water within the tissue (65-80% of wet weight) (Buckwalter and 
Mankin, 1998). It is through the interactions between collagens, proteoglycans and water, 
that hyaline cartilage becomes a resilient tissue capable of lasting a lifetime. 
 
The gross appearance of articular cartilage is smooth and iridescently white; however the 
thickness, cell density, matrix composition and mechanical properties are variable even 
within a joint. Due to the avascular nature of the tissue, the chondrocytes are sustained by 
the diffusion of nutrients and gases. Compared to other tissues like muscles and bone, 
articular cartilage has a low level of metabolic activity. Despite its low metabolic activity 
and ‘unimpressive appearance’, articular cartilage is an elaborate, and highly ordered 
structure in which complex interactions between chondrocytes and surrounding matrix 
actively maintain the tissue (Buckwalter and Hunziker, 1999). 
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Figure 1.3. Normal human hyaline cartilage on tibia and femur.  
Normal fibrocartilagenous meniscus between the articulating surfaces can also be seen. 
Photograph taken by Professor John Fairclough during arthroscopic surgery.  
 
 
1.4.1. Development of articular cartilage 
 
The pathways involved in the development of articular cartilage have been an area of 
interest within many groups for decades, as a result of the inherent lack of understanding. 
The questions that are commonly raised are a) how do articular chondrocytes develop at 
the extremities of developing long bones early in embryogenesis and become distinguished 
from surrounding tissues and structures, and b) how do the articular cells avoid entering 
the endochondral ossification route through which the majority of the chondrocytes form 
skeletal elements (Pacifici, 1995). 
 
Extensive work by Pacifici (1995) has provided strong evidence to suggest that tenascin-C 
(an ECM macromolecule) and syndecan-3 (a cell surface receptor) have roles in not only 
developing synovial joints, but also articular cartilage specifically. Chiquet and 
Fambrough (1984) initially identified tenascin-C as a factor involved in joint development 
as it had been found to be rich at boundaries between different adjacent tissues and 
structures. In the case of the synovial joint, the formation of this boundary; the interzone, 
is what leads to the creation of distinct skeletal elements. Tenascin-C was also found to 
maintain cells in a round configuration which is characteristic of chondrocytes that give 
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rise to articular cartilage and unlike growth plate chondrocytes which are flat and 
irregularly shaped (Chiquet-Ehrismann et al., 1988, Howlett, 1979, Lutfi, 1974). It was 
also found that tenascin-C has the ability to interact with a variety of cell surface receptors, 
including syndecan-3; a component that had previously been shown to be expressed by 
limb prechondrogenic condensations (Gould et al., 1992, Salmivirta et al., 1991). Based on 
these findings, several authors pursued this work with the aim to develop a greater 
understanding of the roles and involvement of these macromolecules in joint development 
(Koyama et al., 1995, Pacifici, 1995, Pacifici et al., 1993). Experiments in chick embryo 
unveiled that at day 6-6.5 of embryogenesis, syndecan-3 gene expression was strongly 
expressed by perichondral cells around the border of the diaphysis. Tenascin-C gene 
expression was weaker than that of syndecan-3, and particularly evident in the inner layer 
of the diaphyseal perichondrium (Pacifici et al., 1999). Throughout development as 
separation of the skeletal elements occurs, there is a gradual increase of tenascin-C at the 
epiphyses with levels reducing at the diaphyses. At later stages, when articular and growth 
plate chondrocytes emerge at the epiphyses (day 18 in chick embryogenesis) tenascin-C 
becomes extremely abundant but confined to articular chondrocytes, precisely delineating 
boundaries between structures. At this same stage, syndecan-3 is absent from articular 
chondrocytes, yet evident in the region of proliferating chondrocytes in the top zone of the 
growth plate (Pacifici, 1995, Pacifici et al., 1993, Savarese et al., 1996). As previously 
mentioned tenascin-C maintains chondrocytes in their stable round configuration allowing 
for the preservation of a normal phenotype throughout postnatal life (Pacifici et al., 1999).   
 
There is no doubt a pattern of organisation throughout the growth and development of 
articular cartilage; the uncertainty lies in what triggers these mechanisms. In the late 
embryo, articular chondrocytes are rounded, randomly dispersed throughout the tissue, 
display low mitotic activity and are separated by a relatively low amount of extracellular 
matrix (ECM) (Howlett, 1979, Lutfi, 1974). Mature articular cartilage on the other hand 
has a distinct, structured organisation and a relatively high matrix-to-cell ratio. It is also 
well documented that when cartilage matures, tissue thickness and overall cell density also 
decrease (Stockwell, 1979). The spatial and temporal patterns of matrix components have 
also been studied. As such there is a distinct shift from an immature isotropic structure to a 
highly anisotropic mature articular cartilage (Archer et al., 1996, Morrison et al., 1996).  
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Collagen expression is not overly dynamic throughout the development of articular 
cartilage. Type I collagen is initially detected throughout the presumptive articular 
cartilage, however it is not detected in later stages following maturation of the tissue. Type 
II collagen is ubiquitous throughout the cartilage matrix. Type V collagen is seen 
pericellularly together with type III collagen during cavitation, and then within the 
articular cartilage following cavitation resulting in the suggestion that the chondrogenous 
cells of the interzone give rise to the articular cartilage (Archer et al., 2003). The gross 
collagenous structure of collagens within the tissue also changes as it develops, going from 
an arrangement that runs generally parallel to the articular surface, to the arrangement of 
the Benninghof ‘arcade’ pattern in which the fibre orientation develops perpendicularly 
from the basal region and arches over to run parallel to the articular surface (Benninghof, 
1925). The presence of proteoglycans during the development of articular cartilage is 
highly varied depending on age, joint or species. 
 
Despite the wealth of information above, the underlying question of how does the structure 
of articular cartilage develop, remains to be answered. Work by Mankin (1962) 
demonstrated how articular cartilage grew by a combination of appositional and interstitial 
growth following experiments on immature rabbit knees. Tritiated thymidine was 
incorporated as a marker for chondrocyte proliferation, showing the two bands of 
proliferative activity. The first lies just inferior to the articular surface and the second 
superior to the resident hypertrophic chondrocytes. Studies by Archer et al., (1994) 
confirmed that in the marsupial Monodelphis domestica, once a secondary centre of 
ossification begins to develop, growth of the presumptive articular cartilage does indeed 
become increasingly appositional. The tissue, with the exception of the articular surface, is 
renewed at or near the articular surface and is resorbed at the base through endochondral 
ossification during the establishment of the subchondral bone. This process is similar to 
the process that occurs at the epiphyseal growth plate; however it suggests the existence of 
an articular cartilage progenitor, or ‘stem’ cell residing within the articular surface (Archer 
and Francis-West, 1999). 
 
Studies by Hayes et al., (2001) confirmed this notion of appositional growth in the 
development of articular cartilage. Monodelphis domestica knee joints were injected with 
bromodeoxyuridine (BrDU) which blocks chondrocyte proliferation after incorporation 
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into the DNA at S-phase. It was found that the transitional layer of cells usually present 
following normal development was absent, and that the cartilage comprised superficial and 
basal layers only. In addition to this, the expression of many growth factors and receptors 
present at the articular surface suggests the possibility that it represents an important 
signalling centre (Archer, 1994, Hayes et al., 2001). Members of the Notch receptor 
family; a group of cell surface signalling receptors which have the ability to regulate cell 
fate decisions, have been found to reside in the surface of bovine articular cartilage 
(Dowthwaite et al., 2004). This family of receptors is involved in a complex signalling 
pathway that regulates the elongation of the growth plate and ossification. Dowthwaite et 
al., (2004) demonstrated that there is a subpopulation of chondrocytes in the articular 
surface that expresses Notch-1, and that these cells may contain a progenitor population. 
Their work goes on to suggest that Notch-1 signalling functions to control proliferation in 
cartilage, based on work which shows that blocking Notch-1 signalling inhibits the 
formation of colonies by cartilage progenitor cells. The precise mechanisms involved in 
the Notch signalling pathway are yet to be fully established, and further work in this area 
would be fruitful in further understanding the development of articular cartilage.  
 
 
 
 
 
 
 
 
 
 
 
Figure 1.4. Diagram summarising hypothetical cell lineage of articular cartilage.  
 
Progenitor cells in the articular surface divide to give two daughter cells, one being another 
progenitor cell and the second being a transit-amplifying unit cell within the transitional zone. The 
transit-amplifying cell can then undergo further cell divisions along the chondrocyte differentiation 
pathway. [Image and figure legend adapted from Hayes et al., (2001)]. 
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1.4.2. Articular cartilage morphology 
 
The structure of articular cartilage varies with the depth from the surface in terms of 
matrix composition, organisation and mechanical properties, as well as cell morphology 
and function (Buckwalter et al., 1990). This organised structure however can be affected 
and altered by age and pathology. 
 
Articular cartilage has four distinct zones, the size and appearance of which varies between 
species, and in different joints within the same species (Hendren and Beeson, 2009). These 
zones are the superficial tangential zone (approximately 10 – 20% of the cartilage 
thickness), the middle zone (60% of the cartilage thickness), the deep zone (30% of the 
cartilage thickness) and the calcified cartilage zone. The shape and orientation of 
chondrocytes differ within these four regions, as does the content and organisation of 
collagen and other macromolecules. In the superficial zone, the chondrocytes are flattened 
and the collagen content is relatively high; tightly organised in a tangential manner so that 
they are parallel to the joint surface. In the middle and deep zones, the chondrocytes have a 
more spherical appearance, and the collagen content decreases with increasing tissue 
depth. There are no distinct boundaries between the upper three zones with the 
morphological changes occurring gradually and through development. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.5. Normal human articular knee cartilage stained with safranin O/fast green. 
Note the smooth surface, small and flat cells in the tangential zone; intermediate and radial 
zone cells are arranged in columns. The tidemark is intact. [Image and figure legend 
adapted from Lorenz and Richter et al., (2006)]. 
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Superficial zone 
 
The superficial zone is possibly the most important region in articular cartilage and it has 
sparked the most interest within researchers. Studies have shown that the superficial zone 
is centrally involved in the regulation of tissue development and growth and that this 
region plays a major role in the morphogenesis of the synovial joint as a whole (Ward et 
al., 1999). Expression of many growth factors and their receptors in this region suggests 
that the articular surface represents an important signalling centre (Archer et al., 1994, 
Hayes et al., 2001). 
 
Despite the superficial zone being the thinnest zone, the structure and composition gives 
this region specialised mechanical and biological properties. It consists of two layers; an 
acellular layer and a deeper cellular layer of flattened, discoid shaped chondrocytes in a 
collagenous matrix. The chondrocytes arrange themselves so that their major axes are 
parallel to the articular surface. The matrix synthesised by these chondrocytes has a high 
collagen concentration and a low proteoglycan concentration when compared to other 
cartilage matrix zones. There is also an increased fibronectin content in this zone, which 
together with surface zone protein (SZP) and hyaluronic acid (HA), may have a role in 
joint lubrication and protection (Nishida et al., 1995). 
 
The parallel arrangement of collagen fibrils in the superficial zone helps to determine the 
tissues mechanical properties as it provides the region with greater tensile stiffness and 
strength, and provides resistance to shear forces generated through movement and loading. 
The dense collagen network also functions to regulate the movement of molecules in and 
out of the cartilage. Removal of the superficial zone increases tissue permeability and 
increases loading of the deeper zones of the structural framework during compression 
(Setton et al., 1993). As such, it is thought that disruptions and/or alterations in this zone 
may contribute to the development of osteoarthritis (OA) by altering the mechanical 
behaviour of the tissue (Guilak et al., 1994). 
 
 
 
 
13 
 
Middle zone 
 
The middle zone of articular cartilage is sometimes known as the transitional zone as the 
morphology and matrix composition of this region is intermediate between the superficial 
and deep zones. As previously mentioned it comprises approximately 60% of the cartilage 
thickness. The chondrocytes residing in this zone are spheroidal in shape and contain a 
higher concentration of synthetic organelles, endoplasmic reticulum and Golgi complex 
membranes when compared to the superficial zone chondrocytes. There is a higher 
proteoglycan content in this region but lower concentrations of water and collagen when 
compared to the superficial zone matrix. The collagen fibrils in the middle zone have a 
larger diameter relative to the fibrils of the superficial zone (Buckwalter and Hunziker, 
1999).  
 
Deep zone 
 
The deep zone of articular cartilage is a progression from the middle zone, whereby the 
collagen fibril diameter is larger, the proteoglycan content in the ECM is higher and the 
water concentration is at its lowest. The cells remain spheroidal in shape, however they 
tend to arrange themselves into columns perpendicular to the joint surface (figure 1.6). The 
collagen bundles of this zone pass through the tidemark and provide and anchoring system 
between the non-calcified and calcified cartilage regions (Buckwalter and Hunziker, 
1999). 
 
The tidemark is a thin basophilic line that corresponds with the boundary between non 
calcified and calcified cartilage. It behaves as a mineralisation watermark demonstrating 
the advancement of the calcified layer to the articular surface (Havelka and Horn, 1999). 
The nature of this interface remains uncertain however it is of interest as it can be 
duplicated during osteoarthritis, suggesting the involvement of this region in the pathology 
of the disease.   
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Calcified cartilage zone 
 
The calcified cartilage zone is a thin region that separates the non-calcified cartilage from 
the subchondral bone. Within this region the chondrocytes are smaller and rounded, and 
contain lesser amounts of endoplasmic reticulum and Golgi complex membranes, 
indicating a low metabolic state (Morris et al., 2002). The calcified cartilage/subchondral 
bone interface is known as the osteochondral junction.  
 
 
 
Figure 1.6. Diagram showing zonal variation in articular cartilage. 
Articular cartilage is composed of four distinct zones: surface (superficial), middle, 
deep and calcified zones. (Image kindly donated by Dr. Kirsty Richardson). 
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1.4.3. Matrix regions 
 
There are three major compartments through which the ECM can be organised. These are 
the pericellular, the territorial and the interterritorial matrix regions which were first 
described by Meachim and Roy (1967) and Meachim and Stockwell (1973). Together, the 
pericellular and territorial matrices provide protection to the chondrocytes from damage 
during loading and deformation of the tissue by binding the cell membranes to the matrix 
macromolecules. They also have a role in transmitting mechanical signals to the 
chondrocytes following loading. The function of the interterritorial matrix is to provide 
mechanical properties to the tissue (Buckwalter and Hunziker, 1999). 
 
Pericellular matrix 
 
The pericellular compartment is the region of variable width surrounding each 
chondrocyte. It is an area that is rich in proteoglycans synthesised by the chondrocytes 
themselves. The pericellular matrix is free of fibrillar collagens but contains non-
collagenous matrix proteins and non-fibrillar collagens including collagens type VI and IX 
that form a fine meshwork of fibres (Hagiwara et al., 1993, Poole et al., 1992, Wotton et 
al., 1991). The cells membrane is attached to a thin rim of pericellular matrix, and 
cytoplasmic extensions from the cells project into and through this matrix to the territorial 
matrix (Buckwalter and Hunziker, 1999). A word that is commonly used is the ‘chondron’ 
which refers to the chondrocyte with its pericellular matrix, bounded by a capsule of fine 
fibrous material. The chondron forms a functional unit with the ability to absorb loads and 
provide protection for the chondrocyte (Poole et al., 1987). The pericellular matrix is 
adjacent to the territorial domain. 
 
Territorial matrix 
 
The territorial matrix contains a basket like arrangement of collagen fibrils that envelopes 
individual, pairs or even clusters of chondrocytes and their pericellular matrices, making 
them distinct morphologic entities. Thin collagen fibrils of the territorial matrix that are 
adjacent to cells adhere to the pericellular matrix, giving this basket like arrangement. The 
function of this matrix is similar to the pericellular matrix in that it serves as further 
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protection to the chondrocytes. The territorial matrix gives way to the interterritorial 
compartment. A distinct increase in collagen fibril diameter and a transition from the 
basket-like like orientation of collagen fibrils to a more parallel arrangement marks the 
conversion between the territorial and interterritorial matrices (Buckwalter and Hunziker, 
1999).   
 
Interterritorial matrix 
 
This region constitutes the bulk of the extracellular space and can be characterised by a 
marked increase in fibril diameter. In this region, the collagen fibrils are not organised to 
surround the chondrocyte; instead the interterritorial matrix contains two populations, 
namely fibrils and fibril bundles, which are either arranged parallel to the surface forming 
arcade-like structures, or randomly oriented fibres (Buckwalter and Hunziker, 1999). The 
general orientation also varies depending on the location within the articular cartilage. In 
the superficial zone, fibril diameters are smaller and the fibrils generally lie parallel to the 
articular surface. In the transition from the middle to the deep zones, the fibrils convert 
from an oblique orientation (relative to the articular surface) to lying in bundles 
perpendicular to the articular surface. This arrangement of collagen fibres is known as the 
‘Benninghoff arcades’ and was originally described by Benninghoff (1925). 
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Figure 1.7. Diagram showing organisation of the fibrillar components within articular 
cartilage.  
The territorial matrix contains a basketlike arrangement of collagen fibrils and organises 
chondrons into distinct morphological entities. The interterritorial matrix forms the bulk of 
the tissue. (Buckwalter and Hunziker, 1999). 
 
 
1.4.4. Articular cartilage components 
 
The chondrocyte 
 
Chondrocytes are the sole constituent cell residing within normal articular cartilage. As 
such, they are responsible for synthesising major structural components including type II 
collagen, large aggregating proteoglycans and other less abundant proteins. They are also 
accountable for the highly organised ECM in which they are surrounded. Intracellularly, 
chondrocytes demonstrate typical features of a metabolically active cell, and comprise 
organelles such as endoplasmic reticulum and Golgi complexes. Chondrocytes may also 
possess short processes or microvilli; extending from the cell into the matrix, and playing a 
role in sensing mechanical changes in the ECM (Buckwalter and Hunziker, 1999). 
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Chondrocytes differ morphologically based on their orientation within the tissue. Cells 
reside singly at the articular surface, and appear flattened or discoid (Archer and Francis-
West, 2003) when compared to cells in the middle zone which appear more spherical. In 
the deep region near the subchondral bone, chondrocytes are generally organised into 
columns which run perpendicular to the articular surface. As articular cartilage is not 
vascularised, chondrocytes rely on diffusion for nutrient and metabolic exchange. As such, 
this system leaves the chondrocytes with a low oxygen concentration (ranging from 10% 
at the surface to less than 1% in the deep layers) relative to other tissues and, therefore, the 
chondrocytes primarily rely on anaerobic metabolism (Archer and Francis-West, 2003). 
Consequently, chondrocytes usually have relatively low numbers of mitochondria and 
most of the cells energy requirements come from glycolysis (Buckwalter and Hunziker, 
1999).  
 
Despite the low metabolic activity of the chondrocyte, the cells must remain active as 
maintaining the articular surface requires turnover of matrix macromolecules. Joint use 
and biomechanical loading also influence the alteration in the matrix macromolecular 
framework. 
 
Chondrocyte activity and function varies as articular cartilage matures. In immature 
articular cartilage, chondrocytes proliferate rapidly and there is a high cell density as the 
cells produce new tissue to expand and remodel the articular surface. With skeletal 
maturation, the cartilage thickness largely remains unchanged and instead, the 
chondrocytes work to maintain and/or replace degraded matrix macromolecules including 
the collagens, proteoglycans and non-collagenous proteins (Buckwalter, 1995a). 
 
Cell distribution within mature articular cartilage is not uniform, and zoned differences are 
detectable and will be summarised later. One interesting hypothesis which was proposed 
by Stockwell (1975) was that there is a large proportion of chondrocytes at the articular 
surface and within the superficial zone, due to the proximity of the synovial fluid and its 
nutrients.  
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Extra-cellular matrix 
 
The ECM of articular cartilage comprises two main components namely a framework of 
structural macromolecules and mobile, interstitial fluid. Together, these give rise to the 
tissue stability which account for the mechanical properties of the tissue as a whole 
(Buckwalter and Mow, 1992).   
 
Interstitial tissue fluid 
 
The fluid phase of the ECM consists of water and inorganic salts, and makes up between 
70 and 80 % of the tissue wet weight. High concentrations of cations within the fluid 
interact with matrix macromolecules and balance out the negatively charged 
proteoglycans. This interaction is essential in maintaining mechanical properties of 
stiffness and resilience within articular cartilage (Buckwalter and Mow, 1992). There is a 
certain degree of mobility of fluid within the tissue which supplies nutrients to the 
chondrocytes and also aids joint lubrication (Buckwalter et al., 1990).  
 
1.4.5. Structural macromolecules 
 
Within articular cartilage the three classes of macromolecules; namely collagens, 
proteoglycans and non-collagenous proteins, together contribute to 20 to 40% of the 
overall tissue wet weight (Buckwalter et al., 1990). These are synthesised by chondrocytes 
from amino acids and sugar. The collagens provide a fibrillar frame in which the 
proteoglycans and non-collagenous proteins bind; and the interstitial fluid fills the 
molecular framework. The concentration of the macromolecules differs throughout the 
cartilage, as does their contribution to the tissue properties.  
 
1.4.5.1. Collagens 
 
The collagen network gives cartilage its form and tensile strength (Buckwalter and Mow, 
1992), and accounts for approximately two-thirds of the dry weight of mature articular 
cartilage. Specifically, the collagens found in articular cartilage include types I, II, III, V, 
VI, IX, X, XI, XII and XIV, however the ratios of these macromolecules shift as the 
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cartilage develops. In mature cartilage, type II is the most abundant and accounts for 90% 
of the total collagen (Eyre et al., 1987). 
 
Type I collagen 
 
Type I collagen, a heterotrimer comprising two α1(I) chains and an α2(I) chain (Benya et 
al., 1978), is a fibrillar collagen that is present at the onset of chondrogenesis early in 
development (von der Mark et al., 1976). It is also present at the articular surface during 
development and in repair tissues. At the growth plate during endochondral ossification, 
type II collagen is replaced by type I collagen, which is secreted within the lacunae of 
hypertrophic chondrocytes (Leboy et al., 1988). In bone, type I collagen is reinforced with 
calcium hydroxyapatite providing tensile strength (Ayad et al., 1998).  
 
Type II collagen 
 
As mentioned, type II collagen is the principal articular cartilage collagen. It is a fibril 
forming collagen synthesised as a homotrimer; consisting of 3 identical polypeptide α1(II) 
chains that exists in two variants, IIA and IIB due to differential splicing (Ryan and 
Sandell, 1990). The two variants show differential distributions during development; with 
type IIA mRNA being expressed by perichondral cells and prechondrocytes, and type IIB 
mRNA expression in overt chondrocytes (Sandell et al., 1991). The type II collagen α 
chains are synthesised as procollagens, with non collagenous N- and C- propeptides. 
Through extracellular processing, proteinases cleave these terminal extensions and 
produce mature triple helices. Striated fibrils are assembled as a result of quarter 
staggering of individual molecules (Eyre, 1991). Type II collagen supports chondrocyte 
adhesion by binding through its helical domain with specific cell surface integrins 
(Holmvall et al., 1995). Integrins mediate the attachment of chondrocytes to the 
surrounding ECM macromolecules increasing the tissue integrity (Ruoslahti, 1991). 
 
Type III collagen 
 
Type III collagen, another fibrillar collagen is a minor collagenous component of articular 
cartilage. It is primarily associated with type I collagen, and the interaction between these 
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two collagens are thought to regulate fibril formation and fibril growth (Duance et al., 
1999). Cross linking studies have also revealed that type III collagen co-localises with type 
II collagen as a minor, but regular component. The exact function of type III collagen in 
cartilage remains unknown; however there is speculation that it is synthesised by 
chondrocytes in response to matrix damage, perhaps as part of a remodelling process (Eyre 
et al., 2006).  
 
Type V collagen 
 
The importance of type V collagen in articular cartilage has not been extensively studied, 
however it is thought to be synthesised in small amounts. There is a high homology 
between type V and type XI collagen and, as such, there is evidence to suggest that there 
hybrid molecules exist (Duance et al., 1999). In several tissues, type V collagen appears to 
co-polymerise with type I collagen, where it may act to control fibril diameter (Birk et al., 
1988). As type V collagen is also found in the meniscus, joint capsule and subchondral 
bone, it has been suggested that this collagen may have significant involvement on the 
normal functioning of the joint (Duance et al., 1999). 
 
Type VI collagen  
 
Type VI collagen is a microfibrillar collagen synthesised as a heterotrimer of three distinct 
chains (Timpl and Engel, 1987). Type VI collagen is preferentially located to the 
pericellular chondron of chondrocytes, where the microfibrils are stabilised by interaction 
with hyaluronan (Kielty et al., 1992). This collagen has also been shown to bind to the 
surface of many cells including chondrocytes (Marcelino and McDevitt, 1995). In 
osteoarthritis, increased type VI collagen expression has led to suggestions that it may 
have an involvement in tissue repair (Arican et al., 1996, Chang and Poole, 1996).  
 
Type IX collagen 
 
Type IX collagen is a cartilage specific fibril-associated collagen with an interrupted triple 
helix (FACIT). It is a heterotrimeric molecule comprised three different chains [α1(IX) 
α2(IX) α3(IX)], each consisting of three collagenous triple-helical domains (COL1-3) 
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separated by four non-collagenous domains (NC1-4) (figure 1.8). Unlike the fibrillar 
collagens, type IX collagen undergoes no processing before depositing into the ECM. In 
some cases, the α2(IX) chain contains an attachment site for chondroitin-sulphate at the 
non-collagenous region NC3 domain. As a result, type IX collagen is often described as 
both a collagen and a proteoglycan (Eyre et al., 1987, van der Rest and Mayne, 1988). 
Type IX collagen is always found in co-existence with type II collagen through covalent 
links, and it has been shown to modulate fibril formation by preventing close parallel 
alignment of the collagen type II fibrils (Wotton et al., 1988). The type IX collagen chains 
contain intermolecular cross-linking sites between type IX and type II collagen, or simply 
between type IX molecules (Eyre et al., 2004). The linkages formed contribute to the 
overall stability of the fibril network and help to resist the swelling pressure of the 
proteoglycans. In mammalian articular cartilage, amounts of type IX collagen decrease in 
relation to type II collagen with increasing cartilage maturity. It makes up approximately 
10% of the collagenous content of foetal mammalian articular cartilage, and 1% in adults 
(Eyre, 1991). This has lead to postulations that type IX collagen contributes to the growth 
and fibre diameter of type II collagen.  
 
Type X collagen 
 
Type X collagen is a short-chain non-fibrillar homotrimer consisting of three α1(X) chains, 
with a short non-helical amino terminus, a single triple-helical domain and a globular C-
terminal domain (Eyre, 1991). It is a cartilage specific collagen that is involved in 
localised regulation; the protein is highly restricted to ECM in the hypertrophic zone 
following synthesis by terminally differentiating chondrocytes (Schmid and Linsenmayer, 
1985). It is thought that the function of type X collagen is to facilitate the process of 
calcification possibly through changes in the matrix organisation (Kwan et al., 1991).Due 
to the localised production of type X collagen in the matrix of hypertrophic chondrocytes 
at the growth plate, it is believed that it is of major importance in endochondral 
ossification. In mature hypertrophic chondrocytes, type X collagen constitutes 45% of the 
total collagen and is therefore often used as a marker for this type of cell (reviewed by 
Shen, 2005). 
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Type XI collagen 
 
This collagen type, together with collagen type II and IX, forms a heteropolymer by 
covalent interactions that result in a fibrillar matrix that gives rise to mechanical stability 
(Mendler et al., 1989). Collagen type XI itself is synthesised as a heterotrimeric 
procollagen comprising three distinct proα1-3(XI) chains. It contains two collagenous 
domains (COL1-2) and three non-collagenous domains (NC1-3). Glycosylation of the 
triple helix creates a bulkier molecule that alters intermolecular spacing in the fibril. 
Alternative splicing of the N-terminal domains may influence interactions between other 
matrix molecules, resulting in fibrils to be stabilised at certain diameters (Duance et al., 
1999). Type XI collagen also interacts with proteoglycans and the chondrocytes 
themselves, suggesting a direct involvement in cell-matrix interactions (Vaughan-Thomas 
et al., 2001).  
 
Type XII and type XIV collagens 
 
These collagens are members of the FACIT family, and are minor collagenous 
components of articular cartilage. Their functions are unknown, however both molecules 
form close associations with type I collagen. Despite being unable to form fibrils and do 
not affect fibril diameter, it has been suggested that they may “bridge adjacent fibrils or be 
involved in mediating matrix deformability through interaction of their NC3 domains with 
other tissue components (Duance et al., 1999). 
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Figure 1.8. Schematic representation of the major collagen types present in articular 
cartilage. 
A). Heterotypic fibril consisting of types: II, IX and XI collagen. B). Type IX collagen. C). 
Type XI collagen. (Image taken from Duance et al., (1999)]. 
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1.4.5.2. Proteoglycans 
 
Proteoglycans are ubiquitous components of the ECM, and are integral, key components 
underlying many interactions within the cartilage matrix. They are a diverse family of 
molecules comprising a core protein component to which one or more glycosaminoglycans 
(GAGs) covalently attach, giving them an extremely high negative charge. The anionic 
proteoglycans form domains with high osmotic pressure which have the ability to take in 
large amounts of water creating a high swelling pressure. Tension is created by collagen 
fibres resisting this swelling, and application of any load to the tissue simply leads to 
temporary minor deformations (Heinegard and Oldberg, 2002). GAGs are unbranched 
polysaccharide chains, with repeating disaccharide units containing a hexuronic acid and a 
hexosamine that is usually sulphated. It is through the negative charge on the carboxyl and 
sulphate groups that the GAGs gain their poly-anionic properties (Heinegard and Oldberg, 
2002). The GAGs found within articular cartilage are hyaluronon (HA), chondroitin 
sulphate (CS), keratan sulphate (KS), dermatan sulphate (DS) and heparan sulphate (HS).  
 
There are two major classes of proteoglycans within articular cartilage; namely large 
aggregating proteoglycans such as aggrecan and versican, and small, non-aggregating 
proteoglycans such as decorin and biglycan. The large aggregating proteoglycans have a 
high affinity for other matrix components leading to the formation of stable structures. The 
small proteoglycans can exist independently within the ECM.   
 
Hyaluronic acid (HA) 
 
Hyaluronic acid is a nonsulphated GAG that is composed of repeating disaccharide units 
of D-glucuronic acid linked to N-acetly-D-glucosamine which form large, negatively 
charged molecules (Rapport et al., 1951). It is an integral component of articular cartilage 
ECM and forms very large molecular aggregates due to its interactions with aggrecan and 
link protein. Cellular interactions between chondrocytes and HA also play an important 
role in organising the tissue and retaining the matrix PG-aggregants within the articular 
cartilage (Ishida et al., 1997). Early in development, HA plays a role in joint cavitation at 
diarthrodial joints, at the site of initial separation whilst also maintaining a regulatory role 
of movement (Pitsillides, 1999).  
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CD44 is a family of surface molecules expressed on many cell types including 
chondrocytes and it is the principal receptor for HA, implicated in many cellular functions 
such as mediating cell migration. Synthesis of HA is in part regulated by the TGF-β family 
of polypeptide growth factors and mis-regulation of CD44 can contribute to a number of 
disease pathologies (Isacke, 1994, Ishida et al., 1997).  
 
Large aggregating proteoglycans 
 
Aggrecan 
 
Aggrecan is one of the major structural proteins of articular cartilage. It has a protein core 
of approximately 250kD and has between 100-150 CS chains and 60 KS chains (Kreis and 
Vale, 1999). The molecule is important due to its interaction with HA and link protein, 
which allow the formation of large, charged aggregates required for normal cartilage 
function (Holmes et al., 1988). It is believed that chondrocytes actively metabolise 
aggrecan throughout the lifetime of the tissue (Hascall et al., 1999). 
 
Figure 1.9. Schematic representation of aggrecan aggregate. 
Diagram of proteoglycan aggregate comprising aggrecan, HA and link protein. (Image 
kindly donated by Dr. Kirsty Richardson). 
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Versican 
 
Versican is another member of the large aggregating proteoglycans which is found 
transitorily within prechondrogenic condensations. As the cartilage develops, versican is 
removed and substituted with aggrecan (Hall and Miyake, 1995). 
 
Small proteoglycans 
 
Biglycan and decorin 
 
Biglycan and decorin are members of the small leucine-rich proteoglycan family (SLRPs) 
consisting of a small 38kD leucine-rich protein core containing CS or DS chains. They 
account for only a small percentage of the ECM of articular cartilage. Biglycan contains 
two extended CS or DS chains whereas decorin has only a single CS or DS chain (Kreis 
and Vale, 1999). The functioning of the molecules is dependent on both the core protein 
and the GAG chains. The core proteins allow the molecules to interact with fibrillar 
collagens and in doing so, help to regulate fibril formation and ECM interactions. It is also 
evident that these SLRPs limit the access of collagenases to their cleavage sites on 
collagen molecules, protecting the fibrils from proteolytic damage. Biglycan and decorin 
have also been reported to interact with other macromolecules in modulating chondrocyte 
metabolism and regulation (Roughley, 2006). 
 
Surface zone protein 
 
Surface zone protein (SZP) is a proteoglycan that has been identified more recently to have 
an involvement in articular cartilage (Schumacher et al., 1994). It has been shown that SZP 
is widely distributed during development, however in the adult it is only synthesised by 
chondrocytes residing in the surface zone of articular cartilage (Flannery et al., 1999a). 
SZP has been classified as a unique proteoglycan based on its distinctive biochemical 
properties. It is thought that SZP is not retained in the ECM as it is also present in the 
synovial fluid. This has led to suggestions that it may be secreted by the superficial zone 
chondrocytes into the synovial fluid rather than being retained in the ECM like other 
proteoglycans. Another interesting factor is that its molecular weight is not altered 
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substantially following the removal of its GAG chains, indicating that it may only have 
few GAG chains on its core protein (Jay et al., 2001). Although the precise function of 
SZP is unknown, the structural composition of the protein allows for cell proliferation, 
cytoprotection and self-aggregation; attributes that are crucial for maintaining the articular 
surface during joint articulation (Flannery et al., 1999a). Furthermore, SZP is known to 
share sequence homology with lubricin, a proteoglycan involved in protecting the articular 
surface and aid in lubrication of the joint further suggesting its role in maintaining articular 
cartilage integrity during movement (Rhee et al., 2005).  
 
Non-collagenous proteins and glycoproteins 
 
In addition to collagens and proteoglycans, articular cartilage also contains a range of non-
collagenous matrix proteins, some of which are specific for the tissue and some with a 
more ubiquitous distribution among connective tissues (Heinegard and Oldberg, 1989). As 
a whole, they consist primarily of protein, and have a few monosaccharides and 
oligosaccharides attached (Heinegard et al., 1995). Specific functions of these matrix 
macromolecules have been poorly studied, however it is believed that they are involved in 
matrix organisation, maintenance and cell-matrix interactions (Neame et al., 1999). 
 
Fibronectin 
 
Fibronectin is a glycoprotein of the ECM that binds to integrins and other matrix 
components. The protein has a major role in cell adhesion and is also involved in cell 
attachment, migration during embryonic development and wound healing, and the 
regulation of cell growth, differentiation and homeostasis (Pierschbacher and Ruoslahti, 
1984). Fibronectin is also involved in cell signalling pathways via α5β1 integrin-mediated 
pathways (Burton-Wurster et al., 1997, Homandberg et al., 2002). In articular cartilage, 
fibronectin is synthesised by chondrocytes as a very minor constituent of the ECM 
(Heinegard and Oldberg, 1989), however it is also present in the synovial fluid at low 
concentrations. During disease, production of fibronectin is elevated by both chondrocytes 
and synoviocytes (Burton-Wurster et al., 1997). 
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Tenascin 
 
Tenascin comprises a family of large ECM glycoproteins including tenascin-C, -X and –R. 
Tenascin-C contains a series of structural domains homologous to those of other proteins 
including fibronectin, however unlike fibronectin, tenascin-C possesses anti-adhesion and 
anti-spreading properties as well as the pro-adhesive effects (Chiquet-Ehrismann et al., 
1988, Spring et al., 1989). Tenascin-C is involved in embryonic development where it is 
present in mesenchymal condensations, cartilage and bone (Erickson and Bourdon, 1989). 
Studies by Mackie et al., (1987) found that as mesenchymal cells differentiate, tenascin-C 
becomes detectable only in the perichondrium and undifferentiated chondrocytes. They 
also found that tenascin-C stimulated chondrogenic cell differentiation, probably via its 
ability to inhibit cell attachment and favouring a round cell shape. Further studies by other 
authors have revealed that tenascin-C resides within the pericellular matrix of cartilage 
where it functions by interacting with integrins and cell surface receptors such as 
syndecans (Salmivirta et al., 1991). In adult articular cartilage, tenascin-C expression is 
low and is confined to the surface zone and perichondrium (Chevalier et al., 1994, Salter, 
1993). This is interesting as tenascin-C is not present in non-articular hyaline cartilage, 
leading to speculation that this glycoprotein may be involved in the load bearing properties 
of articular cartilage (Archer et al., 1990). Similar to fibronectin, expression of tenascin-C 
is elevated in diseased or damaged joints, yet the mechanisms of it involvement in disease 
remain to be fully elucidated (Salter, 1993).  
 
Cartilage oligomeric matrix protein (COMP) 
 
COMP is a cartilage specific acidic protein that is concentrated primarily within the 
chondrocyte territorial matrix. Although its functions are not fully understood, it is thought 
to be involved in cell adhesion via chondrocyte-matrix attachments (Hedbom et al., 1992). 
There has also been a suggestion that COMP may have a value as a marker of cartilage 
turnover and of the progression of cartilage degeneration in patients with osteoarthritis 
(Lohmander et al., 1994, Saxne and Heinegard, 1992, Sharif et al., 1995b). 
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1.4.6. Cartilage matrix turnover 
 
Chondrocytes are ultimately the sole cell type responsible for the tissue homeostasis of 
normal articular cartilage. In the words of Hascall et al., (1999) “a chondrocyte in a normal 
matrix operates to maintain its matrix”. This includes synthetic and catabolic events of 
matrix components as well as the incorporation and organisation of these components into 
the matrix.  
 
1.4.6.1. Proteoglycans 
 
Aggrecan, as previously outlined, is the major proteoglycan in the cartilage matrix that is 
metabolised throughout the lifetime of the tissue (Hascall et al., 1999). Its synthesis 
involves transcription and translation of mRNA, resulting in a protein core to which GAG 
chains are substituted post translationally. These molecules are released into the ECM 
where they form aggregates with HA (stabilised by the link protein). The HA is 
synthesised separately at the plasma membrane. Through a phenomenon known as delayed 
aggregation, secreted proteoglycans are able to first move away from the chondrocyte 
before forming aggregates. This occurs due to the G1 domain of the proteoglycan not 
being fully functional on secretion, and allows for the highly organised structure to be 
ordered appropriately (Bayliss and Roughley, 1985).  
 
The catabolic mechanisms of aggrecan differ from that of the smaller proteoglycans; 
reflecting the distinctly different organisations of the two classes of proteoglycans. Having 
stated that, the key family of enzymes involved in the breakdown of proteoglycans are 
proteinases that are synthesised by the chondrocytes themselves. Matrix 
metalloproteinases (MMPs) are considered to be the main enzymes responsible for 
degradation of aggrecan (and collagens) in cartilage. The mechanisms of proteoglycan 
degradation are finely orchestrated in order to retain a precise balance between synthesis 
and degradation, as elevated levels of MMPs and increased degradation are factors which 
are thought to be instrumental in the development of pathology, including osteoarthritis 
(OA) and rheumatoid arthritis (RA) (Tetlow et al., 2001). 
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Ratcliffe et al., (1988) demonstrated that the major proteolytic cleavage site on aggrecan is 
between the G1 and G2 domains at the Glu373-Ala374 bond, by aggrecanases. Since the 
discovery, aggrecanase-1 and -2 have been designated as ADAMTS-4 and -5 respectively 
as they fall into the family of zinc metalloproteinases whose structure is homologous to the 
ADAMTS (a disintegrin and metalloproteinase domain with thrombospondin motifs) gene 
family (Tang, 2001). It has been shown that ADAMTS-1 also exhibits aggrecanase activity 
in cartilage (Flannery et al., 1999b). 
 
In order to regulate the fine balance of matrix degradation, tissue inhibitors of 
metalloproteinases (TIMP) are also produced locally by the chondrocytes to inhibit MMP 
activity. Specifically, TIMP-3 is a potent inhibitor of ADAMTS-4 and ADAMTS-5 and is 
therefore beneficial for protecting cartilage from degradation (Hashimoto et al., 2001, 
Kashiwagi et al., 2001).  
 
1.4.6.2. Collagen 
 
The family of collagens to date is comprised of 28 distinct molecular types produced by 
one or more genes. They are synthesised by transcription of specific mRNA’s and then 
translated into α chains containing signal peptides, collagenous and non-collagenous 
domains. There are modifications of the procollagen polypeptide in the endoplasmic 
reticulum, including hydroxylation, glycosylation and disulphide bond formation. 
Interchain disulphide bonds between the carboxyl terminal propeptides align the chains 
and initiate the formation of the triple helix. The procollagen molecules then pass into the 
Golgi complex and are then secreted into the ECM in their proforms where they are 
processed by enzymes outside of the cell. The collagen molecules then aggregate into 
collagen fibrils through the formation of covalent cross links. The precise sequence 
ensures the incorporation of the collagens in the ECM in quarter staggered arrays. The 
aggregation of collagen fibrils through intrafibrillar crosslinks is known as fibrillogenesis 
(Alberts et al., 2002). 
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Figure 1.10. Schematic presentation of intra- and extracellular events in the formation of a 
collagen fibril. 
(A) Collagen fibrils are shown assembling in the extracellular space contained within a 
large infolding in the plasma membrane. Here they are shown further assembling into large 
collagen fibres in the extracellular space. Covalent cross-links that stabilize the 
extracellular assemblies are not shown. (B) Electron micrograph of a negatively stained 
collagen fibril reveals its typical striated appearance. [Image and figure legend taken from 
Alberts et al., (2002)].  
 
In adult tissue the turnover of collagen is controlled at a very slow rate (a process that can 
be dramatically accelerated following injury). Observations based on the synthetic rate of 
hydroxyproline have led to an estimated turnover time of 400 years for human femoral 
head cartilage (Maroudas, 1979), however, it has also been suggested that there is a 
possibility that a subfraction of the collagenous matrix is remodelled more rapidly in 
response to mechanical and molecular signals (Eyre, 2002). 
 
In terms of degradation, collagens have a higher resistance when compared to the 
proteoglycans due to their tightly arranged fibrils and their interactions with glycoproteins. 
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According to Eyre et al, (2002) “the classical concept of collagen fibril degradation is 
through an initial cleavage of the collagen (type I, II or III) by collagenase into three-
quarter and one-quarter length fragments”. Collagenase -3 (MMP13), expressed by the 
chondrocytes, is the most active in cleaving type II collagen (Dahlberg et al., 2000). 
Having stated that an essential role for collagenases in all forms of collagen breakdown 
and turnover has become less certain following experiments using genetically engineered 
mice lacking a functional cleavage sequence, in which no abnormal phenotype was evident 
at birth and only mild skin and uterine abnormalities developed after birth (Krane et al., 
1996). 
 
1.4.7. Chondrocyte-matrix interactions 
 
The reciprocal relationship and interdependence of chondrocytes and the ECM ensures 
that the articular cartilage is maintained throughout life. The chondrocytes synthesise the 
matrix which in return provides protection to the chondrocytes from mechanical damage 
during joint use. “Nutrients, substrates for synthesis of matrix molecules, newly 
synthesised molecules, degraded matrix molecules, metabolic waste products and 
molecules that help regulate cell function, like cytokines and growth factors, all pass 
through the matrix, and in some instances may be stored in the matrix” (Buckwalter and 
Mankin, 1998). 
 
The cells are able to bind to the matrix macromolecules through specialised cell surface 
receptors including integrins, providing a means of transmitting signals between the two 
(Loeser, 2000). The exact mechanisms involved in controlling the activities between the 
chondrocytes and the ECM have not been fully elucidated, however it is thought that 
cytokines play important roles (Lotz et al., 1995). A few examples include i) interleukin-1 
(IL-1) as it induces the expression of MMPs resulting in degradation of matrix molecules, 
ii) transforming growth factor-β (tgf-β) that opposes these catabolic activities by 
stimulating matrix synthesis and iii) basic fibroblast growth factor (bFGF) which acts as a 
powerful mitogen. It is thought that the anabolic activities are responses to certain 
structural needs of the matrix, whereas the catabolic activities are the result of “complex 
cascades that includes the activation or inhibition of IL-1, stromelysin, aggrecanase, 
plasmin and collagenase” by several macromolecules (Buckwalter and Mankin, 1998). 
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The ECM also acts as a mechanical signal transducer for the chondrocytes acting through a 
positive feedback mechanism. The matrix can transmit signals that result from mechanical 
loading to the chondrocytes, which as a result, respond to these signals by altering the 
matrix. Studies have demonstrated cyclic loading of the articular surface induces matrix 
synthesis whilst static loading causes matrix degradation (Quinn et al., 1998). Similarly, 
persistent abnormal decreases in joint loading decreases the proteoglycan content in 
articular cartilage consequently altering the mechanical properties of the cartilage 
(Buckwalter, 1995a). Following on from these studies it was found that resumption of 
normal joint use restored the composition and mechanical properties of the matrix, leading 
to the conclusion that “articular cartilage requires a minimum level of loading and motion 
of the joint”(Buckwalter, 1995b). 
 
Upon mechanical loading, the resultant deformation of the matrix triggers physiochemical, 
mechanical and electrical signals that subsequently have roles in stimulating chondrocytic 
responses, whilst also altering or accelerating the flow of nutrients and metabolites 
throughout the ECM. As summarised by Buckwalter and Mankin (1998), “loading may 
also cause persistent changes in the molecular organisation of the matrix, altering the 
response of the chondrocytes to subsequent loading. Thus, the matrix may not only 
transduce and transmit signals, it may record the loading history of the tissue and alter the 
response of the cells on the basis of the loading history.” 
 
1.4.8. Integrins and receptors in cartilage matrix 
 
Integrins are heterodimeric transmembrane glycoproteins that consist of α and β subunits, 
that act as cell surface receptors when attached to specific ECM components. Integrins 
have unique specificities that arise due to varying combinations of α and β subunits. There 
are over 20 known specific receptor combinations although the potential for further 
combinations are great. Integrins are widely distributed throughout the ECM, and are 
essential for many functions including cell adhesion, migration, signal transduction, 
mechanotransduction and matrix assembly. Through these cellular actions, integrins are 
involved in many biological responses including cell differentiation and proliferation, 
tissue organisation and immune response (Hynes, 1992). They recognise and bind their 
ligands by specialised cell attachment sites. Although many integrins have been reported 
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in articular cartilage (including α1β1, α3β1, α5β1, α10β1, αvβ3, and αvβ5) (Ostergaard et 
al., 1998, Salter et al., 1992), the expression of the α5β1 integrin has been found to be 
relatively high in relation to the others (Durr et al., 1993, Salter et al., 1995). This integrin 
functions largely as a fibronectin receptor involved in the adhesion and spreading of 
chondrocytes, as well as a major mechanoreceptor in the articular chondrocytes (Enomoto-
Iwamoto et al., 1997, Ramage et al., 2009).  
 
Annexin V, from the annexin family of matrix binding proteins has also been identified on 
the surface of chondrocytes (Mollenhauer et al., 1999). In cartilage it is believed to bind 
chondrocytes to type II and type X collagen by binding phospholipids in a calcium 
dependent manner (von der Mark and Mollenhauer, 1997). More recently, it has also been 
suggested that annexin V may also have a role in regulating chondrocyte metabolism (Reid 
et al., 2000). 
 
CD44 is a transmembrane protein expressed by chondrocytes that serves as a hyaluronan 
receptor in articular cartilage. Binding of CD44 to hyaluronan regulates matrix assembly 
and retains proteoglycan aggregates in the chondrocyte pericellular matrix (Knudson, 
1993). CD44 exists in a number of molecular weight isoforms; the extracellular domain 
and can be glycosylated or have CS or HS chains attached (Naot et al., 1997), whilst the 
cytoplasmic domain is involved in the regulation of ligand binding affinity (Isacke, 1994). 
 
1.5. Degradation of articular cartilage  
 
In healthy articular cartilage, despite the relatively low metabolic rate as a result of low 
cell density, there is a tightly regulated balance between synthesis and degradation. If 
disturbed however, the tissue lacks the ability to actively respond to damage, and is 
therefore hindered by its limited repair response (Bora and Miller, 1987). In 1743, Hunter 
stated that “an ulcerated cartilage is universally allowed to be a very troublesome disease 
and when destroyed, it is never recovered” (Hunter, 1743). Since then, despite numerous 
studies and strategies developed to combat the problem, this paradigm has not yet been 
disproved.  
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Damaged articular cartilage results either from trauma or injury, or from degeneration due 
to osteoarthritis; a degenerative disease of the joint which affects the cartilage, bone and 
surrounding tissues. These, however, are not isolated cases as cartilage damaged by trauma 
will quite often display early onset of osteoarthritis (OA). 
 
Lesions as a result of injury can occur in people of all ages and can be classified into focal 
or large lesions; depending on size, or depth of the defects. However, ultimately, 
regardless of the size of the defect there is evidence clinically to suggest that when left 
untreated, lesions may develop into symptomatic joint degeneration (Buckwalter and 
Lohmander, 1994). Partial thickness defects are incapable of healing spontaneously and it 
has been suggested this is because they do not penetrate to the subchondral bone and, 
therefore, do not have access to progenitor cells within the bone marrow space (Redman et 
al., 2005). In full-thickness defects, the lesion passes through the tidemark to the calcified 
cartilage and penetrates the subchondral bone, allowing access to the bone marrow 
constituents. Compared with the partial-thickness defects, there is a more extensive repair 
response triggered by this type of defect, commonly resulting in the formation of a 
fibrocartilagenous tissue that does not integrate well with the native tissue, and that forms 
a poor substitute for the original hyaline cartilage (Shapiro et al., 1993). Despite the poor 
reparative response, the knowledge that there appears to be some repair mechanism has 
resulted in the development of many operative procedures based on this idea (Redman et 
al., 2005).  
 
1.6. Osteoarthritis 
 
Osteoarthritis is a multifactoral joint disease through which progressive remodelling and 
degeneration occurs in articular cartilage and surrounding tissues (Wieland et al., 2005). It 
is the most common form of arthritis in the elderly and a major cause of pain, disability 
and dependence due to joint contractures, muscle atrophy and limb deformity (Buckwalter 
and Mankin, 1997). It was believed for many years the changes seen early in OA were age 
related, however it is now accepted that age is not the sole contributor to the development 
of the disease. Onset of OA may occur as a result of trauma or injury to the joint, 
subsequent to infection, as a result of aging or genetic disposition (Mobasheri et al., 2009). 
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According to Martel-Pelletier (2010), the joints most commonly affected by OA are in the 
thumb and fingers, hips, and knees; although the neck and the lower back are also affected.  
 
OA is commonly characterised by the loss of articular cartilage, accompanied by 
attempted repair of articular cartilage, remodelling and sclerosis of the subchondral bone, 
and osteophyte formation (Buckwalter and Martin, 2006), however the disease is more 
widespread and also affects the meniscus and synovial membrane. It results from a 
breakdown in homeostasis due to “mechanical, biological, biochemical, molecular and 
enzymatic feedback loops” (Martel-Pelletier and Pelletier, 2010). The exact etiology of the 
disease is yet to be fully understood due to the nature of the disease, and as such, the 
progressive course of joint degeneration remains to be understood. In order to achieve a 
greater understanding, studies have been carried out on patients with OA however these 
studies are inherently hindered from the start for several reasons; a) once a patient seeks 
medical attention, the disease has passed the early stages and therefore doctors are often 
faced with late stage OA and early changes cannot be assessed, b) patients have different 
pain thresholds and so present to the doctor at different stages of the disease, and c) the 
course of the disease is not consistent between patients. As a result, many animal models 
have been developed in order to elucidate the course of OA, especially in the early stages. 
However, as with many animal models the findings are not always directly transferrable to 
the course of OA in humans (reviewed by Lorenz and Richter, 2006) .  
 
1.6.1. Morphological and clinical signs of OA 
 
Morphologically, articular cartilage displays discolouration and softening as it transforms 
from a firm, shiny white healthy cartilage to a dull, irregular off-white colour in OA 
(Matyas et al., 1999). The extent of damage is highly variable between patients, joints and 
even within a joint, due to different loading conditions within distinct regions.  
 
Clinical signs of OA include joint space narrowing, the formation of osteophytes, changes 
to the subchondral bone including sclerosis and fibrillation of the cartilage. These are 
detected through x-rays, magnetic resonance imaging (MRI) and arthroscopically.    
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1.6.2. Pathophysiology of OA 
 
As chondrocytes are the sole cellular component of articular cartilage, research often 
focuses on the role of the chondrocyte and changes in the cartilaginous compartment of the 
joint when looking into the pathogenesis of OA. As a result, much more is known about 
the changes that occur in the cartilage compared to the changes in the surrounding tissues. 
 
1.6.3. Cartilage changes in OA 
 
Progressive loss of the structure and function of articular cartilage is one of the typical 
features of OA. The progression of the disease can be divided into three overlapping 
stages. At the beginning, an imbalance between anabolic and catabolic processes leads to 
the overexpression of matrix degrading enzymes, consequentially resulting in a loss of 
collagen and proteoglycans from the matrix. This stage is also coupled with an increase in 
water content due to an increase in permeability, resulting in a reduction to the stiffness of 
the ECM (Martin and Buckwalter, 2002). In the second stage, chondrocytes proliferate and 
synthesise augmented levels of matrix molecules in an attempt to compensate for the 
damage, however enzymes and cytokines capable of degrading matrix macromolecules are 
also produced; further increasing the overall degradation. Cell clusters are formed as a 
result of chondrocyte proliferation, and a repair tissue of newly formed matrix is 
sometimes apparent. In the third stage, the reparative attempts are outweighed by 
degradation and the tissue lacks the ability to restore itself. There is a decline in 
chondrocytic anabolic and proliferative responses, concurrent with a progressive loss of 
articular cartilage (Lorenz and Richter, 2006). The end stage of the disease is reached 
when there is a complete loss of articular cartilage, and the joint consists of articulating 
surfaces of thickened subchondral bone.   
 
1.6.4. Histological changes in OA 
 
A recent review by Lorenz and Richter (2006) has outlined the histological changes in OA 
as summarised below. 
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In the early stages of OA changes to the cartilage surface are usually seen, as it changes 
from a smooth surface to an irregular one as a result of mild fibrillations in the superficial 
zone (McDevitt et al., 1977). As the disease progresses, cellular structure is altered and a 
loss of proteoglycans is evident (Fernandes et al., 1998). The discoid cells of the 
superficial zone become round and hypertrophic, before disappearing from the tissue and 
chondrocyte clusters with large nuclei become evident in the tangential zone.  
 
In more advanced stages of OA, the cartilage surface is broken by large fissures which 
sometimes extend into the calcified zone (Pfander et al., 1999). Chondrocyte clusters are 
especially apparent around fissures and the organisation of the cartilage becomes 
completely disordered. The hyaline cartilage is replaced by a repair tissue resembling 
fibrocartilage, with fibroblast like cells (Miosge et al., 2004); and in some cases pannus 
overlays the cartilage (Shibakawa et al., 2003). Proteoglycan loss extends into the deep 
zone if not lost completely and the tissue shows signs of complete breakdown, where the 
bone becomes totally denuded of cartilage.  
 
1.6.5. Molecular changes in OA 
 
Changes can be assessed by various methods including immunohistochemical analysis, 
biochemical analysis as well as gene expression analysis; all of which help in gaining a 
greater understanding of the progressive changes seen in OA. Having said that the patterns 
seen through the different methods are similar and agreeable to one another. 
 
1.6.6. Collagen changes in OA 
 
During OA when cartilage metabolism is increased, type II collagen expression is 
increased in the deep zone and decreased in the upper cartilage regions (Pfander et al., 
1999, Young et al., 2005). As OA progresses, type II collagen staining becomes apparent 
in the region of chondrocyte clusters, fibrillations and clefts (Miosge et al., 2004, Pfander 
et al., 1999). Collagen type I expression is known to be upregulated in OA, especially in 
the superficial zone where collagen type II is reduced (Pfander et al., 1999). Osteophytes, a 
common feature of OA also mainly consist of collagen type I, with an outer layer of 
collagen type III (Nerlich et al., 1993). Immunohistological labelling for collagen type VI 
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revealed an increase in the middle, mildly damaged cartilage regions, whilst the upper, 
more affected regions showed a loss of collagen type VI staining, concurrent with the 
reduced proteoglycan labelling (Hambach et al., 1998). Collagen type X expression is also 
altered in OA, as irregular distributions indicate a shift towards a hypertrophic phenotype. 
Type X collagen is seen predominantly around chondrocyte clusters, and in the deep 
regions of osteoarthritic cartilage (Boos et al., 1999, von der Mark et al., 1992). 
Disruptions to the minor collagens IX and XI that function to stabilise the collagen-fibril 
meshwork also lead to the weaker matrix seen in OA cartilage (Muir, 1986). Interestingly, 
the overall content of collagen remains unchanged (Appleyard et al., 2003), however, the 
ratios of collagens changes highlighting the altered balance between synthesis and 
degradation. A table summarising these changes through immunohistochemistry can be 
seen in table 1.1, adapted from Lorenz and Richter (2006).  
 
 
 
Table 1.1. Immunohistological analysis of arthritic cartilage in relation to normal 
cartilage. [Adapted from Lorenz and Richter, (2006)]. 
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1.6.7. Matrix metalloproteinases and aggrecanases in OA 
 
As a result of the increased cartilage metabolism, there is an enhanced production of 
degradative proteinase genes which is associated with the gradual loss of proteoglycans 
and type II collagen degradation. These include MMP -1, MMP-2, MMP-3, MMP-8, 
MMP-9, MMP-13 and MMP-14, together with the aggrecanases ADAMTS-4, ADAMTS-
5 and ADAMTS-9 (Mohtai et al., 1993, Murphy and Nagase, 2008). In unison, these are 
responsible for the degradation of the cartilage matrix macromolecules. Despite the 
collagenases (MMP-1, -8 and -13) collectively acting upon collagen fibrils, they are 
specific to certain collagens and as such, they also have specific topographical locations, 
indicating that perhaps there is a selective process during OA. There is speculation that 
MMP-9 could be responsible for progressive cartilage changes in OA, as it is selectively 
expressed in the fibrillated cartilage (Aigner et al., 2003).  
 
1.6.8. Other proteins & OA 
 
There is also increased expression in regulatory proteins such as IL-1 and TNF-a; IL-Iβ is 
a major inflammatory cytokine that is capable of inducing chondrocytes to synthesise 
MMPs in OA joints (Pelletier et al., 2001). Expression of stress and apoptotic markers 
(including caspases 3 and 9), and transcription factors (including Sox9 and Runx2) are also 
elevated during the course of OA (Goldring and Marcu, 2009, Goldring et al., 2008). 
 
COMP, one of the structural proteins in the ECM undergoes degradation during normal 
cartilage turnover, and fragments are released into the synovial fluid. An increase in these 
fragments in the synovial fluid has been linked to the early stages of OA (Lohmander et 
al., 1994). Similarly, other structural proteins including; cartilage matrix protein (CMP) 
and cartilage intermediate-layer protein (CILP) expression is increased in osteoarthritic 
cartilage (Okimura et al., 1997, Lorenzo et al., 2004). Fibronectin is also greatly increased 
in osteoarthritic cartilage (Brown and Jones, 1990). Through the words of Roughley 
(2001) “is it interesting that fibronectin fragments, resulting from proteolytic degradation, 
are able to propagate degradation of aggrecan at the same sites as expected for the action 
of aggrecanase (Homandberg et al., 1997). It has been suggested that the fibronectin 
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fragments that accumulate in the joint may stimulate the local production of inflammatory 
cytokines, such as IL-1, that upregulate aggrecanase expression.”  
 
1.6.9. TGF-β & OA 
 
TGF-β has both pro- and anti-inflammatory properties, and although it is crucial in 
regulating vital cellular activities, active TGF-β is also markedly increased in the 
osteoarthritic joint. It is pivotal in the formation of osteophytes, and has the ability to 
stimulate MMP expression contributing to the degradation seen in diseased cartilage 
(Bertrand et al., 2010, Scharstuhl et al., 2002). In terms of pathways, the protective role of 
TGF-β acts via the ALK5 receptor and downstream signalling pathway SMAD2/3 
resulting in increased TIMP, counteraction of IL-1 and overall prevention of hypertrophy. 
The destructive role of TGF-β occurs when it interacts with the ALK-1 receptor which 
signals to SMAD1,5,8 inducing MMP-13 and other degradative enzymes. As such, 
Davidson et al., (2009) recently demonstrated that in OA, there is a shift in receptor usage 
from ALK5 to ALK-1 emphasising the pathogenic role of TGF-β. 
 
1.6.10. Syndecan-4 & OA 
 
More recently, the transmembrane heparan sulphate proteoglycan syndecan-4 has been 
shown to be of pivotal importance for chondrocyte mediated cartilage breakdown in OA 
(Echtermeyer et al., 2009). Through the GAG chains, syndecan-4 interacts with ECM 
molecules including collagens, fibronectin and tenascin amongst others. It also acts as a 
receptor for integrins and for a number of growth factor receptors (Molteni et al., 1999, 
Tkachenko et al., 2005). Whilst other syndecans have also been detected in chondrocytes 
and in OA, syndecan-4 is of particular interest as it regulates mesenchymal cell function 
during tissue repair (Echtermeyer et al., 2001, Lim et al., 2003). A review by Bertrand et 
al., (2010) raises the question of whether syndecan-4 is functionally involved in the 
cartilage remodelling process during OA, as studies by the author have revealed that it is 
expressed in hypertrophic chondrocytes in OA, and that its inhibition by specific 
antibodies results in decreased activation of ADAMTS-5 (Echtermeyer et al., 2009). In 
summary, “syndecan-4 is a key player in cartilage degradation during OA, by regulating 
on the one hand, the expression of matrix degrading enzymes (MMP-3) by mediating IL-1 
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signalling and on the other hand, by directly binding ADAMTS-5 and thereby 
participating directly in cartilage degradation” (Bertrand et al., 2010). 
 
1.6.11. Hypoxia inducible factor-2α (HIF-2α) & OA 
 
New targets for therapeutic strategies are constantly being sought, and recent studies have 
identified transcription factor HIF-2α as a central mediator of OA development; induced 
by IL-1β and other pro-inflammatory cytokines. In vivo experiments have shown that 
ectopic expression of HIF-2α in mouse knee joints resulted in severe cartilage destruction, 
conversely mice in which HIF-2α was knocked down were found to resist degradation 
usually found in OA induction models (Yang et al., 2010). In OA patients, it was found 
that HIF-2α levels were elevated in damaged regions compared with undamaged regions. 
Parallel to this finding Saito et al., (2010) identified HIF-2α whilst screening for factors 
that induce collagen type X expression. Proinflammatory cytokines as well as nuclear 
factor kB (NF-kB) are upstream regulators of HIF-2α, and it is thought that mechanical 
stress might trigger OA by inducing the NF-kB signalling and therefore HIF-2α expression 
in joint cartilage (Flemming, 2010).  
 
1.6.12. Mechanisms 
 
Despite the breadth of knowledge regarding OA, mechanisms and pathways involved in 
the disease process have yet to be fully understood. It is often suggested that many of the 
changes occurring in the osteoarthritic process recapitulate changes which are seen early in 
development; including cell proliferation and differentiation. As such, many of the 
signalling pathways involved in cartilage development are now linked to OA process, 
including those induced by FGF, Wnt, BMP, TGF-β and hedgehog signalling (Chia et al., 
2009, Dell'Accio et al., 2006, Lin et al., 2009, Lories and Luyten, 2005, van den Berg, 
1995). 
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1.7. OA: a disease involving other tissues 
 
1.7.1. Subchondral bone 
 
There has been a recent surge in the number of articles relating to subchondral bone 
changes associated with osteoarthritis, challenging the previous concept that degeneration 
and erosion of articular cartilage is the primary pathological mechanism of OA. The 
subchondral bone is an active element during OA as it provides catabolic factors to the 
neighbouring cartilage; promoting abnormal cartilage metabolism. A study by Petersson et 
al., in 1998 demonstrated through biochemical investigation that the serum levels of 
factors released from cartilage and bone during the early stages of OA in humans 
suggested that the pathological processes in cartilage and bone did coincide. Evidence 
from other human and animal models have also shown not only that the subchondral bone 
and cartilage should be seen as an interdependent unit, but also that in certain cases, 
changes to the subchondral bone may precede the cartilage degeneration (Buckland-
Wright, 2004, Johnson, 1962, Radin and Rose, 1986).  
 
In support of an altered metabolism early in the OA process in the subchondral bone is that 
osteocalcin (a common marker of bone formation) and osteopontin (a bone specific matrix 
protein) levels in synovial fluid and serum respectively were significantly higher in 
patients with knee OA (Sharif et al., 1995a). As levels of serum osteopontin rise quickly 
following trauma, this implies that alterations in bone cell activity may occur quite early in 
the disease (Lajeunesse et al., 2003). 
 
The alterations in the subchondral bone which are evident in OA include subchondral 
sclerosis (thickening), changes in the architecture of the trabecular bone, the formation of 
new bone at joint margins, known as osteophytes and the development of subchondral 
cysts. Histologically, there is also evidence of tidemark advancements and duplications 
associated with vascular invasions of the calcified cartilage from the subchondral bone 
(Martel-Pelletier and Pelletier, 2010, Petersson et al., 1998).  
 
With regards to subchondral bone sclerosis, it is interesting to note that it is not 
accompanied by an increase in mineral density. The scleroses result from increased 
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stiffness and an increase in material density, but not bone mineral density. As such, 
subchondral bone demonstrates an increased osteoid collagen matrix and abnormal 
mineralisation patterns during OA resulting in overall hypomineralisation (Grynpas et al., 
1991). There is speculation that abnormal collagen type I content, as a result of elevated 
TGF-β levels, is a major contributing factor leading to abnormal mineralisation 
(Couchourel et al., 2009). Type I collagen, a heterotrimer of α1 and α2 chains, is elevated 
in OA. The average ratio of alpha chains in normal bone is 2.4:1; however studies have 
shown that in OA this ratio varied between 4:1 and 17:1 (Bailey et al., 2002). As 
summarised by Lajeunesse et al., (2003) “a reduction in α2 chains may lead to a tighter 
packing of collagen fibrils and, coupled with the reduction in cross-links observed in bone 
tissue (Mansell and Bailey, 1998) and the overhydroxylation of lysine in collagen fibrils 
(Bailey et al., 2002), may explain the reduction in bone mineralisation.” 
 
1.7.2. Synovial membrane 
 
Through enzymatic feedback loops, the synovial membrane and surrounding tissues 
maintain an equilibrium to ensure normal homeostasis is achieved. In OA, this equilibrium 
is disrupted and pro-inflammatory cytokines are activated in an attempt to counteract the 
destructive changes in the neighbouring cartilage. This in turn results in an increased 
response by the synovial membrane and as such, a vicious circle is created.  
 
 IL-1β and TNF-α production by the synovial membrane are key perpetrators in the 
development of OA (Smith et al., 1997). IL-1β stimulates proteolytic and catabolic 
pathways of ECM degradation whilst also suppressing the anabolic pathways. As such, IL-
1β can either decrease the synthesis of essential matrix macromolecules including collagen 
type II, or increase collagens which are not usually associated with normal articular 
cartilage; contributing to the loss of strength seen in diseased cartilage (Goldring et al., 
1988). Other pro-inflammatory cytokines such as IL-6 as well as some chemokines such as 
IL-8 are also considered to be potential contributing factors in the pathogenesis of OA; 
however the precise roles in the process have yet to be established (Martel-Pelletier and 
Pelletier, 2010).  
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Histologically changes can also be seen in the synovial membrane from patients with all 
grades of OA. These include thickening of the lining layer, increased vascularity coupled 
with inflammatory cell infiltration (Smith et al., 1997). 
 
1.7.3. Meniscus 
 
An integral part of the biomechanical system of the knee joint is the meniscus. It is not 
only essential for the distribution of axial forces but also for the absorption of shock. 
Meniscal extrusion and menisectomy both modify the pattern of load distribution, leading 
to compartmental instability (Thompson et al., 1991). Meniscal extrusion is frequently 
associated with established knee OA (Berthiaume et al., 2005) and consequently, the 
femoral and tibial bone surfaces are faced with increased susceptibility of OA during 
dynamic movements of the knee. 
 
1.8. Repair 
 
Achieving successful repair of articular cartilage is an ongoing battle that has faced 
scientists and surgeons for decades. As the tissue is avascular, aneural and alymphatic it 
lacks the ability to actively respond to damage, and is therefore hindered by its limited 
repair response (Bora and Miller, 1987). Hunter, in 1743 claimed that articular cartilage 
‘once destroyed, is not repaired’, and this observation directed many of the early 
treatments aimed to alleviate pain and discomfort, and allow greater movement as opposed 
to repairing the cartilage itself. More recent treatments involve surgical interventions 
aimed at inducing repair (Hunziker, 2001). 
 
1.8.1. Surgical interventions 
 
Strategies have developed from basic surgical techniques into technical methods which 
combine current knowledge of chondrogenesis and pathogenesis together with advances in 
tissue engineering. 
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1.8.2. Conservative strategies 
 
Arthroscopic repair procedures represent more conservative and less invasive treatments 
for damaged cartilage; at the expense of effectiveness. Lavage and debridement are 
common methods used to alleviate pain, however are not known to biologically repair 
damaged tissue (Jackson and Dieterichs, 2003). Lavage involves irrigation of the joint 
(Livesley et al., 1991) and it is suggested that this irrigation process washes away active 
pain-signalling or pain mediating molecules, as well as removing proteoglycans from the 
superficial cartilage matrix (Hunziker and Kapfinger, 1998). There is still little evidence to 
show that this method does in fact initiate a repair response in damaged cartilage, and there 
is no evidence to suggest that lavage has symptom improving benefit. Debridement and 
shaving are also arthroscopic techniques, popularised by Magnuson in 1946 which aim to 
remove diseased or damaged tissue, allowing for a smoother surface and the consequent 
reduced friction at the joint interface (Chang et al., 1993). Apart from being a temporary 
method of pain relief, it is similar to lavage in that biologically it does not aid cartilage 
repair. 
 
Other arthroscopic procedures involve bone marrow stimulation techniques, which require 
penetration of the subchondral bone (Gilbert, 1998). These techniques, namely abrasion 
arthroplasty, Pridie drilling and microfracture mimic full-thickness defects; potentially 
allowing for repair responses to be triggered within the damaged areas. It is believed that 
the underlying bone provides access to pools of various stem cells and growth factors 
which aid the reparative process (Shapiro et al., 1993, Rodan, 1992). Having stated that, 
these methods were used mainly for patients with painful conditions with the aim of 
bringing symptomatic relief and as such, the procedures are palliative, not curative, and the 
outcome is variable (Hunziker, 2001, Beris et al., 2005, Steadman et al., 2003). 
 
1.8.3. More invasive strategies 
 
Osteotomies are surgical procedures whereby the bone is cut in order to shorten, lengthen 
or change the alignment. This intervention is most frequently adopted to relieve pain, and 
to reduce or prevent the progression of osteoarthritis. Improving the joint alignment alters 
the biomechanics, inducing a change in contact areas. The aim is to alter the forces so that 
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weight is transferred through an area of healthy cartilage, resulting in less pain following 
joint movement (Arnoldi et al., 1971). Another important aspect of osteotomies are that 
they induce focal bleeding, which is followed by a localised healing response and a change 
in the pattern of vascular supply to the joint. It is also common for surgeons to combine 
osteotomies with other surgical procedures such as debridement, or Pridie drilling in an 
attempt to trigger a more extensive repair mechanism. In fact, there have been reports that 
osteotomies lead to the formation of a new articular surface however results are variable 
among patients (Buckwalter, 1999). 
 
1.8.4. Surgical interventions: introducing materials 
 
1.8.4.1. Autologous tissue grafts 
 
Perichondrial and periosteal grafts involve transplantation techniques where tissue is 
grafted into full-thickness articular cartilage defects. This procedure began in the 1970’s as 
a method of inducing repair of damaged articular cartilage. The underlying principle 
behind this technique was based on the knowledge that the cambial layer of periosteum 
and perichondrium exhibits continuous chondrogenic activity attributed to its chondrocyte 
precursor cells (Cohen and Lacroix, 1955). It is believed that when a graft is laid on a full 
depth articular cartilage defect, these precursor cells that reside in the germinative cambial 
layer are capable of reactivation; and proliferative and differentiation activities trigger the 
cartilage repair response (Hunziker, 2001, O'Driscoll, 1999). As periosteum is more 
obtainable it is used more frequently than perichondrium (Beris et al., 2005). In human 
patients, clinical results have not been totally successful mainly due to poor integration 
observed at the interface between the graft and the native tissue, and the low proliferative 
activity of repair cells; thus failing to restore the hyaline articular cartilage. Graft 
calcification is also a frequent occurrence contributing to the numbers of unsuccessful 
treatment attempts (Minas et al., 2009). Surgical procedures have been modified to try to 
combat the practical problem of graft detachment using sutures or glue, however, results 
have varied and have been inconclusive. 
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1.8.4.2. Osteochondral transfer 
 
Autogenic and allogenic transfer of osteochondral plugs forms the basis of this procedure. 
Autogenic osteochondral transplantation, commonly known as mosaicplasty is employed 
mainly for smaller sized cartilage defects (Jakob et al., 2002). The process involves 
removal of cylindrical plugs from non-weight-bearing regions, and their transplantation 
into the debrided full depth cartilage (Hangody et al., 1997). Frightfully little research 
went into investigating this procedure and its effectiveness and destructiveness before it 
was applied clinically in human patients (Hunziker, 2001). Results have suggested short 
term benefits, including decreased pain and increased joint function, however, there are 
also many problems and questions raised regarding this intervention (Jakob et al., 2002). 
 
Allogenic transfers use tissue derived from cadavers in an attempt to repair large 
osteochondral defects, on the basis that large volumes of tissue can be retrieved. This 
approach aims to simply provide a substitute for damaged or lost articular cartilage, and 
does not aim to induce a repair response. 
 
1.8.4.3. Repair of articular cartilage using tissue engineering 
 
Tissue engineering, as described by Hunziker (2001) can be defined as the art of 
reconstituting mammalian tissues both structurally and functionally. Usually, there are 
three main components which form the basis of tissue engineering; a matrix scaffold that 
provides a suitable surrounding, appropriate cells, and the addition of signalling molecules, 
such as cytokines and/or growth factors (Kuo et al., 2006). 
 
One of the most commonly recognised methods of cartilage repair using tissue engineering 
is the autologous chondrocyte transplantation method which was introduced in the 1970’s 
by Bentley et al., (1971) using partial-thickness defects of a rabbit model, and was 
transferred into human clinical practice in 1994 (Brittberg et al., 1994). The procedure 
initially involves the excision of healthy articular cartilage from a non-weight-bearing 
region of the joint, which is subsequently enzymatically digested in order to release 
chondrocytes from the extracellular matrix. The cells are then expanded in culture until 
there is a sufficient concentration of cells to fill the defect. A second surgical procedure is 
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then carried out which involves debriding the lesion back to the point of healthy cartilage, 
and taking a periosteal graft from a nearby location. The graft is then sutured over the 
defect, creating a flap under which cells can be securely injected. Fibrin glue is also added 
to seal the graft and further prevent cells from floating away (Brittberg, 1999). 
 
Results from this treatment have been fairly consistent and there is a general acceptance 
that reduced pain and improved joint function are achieved. Histological analysis has 
shown, however, that there are variations in the efficiency of inducing repair with hyaline 
like cartilage at different locations (Breinan et al., 1997). Other varying results suggest 
there may be a difference in the short term but no significant improvements in the long 
term. Overall, the effectiveness of this technique has been justifiably questioned, and 
results have been varied and inconclusive. Additionally, there is not one consistent 
technique but rather variations of a common theme, making comparisons and conclusions 
often hard to draw. Even though autologous chondrocyte transplantation (ACT) is a widely 
used technique for repairing cartilage there are major factors that need to be given 
consideration. These include donor site morbidity, chondrocyte de-differentiation in vitro, 
and fibrocartilage formation as opposed to hyaline cartilage repair (Csaki et al., 2008). 
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Figure 1.11. Schematic diagram showing the different stages involved in the process of 
autologous chondrocyte transplantation. [Adapted from Redman et al., (2006)] 
 
 
 
1.8.4.4. Scaffolds 
 
Since the introduction of the conventional ACT, there have been many developments that 
have aimed to improve the effectiveness of the technique, in order to achieve successful 
repair of articular cartilage, using biocompatible structurally and mechanically stable 
scaffolds. The scaffolds create a three dimensional environment, in which chondrocytes 
can be loaded before being re-implanted in the defect and must, therefore, be reabsorbable 
and non-toxic for the cells (Tuli et al., 2003). There are natural as well as synthetic 
substances that are suitable for scaffolds used in cartilage engineering. Among the most 
common natural materials are collagen- and hyaluronan based matrices as they constitute 
native articular cartilage. Results have been encouraging, as preliminary clinical studies 
using Hyalograft C, a hyaluronan based scaffold, demonstrated 96.7% of the repair tissue 
formed to be similar to hyaline cartilage (Pavesio et al., 2003). The advantage of synthetic 
scaffolds is that the problem of possible immune reactions is eliminated. 
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1.8.5. Stem cells for cartilage repair 
 
It is evident that despite extensive efforts to achieve successful repair of articular cartilage, 
there appears to be a missing ingredient hindering the process. Stem cells provide an 
alternative cell source with the potential for successfully regenerating cartilage, and have 
largely become the focus of many studies in cartilage repair. 
 
Whilst the term ‘stem cell’ is used loosely, often it encompasses progenitor cells that have 
limited replicative capacity and restricted differentiation potential to certain lineages. True 
stem cells are undifferentiated cells with endless self-renewal capacity, and the potential 
for multilineage differentiation. They are also easily obtainable and expandable in vitro 
making them promising candidates as the necessary vehicle for cartilage repair (Caplan 
and Goldberg, 1999). Stem cells reside in various ‘niches’ in the embryo, foetus and 
adults, and can be recruited to repair and replenish dying or damaged tissue, without the 
immunological responses that often accompany allogenic grafts (Fuchs et al., 2004).  
 
Stem cell plasticity has been confirmed in bone-marrow-derived MSCs, which have been 
successfully differentiated into various specific cell lineages such as cartilage, bone, 
tendon, adipose tissue and muscle (Caplan, 1991, Barry, 2003, Csaki et al., 2007, Minguell 
et al., 2001, Pittenger et al., 1999, Short et al., 2003). MSCs have also been isolated from 
other sources including umbilical cord blood, adipose tissue and peripheral blood (Zuk et 
al., 2002, Bieback et al., 2004, Huss et al., 2000). Once in vitro MSCs have the capability 
to retain their differentiation potential for several passages (Pittenger et al., 1999). The 
cells are characteristically fibroblast-like in morphology, and express several adhesion 
molecules and receptors; allowing them to bind to adhesive proteins on the plastic under 
culture conditions (Conget and Minguell, 1999). 
 
Undifferentiated progenitor cells have also been identified in articular cartilage itself, 
presenting a very promising source for the regeneration of cartilage. Dowthwaite et al., 
(2004) demonstrated successful isolation of a specific articular cartilage progenitor cell 
from bovine tissue, using a differential adhesion assay described by Jones and Watt in 
1993.  
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1.8.5.1. Chondrogenic differentiation of MSCs 
 
Stem cells reside in what is known as a niche, a microenvironment encapsulating the cells 
and providing local and systemic signals for their regulation and maintenance. Scadden 
(2006) defines a niche as a specific anatomical location that regulates how stem cells 
participate in tissue generation, maintenance and repair, whilst saving the cells from 
depletion and protecting the host from over-exuberant stem cell proliferation. Elements of 
the stem cell niche include cellular components such as cell–cell interactions, acellular 
elements such as ECM components, growth factors and membrane bound molecules, as 
well as the physiochemical nature of the environment. The interplay between stem cells 
and their niche creates the dynamic system necessary for sustaining tissues, and for the 
ultimate design of stem-cell therapeutics (Scadden, 2006). 
 
Adult stem cells remain in an undifferentiated state, and therefore, it is necessary to induce 
chondrogenic differentiation in culture conditions to achieve chondrogenic cells, using the 
knowledge of stem cell–niche interactions, chondrogenic development and cartilage 
homeostasis and function (Mobasheri et al., 2009). Chondrogenic differentiation, as 
described by Johnstone et al., (1998) requires a 3D environment, and the addition of 
various combinations of growth factors. Of the various cytokines and growth factors used 
to induce chondrogenesis, isoforms of the TGF-β family are the most common (Johnstone 
et al., 1998). Others include specific bone morphogenetic proteins (BMPs), fibroblastic 
growth factor-2 (FGF-2), IGF-1, as well as synthetic dexamethasone (Pittenger et al., 
1999, Johnstone et al., 1998, Awad et al., 2003, Grigoriadis et al., 1988, Nixon et al., 2000, 
Shea et al., 2003, Tsutsumi et al., 2001, Zhou et al., 2004). The pathways and mechanisms 
of action behind these signalling molecules are yet to be fully understood. The addition of 
FGF-2 into MSC culture conditions is also believed to stimulate chondrogenesis, as it has 
been demonstrated that more cartilage-specific proteoglycans are produced with the FGF-2 
supplement (Solchaga et al., 2005). Dexamethasone has been shown to be a powerful 
supplement, inducing chondrogenesis via the glucocorticoid receptor by enhancing 
stimulation of the TGF-β superfamily, and consequent collagen II and cartilage-specific 
proteoglycan production (Derfoul et al., 2006). 
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1.8.5.2. Applications of MSCs for cartilage repair 
 
There are many ongoing studies that aim to elucidate the most effective application of 
MSCs for the repair or regeneration of articular cartilage. Of these, several aim to develop 
previous theories and several propose new ideas. Perhaps the simplest technique is intra-
articular injection, whereby MSCs are isolated and injected into the joint space providing a 
pool of cells to aid the repair of damaged tissues. MSCs have also been combined with 
hyaluronic acid for intraarticular injections (Murphy et al., 2003). Lee et al., (2007) 
postulate that hyaluronic acid facilitates the migration and adherence of MSCs to the 
defect, and demonstrated how this treatment was effective in inducing a repair response in 
a porcine model. This method, however, does not anchor the cells to the region and may 
result in cell migration into the marrow cavity. Consequently, the intra-articular injection 
may only provide very short-term responses. The use of a scaffold or periosteal flap (used 
in ACT) aims to eliminate this issue, and retain the cells at the site of the defect. Using the 
concept of conventional ACT analogous MSCs have been isolated and expanded in vitro 
before being implanted back into a defect. Long-term results have been conflicting as 
some studies report the formation of new cartilage and others report tissue degradation 
(Murphy et al., 2003, Im et al., 2001). This is possibly because the implanted cells rely on 
local and systemic signals to integrate and differentiate into reparative tissue. Foreign, 
undirected MSCs may, therefore, have little influence on the repair or regeneration of 
cartilage and this may be the reason for the ambiguous results.  
 
The logical progression, as carried out by Jiang et al., (2003) focused on inducing 
chondrogenesis of MSCs in vitro and implanting these directed cells back into the defect. 
The data from this study however was also unsatisfactory due to inconsistent results. 
Matrix-assisted MSC therapies using scaffolds to provide a suitable environment, are 
being studied extensively as in theory they could provide suitable mechanical and 
biochemical properties in which MSCs can be seeded. A review by Noth et al., (2008) has 
summarised an ideal scaffold, which should be biocompatible and biodegradable upon 
tissue healing, porous (to permit cell penetration), permeable (to allow nutrient delivery 
and gas exchange), adaptable to the mechanical environment, conducive to cell attachment 
and migration, and allow appropriate ECM formation and transmission of signalling 
molecules. However, to date, there are no scaffolds that fulfil all these requirements whilst 
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achieving integrated hyaline-like repair of tissue (Mouw et al., 2005). In many studies, 
there have been reports of hyaline-like cartilage formation together with fibro-cartilage 
formation; this is not the ultimate goal in terms of producing a totally viable repair tissue 
and, therefore, further developments are being sought. There is also the recurring problem 
of integration between the repair tissue and the native cartilage. A greater understanding of 
the underlying mechanisms of cartilage repair is needed in order to eradicate this problem. 
 
Despite encouraging results, the methods described above present a few common 
problems. As MSCs and progenitor cells are isolated in small numbers, in order for any of 
the techniques to be effective there needs to be sufficient number of cells and these must, 
therefore, be expanded in vitro before being placed back in the defect. This raises issues of 
cell de-differentiation, genetic stability and pathogen transmission. 
 
In terms of articular cartilage progenitor cells, several research groups have been able to 
identify a potential population of cells within both normal and osteoarthritic human 
articular cartilage (Dowthwaite et al., 2004, Alsalameh et al., 2004, Fickert et al., 2004, 
Williams et al., 2010) presenting a source of native cells with the potential to restore 
damaged cartilage. If and when the cells and mechanisms of activation are fully 
understood, the prospects of regenerative processes are high. This may either be in vitro, 
by means of expanding and inducing the cells into a chondrogenic repair response and then 
implanting the cells back using an appropriate biodegradable scaffold, cell suspension, or 
in vivo. Once a deeper understanding is achieved, it is possible that these native progenitor 
cells may by induced or triggered in vivo using minimally invasive methods of delivery.    
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1.9. Aims of the thesis 
 
There is clinical evidence to suggest that under permissive conditions, hyaline cartilage 
has the capacity for recovery. That said, there is a longstanding view that osteoarthritic 
cartilage is deemed irreparable. This study therefore tests the hypothesis that the joint 
surface deemed clinically irrecoverable contains a sub-population of viable cartilage stem 
cells, which have the potential to regenerate.  
 
The overall aim of this study was to investigate progressive changes during the 
osteoarthritic process whilst also investigating the presence and potential of 
chondroprogenitor cells within osteoarthritic articular cartilage.  
 
This thesis therefore aims to: 
 
1) Describe a new scoring system to assess osteoarthritis severity.  
2) Map out histologically the progressive changes that occur throughout progression 
of the disease.  
3) Correlate disease severity to expression of putative stem cell markers. 
4) Determine whether chondroprogenitor cells previously documented in normal 
hyaline cartilage also reside in osteoarthritic tissue. 
5) Isolate, clone and extensively cultivate osteoarthritic chondroprogenitor cells. 
6) Assess whether clonally derived osteoarthritic chondroprogenitor cells have the 
capability to undergo tri-lineage differentiation in vitro. 
7) Compare chondroprogenitor cells isolated from normal and osteoarthritic tissue. 
8) Assess the integration potential of chondroprogenitor cells in a 3-d environment.  
 
 
 
 
NOTE 
This Chapter forms the basis of a review article published in Expert Opinion on Biological 
Therapy. See page 316. 
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Chapter 2: 
A novel scoring system for osteoarthritis of the knee 
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2.1. Introduction  
 
The preconceived notion, which is still widely accepted, is that OA is primarily a disorder 
of the articular hyaline cartilage. The onset of the disease however, is still a topic of much 
discussion. Many believe that OA is a result of a ‘wear and tear’ process, which causes the 
cartilage to degenerate whilst denuding the joint surfaces (Radin, 1976). Others believe 
that it is triggered as a result of abnormal loading to joints and that the cartilage changes 
result from altered joint biomechanics (Englund, 2010). There is also the view that 
structural changes in the matrix, together with intrinsic and extrinsic growth factors, 
cytokines and other signalling factors mediate the response to the cartilage (Goldring and 
Marcu, 2009). As chondrocytes are the sole cellular component of articular cartilage, 
research is often focussed on their role in the pathogenesis of OA. However, it is important 
to remember that within the joint the articular cartilage is in direct contact with the 
subchondral bone, the synovial fluid and the synovium. It is widely accepted and well 
documented that during the course of OA, changes occur in these surrounding tissues 
(Martel-Pelletier and Pelletier, 2010), and the question is often raised regarding the pre-
eminence of the disease; does OA initially affect the articular cartilage or are there changes 
within other tissues that precede these? This is a challenging question as clinical signs are 
not always evident at the earliest stages of the disease and so initial changes are 
overlooked. Similarly, investigative studies often focus on changes in the later stages of 
the disease; unveiling little information about early changes and capping the potential for 
understanding the initial responses.  
 
Of the neighbouring tissues, changes to the subchondral bone have triggered great interest 
within many research groups (Karsdal et al., 2008, Lajeunesse and Reboul, 2003, Li and 
Zhang, 2009, Mansell et al., 1997, Westacott et al., 1997). A review by Lajeunesse et al., 
(Lajeunesse et al., 2003) summarises how some bone parameters such as abnormal bone 
mineral density, osteoid volume, and bone mechanical parameters may be indicators of 
bone turnover relating to OA patients, and addresses the question relating to whether 
growth factors, degradative enzymes and cytokines from the subchondral bone may seep 
through channels in the tidemark and affect the overlying cartilage. As such, there is 
evidence to suggest that thickening of the subchondral bone precedes fibrillation of the 
cartilage within some animal models, as a result of increased resistance of the bone to 
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compression (Bailey and Mansell, 1997). Aside from the question of whether increased 
bone metabolism is a primary event triggering a cascade response resulting in cartilage 
destruction or vice versa, the role of the subchondral bone throughout the pathogenesis of 
OA is also a topic of great interest within many research groups.  
 
Assessing the severity of OA 
 
In order to assess the severity of the disease, clinicians and scientists have devised many 
scoring systems, each focussing on different combinations of pathological features 
characteristic of OA. Clinically-based scoring systems have evolved using techniques 
including magnetic resonance imaging (MRI), X-rays and arthroscopic evaluation in 
attempts to assess disease progression. These systems look specifically at joint space 
narrowing, prevalence of osteophytes and, more recently, detection of glycosaminoglycan 
(GAG) levels within the articular cartilage using MRI analysis (Ling et al., 2008). 
Research-based scoring systems focus on histological and histochemical parameters when 
assessing OA severity. Early work by Collins et al., (Collins and Mc, 1960) and Mankin et 
al., (Mankin et al., 1971) led to a system for pathological grading of cartilage changes in 
relation to OA. Since then, many systems for grading cartilage have been devised to assess 
not only OA severity, but also in vivo cartilage repair and in vitro tissue engineering 
studies. The most commonly used system in assessing OA severity remains the Mankin 
scoring system, often referred to as the Histological-Histochemical Grading System 
(HHGS). This system was originally designed for grading OA in human hip articular 
cartilage, scoring the structure, cells, safranin O staining as well as the tidemark integrity 
(Mankin et al., 1971). Several other similar systems have stemmed from the HHGS and 
are commonly known as ‘modified Mankin’ systems, which tend to be adaptations for 
individual studies. The HHGS together with its modifications have been used extensively 
in human studies as well as in animal models (Ghosh et al., 1995, Goodman et al., 1991, 
Kim et al., 1991). In terms of cartilage repair, the O’Driscoll, Oswestry and ICRS scoring 
systems are amongst the most frequently used (Mainil-Varlet et al., 2003, O'Driscoll et al., 
1988, Roberts et al., 2003).  
 
More recently, the OARSI Osteoarthritis Cartilage Histopathology Assessment system was 
devised with the aim to provide a more useful method of assessment through ‘grading’ and 
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‘staging’ articular cartilage. The severity and extent of cartilage surface involvement in the 
local osteoarthritic process is assessed and categorised from ‘normal’ through to ‘severe’ 
and from ‘no OA activity seen’ through to >50% of articular surface affected’(Pritzker et 
al., 2006).  
 
Subchondral bone and articular cartilage as a unit 
 
Despite the abundance in the literature linking changes of the subchondral bone to the 
degenerative overlying cartilage, when it comes to assessing the severity of OA by means 
of a histopathological scoring system these correlations are often overlooked. As 
aforementioned, the predominant parameters focus largely on the articular cartilage, 
however, being in direct contact with the underlying bone, it is likely that messages or 
signals have an uninterrupted pathway of communication.  
 
The primary aim of this chapter was to devise a scoring system to assess the severity of 
OA, which incorporates changes of the subchondral bone. We hoped to confirm that the 
overall score obtained through the new scoring system was indicative of the degenerative 
state of the tissue as a unit, including the cartilage and subchondral bone.  
 
The second aim was to correlate changes to the subchondral bone with changes in the 
cartilage-based parameters, in order to establish relationships between the two tissues and 
obtain a greater understanding of changes that occur throughout OA.  
 
The rationale behind including the subchondral bone into a histological scoring system 
was not only to grade the unit as a whole without isolating one factor from the other, but 
also as a potential tool to be used and translated clinically. By correlating changes of the 
subchondral bone to the overlying cartilage, it may be possible to establish the pattern of 
change that occurs within the bone throughout the progression of the disease. Clinically, 
this could provide a basis for a tool for early diagnosis of OA, in a minimally invasive way 
using bone as a sole component for grading.  
 
The third aim of this chapter was to assess the reproducibility of the scoring system by 
testing inter- and intra-observer variability. 
61 
 
2.2. Materials  
 
 
 
Table 2.1. Materials and suppliers. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Material Catalogue 
number 
Supplier 
 
DPX mounting medium 
 
RAYLLAMB/DPX 
 
Raymond A Lamb 
Medical Supplies, 
Eastbourne, UK 
 
 
10 % Formalin solution, neutral 
buffered 
Phosphate buffered saline 
Ethylenediaminetetraacetic acid 
disodium salt dihydrate 
 
 
HT501128 
 
P4417 
E4884 
 
Sigma Aldrich, UK 
Paraffin wax pastilles  298682F VWR – Jencons, 
Leicestershire, UK 
Polysine adhesion glass slides MNJ-800-010F Thermo Fisher 
Scientific, UK 
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2.3. Methods 
 
2.3.1. Source of material 
 
Tibial plateaux (TPs) were obtained from OA patients who underwent partial 
(unicondylar) or total (bicondylar) knee replacement. OA was diagnosed following 
physical, radiographic and biochemical examination. Tibial plateaux from male and female 
patients ranging from 45 to 85 years of age were used in this study. South East Wales 
Research Ethics Committee safety and ethical guidelines were followed. Written informed 
consent was obtained from each patient and extensive precautions were taken to preserve 
the privacy of the participants donating tissue. Following surgery, tissue was immediately 
transported from the hospital to the laboratory in sterile saline solution. Only tissue from 
the tibial plateaux were used for this study; cartilage and bone obtained from the femoral 
head were omitted in order to maintain consistency. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1. Labelled photograph of a tibial plateau excised from a total knee replacement. 
Scale bar = 2cm. 
 
2.3.2. Fixation and decalcification 
 
The tibial plateaux were fixed overnight in 10% neutral buffered formalin. Following 
fixation, they were washed in PBS (three changes of 10 minutes). Subsequently, they were 
decalcified in 12% ethylenediaminetetraacetic acid (EDTA) disodium salt dihydrate 
63 
 
solution at pH 7.5 for up to four weeks at 37°C. Every fifth day, the EDTA was discarded 
and replenished. Following decalcification, samples were washed in PBS. 
 
2.3.3. Excision and paraffin embedding of osteochondral plugs 
 
The tibial plateaux were assessed based on their topography; mapped and classified into 
regions of varying cartilage integrity (figure 2.2). These were then dissected using a sharp 
scalpel into osteochondral plugs (OCPs). The size of the plugs varied slightly in 
accordance to the size of the mapped region. From one tibial plateau approximately 4 
osteochondral plugs were excised. However, this varied depending on the nature of the 
cartilage observed within each individual TP. The osteochondral plugs were then 
dehydrated in graded alcohols (70%, 95% and 100% x3) with changes of 60 minutes each 
before being cleared in xylene (two changes of thirty minutes), infiltrated with three 
changes of paraffin wax at 56°C and embedded in paraffin wax.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.2. Photograph of a tibial plateau. Labelled red boxes demonstrate examples of 
mapped osteochondral plugs. Scale bar = 2cm. 
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2.3.4. Sectioning 
 
Following embedding, serial sections were cut at 8µm on a Leitz 1512 microtome. 
Sections were floated on a heated water bath (45°C) before being mounted on polysine 
coated slides. The slides were air-dried for approximately 30 minutes on a heated rack and 
then dried overnight in an incubator heated to 45°C. 
 
2.3.5. Staining of sections 
 
Sections were dewaxed using xylene (two changes of 2 minutes) and rehydrated through a 
series of graded alcohols (two changes of 2 minutes in 100%, followed by one change of 2 
minutes in 95% and 70%). The sections were then washed in running water for a further 2 
minutes before being stained with Masson’s trichrome (appendix). Following staining the 
sections were dehydrated through graded alcohols, cleared in xylene (two changes of 2 
minutes) prior to being mounted under coverslips using DPX. 
 
2.3.6. Microscopy and imaging 
 
Slides were viewed using a Leica DMRB light microscope and imaged using a Moticam 
2000 camera. Image processing was carried out using Adobe Photoshop (version 6.0.1).  
 
2.3.7. Scoring the osteochondral plugs 
 
A new scoring system was devised through which cartilage thickness, percentage of total 
bone area, tidemark integrity, cartilage surface integrity and cartilage morphology were 
assessed. Cartilage thickness and percentage of total bone area were assessed 
quantitatively using the method described below. This combination of features allows for a 
semi-quantitative assessment of the overlying cartilage together with the underlying bone. 
A criteria summary table for the qualitative factors can be seen in table 2.2.  
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2.3.7.1. Cartilage thickness 
 
In order to determine the cartilage thickness, slides were imaged at the lowest possible 
magnification (x4). Three equally spaced points along the width of the section were 
measured in order to obtain an average thickness throughout the section. The measurement 
was taken from the surface of the cartilage horizontally down to the tidemark at the three 
locations (refer to figure 2.3). Calculating an average of the 3 measurements generates a 
value of cartilage thickness that can be used quantitatively. 
 
 
Figure 2.3. Cartilage thickness measurements were taken from three equally spaces points 
along the width of the section in order to obtain an average. Scale bar = 1.5mm. 
 
 
2.3.7.2. Bone area 
 
Percentage of total bone area of the imaged sections was assessed using Adobe Photoshop 
(version 6.0.1). By bone area, we refer to the region below the tidemark, including the 
bone matrix, whether mineralized or not, and osteoid. This was calculated as a percentage 
of the total area which includes bone marrow and other soft tissues. The bone area 
measurement was consistently observed from the tidemark to a depth of 2mm.  
 
66 
 
2.3.7.2.1. Method of area calculation 
 
Using Adobe Photoshop, a line was drawn over the tidemark as a marker to delineate the 
region to be calculated. Under the ‘Image Size’ setting, the resolution was changed so that 
it was consistently 300 pixels per inch. The ‘Magic Wand’ tool (which allows for selection 
of part of an image based on its colour) was then used to select the area of stained bone 
within the 2mm region (figure 2.4). Using the Image> Histogram function, it is possible to 
obtain the total number of pixels in the selected region (a pixel is the smallest addressable 
screen element). In order to calculate the total number of pixels in the whole region 
including the spaces where the bone marrow and soft tissues would reside, a line was 
drawn around the borders so that the whole area to be calculated is defined. The ‘Magnetic 
Lasso’ tool (which automatically clings to edges of contrast objects) was then used to 
select the entire region so that the total number of pixels could be obtained. An area 
percentage was then calculated in order to ascertain a quantitative value of bone area per 
section. 
 
 
 
 
 
 
 
 
 
 
Figure 2.4. The area of bone in the subchondral region to a depth of 2mm. Scale bar = 
1mm. 
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2.3.7.3. Tidemark integrity, cartilage surface integrity and cartilage morphology 
 
Tidemark integrity, cartilage surface integrity and cartilage morphology was scored based 
on the scoring criteria (refer to table 2.2). Lower scores were indicative of a more normal 
state, whereas higher scores suggest a more diseased state of tissue. Tidemark integrity 
was scored between 0 and 4; 0 being ‘normal’ an 4 indicating a lack of tidemark due to the 
absence of cartilage. Similarly, cartilage surface integrity was also scored between 0 and 4 
(4 indicating no cartilage surface integrity due to a complete lack of cartilage). Cartilage 
morphology was scored between 0 and 3; again, where 0 represents a ‘normal’ state and 3 
indicating an absence of cartilage.  
 
2.3.7.4. Overall scoring  
 
Using the criteria described for scoring the qualitative parameters it is possible to obtain a 
total score between 0 and 11 for each scored slide. In order to incorporate the cartilage 
thickness and percentage of bone in the subchondral region into the overall scoring, they 
were categorised based on the following boundaries:  
 
 
 
 
 
 
 
 
 
This approach enables an overall sum of scores between 0 and 17 to be calculated, where 
the more ‘normal’ the sample, the lower the score.  
 
In this study, we have used both the categorical scores and the continuous data in order to 
analyse quantitative data used in the scoring system. 
 
 
Bone area 
Percentage (%) Score 
10.0 – 29.9 0 
30.0 – 49.9 1 
50.0 – 69.9 2 
70.0 – 89.9 3 
Cartilage thickness 
Millimetres (mm) Score 
0.00 – 0.49 3 
0.50 – 1.49 2 
1.50 – 2.49 1 
2.5 + 0 
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2.3.8. Inter- and intra-observer variability 
 
In order to assess the validity and reproducibility of the scores obtained, 10 slides were 
randomly picked as a sample set to be scored. These slides were graded by 5 separate 
individuals who had no previous connection with the scoring system.   
 
This same sample set was also graded on 3 separate occasions by myself in order to 
determine the intra-observer variability.  
 
2.3.9. Analysis 
 
Data were analysed in several stages. Initially the mean sum of OCPs excised per patient 
was analysed with regards to age, sex and anatomical location. Secondly, the data were 
graphed in order to delineate the impact of the cartilaginous and boney parameters on the 
overall scores, looking into whether or not their addition resulted in significant differences 
or not. Thirdly, correlations between histological parameters were analysed. Fourthly, the 
system was tested to see whether or not the overall score could be used to differentiate 
between milder and more severe changes within specific tissue parameters. Lastly, inter- 
and intra-observer variability was assessed.  
 
2.3.9.1. Statistical analysis 
 
Statistical analysis was carried out using Minitab 16, SPSS 16.0 and Microsoft Office 
Excel (2003). Data were examined for normality using the Anderson-Darling statistic. 
Pearson’s and Spearman’s Rank correlation coefficients were calculated for parametric 
and non-parametric variables respectively. Student t-tests were used when comparing two 
sets of normally distributed data; otherwise the Mann Whitney test was used. One-way 
ANOVAs were carried out in order to assess the significance of the variability results.  
 
 
 
 
  
Table 2.2. Criteria for the scoring of individual parameters namely tidemark integrity, cartilage surface integrity and cartilage morphology. 
 
Score Tidemark integrity: Cartilage surface integrity: Cartilage morphology: 
0 
 
Tidemark normal 
 
Smooth surface 
: Superficial layer intact 
 
Normal morphology 
: Organised chondrocyte arrangement 
  
1 
 
Tidemark intact 
: Linear 
: Evidence of cellular invasions 
 
Uneven surface 
: Mild surface irregularity 
 
Altered morphology 
= Includes 1 or more of the following 
: Irregular cell organisation 
: Cell clusters 
 
2 
 
Moderate tidemark disruption 
: Cellular invasions 
: Evidence of vascular invasions 
: Evidence of tidemark duplication  
 
Fibrillated surface 
: Moderate fibrillation 
 
Abnormal morphology 
: Exceptional difference in cellularity 
-Highly cellular/ acellular 
: Cellular organisation highly varied 
 
3 
 
Complete tidemark disruption 
: Non-linear 
: Greater cellular invasions 
: Numerous vascular invasions 
 
 
 
 
 
 
 
 
 
 
 
 
Fissured surface with excessive fibrillation 
: Fissure extends further than surface zone 
 
No cartilage 
: Denuded 
4 
 
No tidemark 
: No cartilage 
 
 
No cartilage 
: Denuded 
 
       Table 2.3.  Scores and overall sum of scores for each osteochondral plug.  
   OCP # 
Medial/ 
Lateral 
Cartilage 
thickness Bone density Tidemark  
Surface 
Integrity 
Cart.  
Morphology Sum 
Mean 
sum 
Patient # Age Sex   mm (0-3) % (0-3) (0-4) (0-4) (0-3) (0-17) (0-17) 
 
1 
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Female 
1 Medial 0.11 3 70.07 3 2 2 1 11  
6.00 2 Lateral 2.41 1 27.63 0 0 0 1 2 
3 Medial 1.67 1 57.61 2 1 2 0 6 
4 Lateral 3.36 0 35.61 1 1 2 1 5 
 
2 
 
73 
 
Male 
5 Lateral 0 3 66.02 2 4 4 3 16  
13.75 6 Lateral 0 3 62.99 2 4 4 3 16 
7 Lateral 0 3 73.16 3 4 4 3 17 
8 Medial 1.69 1 51.81 2 1 1 1 6 
 
3 
 
64 
 
Male 
9 Medial 0.62 2 47.73 1 3 0 2 8  
8.33 10 Medial 1.41 2 66.89 2 3 1 2 10 
11 Medial 3.5 0 45.29 1 1 3 2 7 
 
4 
 
85 
 
Female 
12 Lateral 2.03 1 28.62 0 0 1 0 2  
9.25 13 Medial 1.92 1 39.34 1 1 1 0 4 
14 Medial 0 3 64.13 2 4 4 3 16 
15 Medial 0 3 32.53 1 4 4 3 15 
 
5 
 
72 
 
Male 
16 Medial 0 3 59.03 2 4 4 3 16  
9.17 17 Lateral 2.32 1 30.88 1 2 0 2 6 
18 Medial 0.44 3 74.32 3 1 1 0 8 
19 Medial 0 3 75.36 3 4 4 3 17 
20 Medial 1.25 2 66.95 2 0 1 1 6 
21 Lateral 3.32 0 48.44 1 0 1 0 2 
 
6 
 
45 
 
Female 
22 Lateral 1.87 1 31.52 1 0 0 0 2  
4.33 23 Lateral 3 0 48.3 1 0 1 1 3 
24 Medial 1.99 1 50.96 2 1 3 1 8 
 
7 
 
67 
 
Female 
25 Medial 1.44 2 56.6 2 0 2 1 7  
9.00 26 Medial 0.12 3 82.05 3 4 4 3 17 
27 Lateral 1.88 1 27.47 0 1 2 1 5 
28 Medial 0.81 2 21.13 0 2 1 2 7 
 
8 
 
62 
 
Female 
29 Lateral 2.65 0 50.25 2 1 2 1 6  
7.67 30 Medial 1.08 2 52.16 2 1 1 1 7 
31 Medial 0.61 2 55.6 2 2 3 1 10 
 
9 
 
67 
 
Male 
32 Medial 0.36 3 67.73 2 0 3 1 9  
6.00 33 Lateral 1.85 1 34.81 1 2 0 1 5 
34 Medial 1.9 1 51.51 2 1 2 1 7 
35 Lateral 3.3 0 53.96 2 0 1 0 3 
 
10 
 
69 
 
Male 
36 Medial 1.71 1 22.01 0 2 2 1 6  
7.50 37 Medial 2.25 1 48.78 1 0 1 0 3 
38 Lateral 2.06 1 40.7 1 1 2 0 5 
39 Lateral 0 3 50.04 2 4 4 3 16 
71 
 
2.4. Results 
 
Based on the criteria mentioned previously the five parameters were scored and an overall 
sum of scores between 0 and 17 was generated for each osteochondral plug. In this study 
the overall scores obtained ranged between 2 and 17. Table 2.3 summarises all of the 
scores obtained for individual parameters together with the sum of scores for each 
osteochondral plug.   
 
2.4.1. Scoring of the histological sections from the osteochondral plugs 
 
Figures 2.5 to 2.17 show representative OCP’s from each score obtained. As previously 
outlined, a lower score suggests a more normal state of tissue. Figure 2.5 demonstrates the 
lowest score obtained (score=2) when analysing the OCP’s. There is a relatively thick 
layering of articular cartilage (cartilage thickness (CT)= 2.41mm) which falls within the 
range of normal articular cartilage. The OCP represents mild, initial changes that occur in 
osteoarthritis. The characteristic distribution of chondrocytes within the tissue can be seen; 
there is a flattened layer of cells in the superficial zone, accompanied by the rounded 
isolated cells in the mid-zone. The columns of cells which are typically seen in the deep 
zone are also evident. Early signs of OA include the small groups or clusters of cells. 
Tidemark duplication can also be observed. The articular surface, tidemark and 
subchondral bone are comparable to normal articular cartilage.  
 
Figure 2.6 represents an OCP with an overall score of 3. This OCP shows close 
resemblance to the OCP of score 2. When comparing the two, it is apparent that the 
cartilage thickness is reduced (by approximately 6 percent) and that mild surface 
irregularities are developing. It could be argued that there is an increase in the number of 
cell clusters seen throughout the tissue, however, as a whole, scores 2 and 3 appear to be 
very similar histologically.  
 
Following on from score 3 are scores 4-6, which can be seen in figures 2.7 to 2.9. These 
appear to show the next level in the progression of the disease. Despite the adequate 
cartilage thickness, it can be seen collectively that surface integrity is compromised in 
these OCP’s. Fissuring of the surface is evident, combined with evidence of clustered cells 
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lining the fissured surfaces. In figure 2.7C, a collection of cells within a fibrous pocket 
appears to reside within the SZ. These do not present the typical chondrocytic features and 
so it could be suggested that they are a different cell type. Throughout the tissue, the 
chondrocyte organisation does appear to follow a general trend. However, this trend does 
not appear to correlate with the increasing scores. The trend is that there is an increase in 
cell clusters; however, as mentioned this increase varies between samples. Another 
observation is that the vertical columns of chondrocytes that are usually restricted to the 
deep zone appear to extend beyond this deep zone and into the mid-zone. The tidemark 
between scores 4 and 6 also show great similarities in that they are linear, with moderate 
cellular and vascular invasions threatening the area. Figure 2.8D illustrates a breach of the 
tidemark where cells from the subchondral bone, accompanied by vasculature, are 
migrating into the deep zone of the articular cartilage.  
 
Progressively, scores 7 and 8 depict the next stages in the advancement of the disease. At a 
glance it can be seen that there is still cartilage covering the underlying bone, however the 
quality of the cartilage is severely compromised. The OCP representing score 7 (figure 
2.10) shows excessive fibrillation, comprising deep fissures throughout the articular 
surface. A higher power view of what would be named the superficial zone shows a 
cellular lining throughout the fissured surface. This population appears to be a mixture of 
chondrocyte-like and non chondrocyte-like cells. Examining the tidemark in figure 2.10A 
and D, it can be seen that there are numerous tidemark breaches into the deep zone. 
Interestingly, in the specific case, on the right side of figure 2.10A (higher power can be 
seen in figure 2.10E), an unusual structural arrangement can be seen. There appears to be a 
pocket which is enclosed by a circular fibrous ring (outlined by the X’s) which appears to 
be partly detached from the surroundings. Within this ring is a combination of cells and 
what appears to be vascular vessels anchored into a thick fibrous sheet. This is not only 
interesting because it is atypical, but is also suggests a phenomenon which questions the 
structure of cartilage; as cartilage is renowned for its aneural and avascular composition.   
 
The OCP which represents score 8 depicts another case whereby a cartilaginous layer is 
apparent; however this layer does not appear to represent the usual structure of cartilage. 
In figure 2.11, it can be seen that the cartilage and subchondral bone show little 
resemblance to what would be seen in a normal articular unit other than the two tissues 
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being in proximity to one another. The overlying cartilage resembles fibrocartilage rather 
than hyaline cartilage and this seems to cover the whole surface (as indicated by the white 
star in figure 2.11B). The red stars in figures 2.11B and C pinpoint small regions in what 
would be classified the deep zone where the organisation resembles remaining hyaline 
cartilage; it appears that this region is engulfed by the fibrocartilagenous covering. The 
tidemark is also an interesting factor as it is difficult to delineate. The chondro-osseo 
interface in this OCP is a mesh with several large passages interconnecting the two. The 
black arrows in figures 2.11B and C draw attention to regions within the cartilage where 
vascularisation is occurring, similar to what was seen in the OCP of score 7. The vascular 
regions in figure 2.11B look as though they have resulted from the flow of cells that have 
breached what would have been the tidemark. As a whole, it is interesting to note however 
that the articular surface looks smooth and it would not be fair to say that there is any 
fibrillation present, despite the overall state of the tissue.    
 
Scores 9 and 10 (figures 2.12 and 2.13) represent OCPs illustrating the progression into the 
latter stages of cartilage degradation involved in OA. The cartilaginous layering does not 
cover the entire surface; there are areas where degradation has extended down to the 
subchondral bone. In what remains of the cartilage, fissuring and fibrillation extend 
beyond the surface. The chondrocytes reside largely in clusters and there is only a small 
proportion of isolated cells. Looking at the tidemark, it is evident that established vascular 
canals have been formed. In figure 2.13B an accumulation of cells are located below a 
deep fissure, extending to the tidemark. It is difficult to say whether these cells have 
extended from the surface down, or if they have emerged from the subchondral bone and 
are moving upwards. Looking at figure 2.12D it can be seen that there are multiple 
tidemarks below the original one. A marked difference between scores 9 and 10 is the 
bone thickness. It can be seen that there are far fewer marrow cavities in score 10 and, 
therefore, a higher bone density.  
 
From score 11 to 17, the remaining tissue comprises predominantly of bone. The OCP 
representing score 11 (figure 2.14) has a small region with a very thin (approximately 
200µm) covering of cartilage, however the other OCPs up to score 17 have no cartilage at 
all. A closer look at figure 2.14B shows that despite only a thin layer of cartilage, there are 
still tidemark breaches and, in this case, it can be seen that the breach is an extension of a 
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bone marrow cavity. Interestingly in figure 2.14C, a pocket of soft tissue is outlined by X’s 
and extends from the surface and into the bone. The cells within this region appear to be 
within lacunae, similar to what would be seen in hyaline cartilage. Surrounding this pocket 
are large marrow cavities, suggesting remodelling of some sort.  
 
In this study, no OCPs achieved a score of 12, 13 or 14. This indicates that once the 
degradation has reached a certain point, there are fewer intermediate points; once there is 
no cartilage the bone adapts to the new conditions and there are no in-between stages. 
Having said that, in this study, the difference between OCPs from scores 15 to 17 are that 
the higher the score the greater the bone density. It can be seen in figure 2.15, that there 
are marrow cavities filling up a large proportion of the bone, whereas in figure 2.17, the 
area occupied by marrow cavities is remarkably smaller. The articulating surface of the 
OCP from score 17 appears to be eburnated bone.  
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Score 2: 
 
 
 
 
 
Figure 2.5. A representative osteochondral plug from tibial plateau with an overall score of 2.  
 
Figure A. Low power view of a Masson’s stained OCP with an overall score of 2. The articular 
cartilage (AC) is separated from the underlying subchondral bone (SCB) by the tidemark (TM). 
Scale bar = 1.5mm. 
Figure B. The superficial zone (SZ) of the OCP with a score of 2. The arrows indicate clusters of 
cells forming in the superficial-mid zone. The top arrow indicates a group of cells in a horizontal 
columnar arrangement. Scale bar = 200 µm.  
Figure C. The deep zone (DZ) of the OCP with a score of 2. The top left arrow indicates the 
characteristic vertical column as seen in normal hyaline cartilage. The bottom arrow indicates 
tidemark duplication. Scale bar = 200 µm.  
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Score 3: 
 
 
 
Figure 2.6. A representative osteochondral plug from tibial plateau with an overall score of 3.  
 
Figure A. Low power view of a Masson’s stained OCP with an overall score of 3. The linear 
tidemark (TM) separates the cartilage from the underlying subchondral bone. The fissure seen is a 
processing artefact. Scale bar = 1.5mm. 
Figure B. The superficial zone (SZ) of the OCP with a score of 3. Top arrow highlights slight 
fibrillation of the surface. There is also evidence of cells clusters forming in the superficial zone as 
indicated through the lower arrow. Scale bar = 200 µm.  
Figure C. The mid-zone (MZ) of the OCP with a score of 3. There are relatively low numbers of 
the characteristic isolated, rounded chondrocyte usually found in normal articular cartilage (top 
arrow). The lower arrows indicate the abundance of cell clusters. Scale bar = 200 µm. 
Figure D. The deep zone (DZ) of the OCP with a score of 3. There is a continued presence of 
clusters of chondrocytes within the deep zone. Although there are columns of cells, it does not 
appear to be the predominant chondrocyte organisation within this region. There is evidence of 
cellular migration towards the linear tidemark. Scale bar = 200 µm. 
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Score 4: 
 
 
 
Figure 2.7. A representative osteochondral plug from tibial plateau with an overall score of 4.  
 
Figure A. Low power view of a Masson’s stained OCP with an overall score of 4. The tidemark 
(TM) separates the cartilage from the underlying subchondral bone. Scale bar = 1.5mm. 
Figures B & C. The superficial zone (SZ) of the OCP with a score of 4. Arrow in Figure B 
highlights increased surface fibrillation. Characteristic flattened surface chondrocytes are absent. 
Top arrow in figure C indicates a highly cellular region in the superficial zone. Chondrocyte 
clustering is evident in both figures B and C. Scale bar = 200 µm.  
Figure D. The mid-zone (MZ) of the OCP with a score of 4. The arrow indicates presence of 
chondrocyte clusters in this region. Scale bar = 200 µm. 
Figure E. The deep zone (DZ) of the OCP with a score of 4. The top two arrows highlight the 
presence of clusters as well as columns. Clusters appear to be more numerous when compared to 
the deep zone of OCPs with lower overall scores. Lower arrows highlight the presence of tidemark 
breeches. Tidemark duplication is also evident. Scale bar = 200 µm. 
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Score 5: 
 
 
Figure 2.8. A representative osteochondral plug from tibial plateau with an overall score of 5.  
 
Figure A. Low power view of a Masson’s stained OCP with an overall score of 5. The tidemark 
(TM) separates the cartilage from the underlying subchondral bone. Overall reduction in cartilage 
thickness is apparent. Scale bar = 1.5mm. 
Figure B. The superficial zone (SZ) of the OCP with a score of 5. The top arrow indicates greater 
surface fibrillation relative to the lower scores. Lower arrow indicates a characteristic flattened 
surface zone chondrocyte. Cell clusters are apparent yet sparse. Scale bar = 200 µm.  
Figure C. The mid-zone (MZ) of the OCP with a score of 5. The arrow indicates vertical columns 
normally seen in the deep zone of articular cartilage. Scale bar = 200 µm. 
Figure D. The deep zone (DZ) of the OCP with a score of 5. Top arrow highlights the presence of 
typical vertical columns. Lower arrows highlight the presence of cellular and vascular tidemark 
breeches. Scale bar = 200 µm. 
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Score 6: 
 
Figure 2.9. A representative osteochondral plug from tibial plateau with an overall score of 6.  
 
Figure A. Low power view of a Masson’s stained OCP with an overall score of 6. The linear 
tidemark (TM) separates the cartilage from the underlying subchondral bone. Bone thickening is 
apparent. Scale bar = 1.5mm. 
Figure B. The superficial zone (SZ) of the OCP with a score of 6. Moderate fibrillation can be 
seen in superficial zone. Cell clusters as indicated by the arrows are evident near the fissured 
surfaces. There is an absence of cells in the transitional region between the surface and the mid 
zone. Scale bar = 200 µm.  
Figure C. The mid-zone (MZ) of the OCP with a score of 6. The arrows highlight the presence of 
chondrocyte clusters as well as vertical columns in the mid-zone. There are few rounded isolated 
cells as would be seen in the normal articular cartilage. Scale bar = 200 µm. 
Figure D. The deep zone (DZ) of the OCP with a score of 6. Top arrow highlights the presence of 
columns that appear at a tangent rather than vertical. Lower arrows indicate the cellular migration 
towards the tidemark as well as the cellular and vascular breaches of the tidemark. Scale bar = 200 
µm. 
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Score 7: 
 
Figure 2.10. A representative osteochondral plug from tibial plateau with an overall score of 7.  
 
Figure A. Low power view of a Masson’s stained OCP with an overall score of 7. The linear 
tidemark (TM) separates the cartilage from the underlying subchondral bone. Bone thickening is 
excessive and surface fibrillation apparent. Scale bar = 1.5mm. 
Figure B. The superficial zone (SZ) of the OCP with a score of 7. Fibrillation extending deeper 
than the surface zone is evident. Fissured surfaces appear to be highly cellular as indicated by the 
arrow. Scale bar = 200 µm.  
Figure C. The mid-zone (MZ) of the OCP with a score of 7. The arrow indicates the presence of 
cell clusters. Scale bar = 200 µm. 
Figure D. The deep zone (DZ) of the OCP with a score of 7. The top arrows highlight the presence 
of characteristic vertical chondrocyte columns. The lower arrow exemplifies the cellular breaches 
of the tidemark. Scale bar = 200 µm. 
Figure E. Part of the mid zone (MZ). An abnormal pocket is evident as outlined by the X’s. There 
appears to be a circular fibrous covering surrounding the abnormal region containing vascular 
vessels. Scale bar = 400 µm.  
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Score 8: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.11. An osteochondral plug from tibial plateau with an overall score of 8.  
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Figure 2.11. An osteochondral plug from tibial plateau with an overall score of 8.  
 
Figure A. Low power view of a Masson’s stained OCP with an overall score of 8. The reduced 
thickness of the articular cartilage is apparent. The tidemark is barely recognisable as there are 
numerous extensive breeches. There is no distinction between the zones of articular cartilage. Scale 
bar = 1.5mm. 
Figure B. The region highlighted by the left red box in figure A. Tissue appears highly cellular 
with a fibrous organisation (indicated by the white star). Black arrows point toward a major breech 
from the subchondral bone, where vascularisation is evident. The red star indicates a different 
region which appears to be hyaline cartilage-like, with chondrocytes located within lacunae. Scale 
bar = 200 µm.  
Figure C. The region highlighted by the right red box in figure A. Black arrows indicate 
vascularisation within the cartilaginous region, surrounded by the fibrous covering. The red star 
indicates a hyaline-like region encapsulated by the thick fibrous covering. Scale bar = 200 µm. 
Figure D. A panoramic view of the articulating surface. Cellular organisation is not representative 
of hyaline cartilage and there is extensive tidemark disruption. The surface does not appear to be 
fissured. Red stars correlate to those in figures B and C. Scale bar = 400 µm. 
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Score 9: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.12. A representative osteochondral plug from tibial plateau with overall score of 9.  
 
Figure A. Low power view of a Masson’s stained OCP with an overall score of 9. The linear 
tidemark (TM) separates the cartilage from the underlying subchondral bone. Regression in 
cartilage thickness is evident, together with fissuring throughout the whole surface. Bone 
thickening below the tidemark is apparent. Scale bar = 1.5mm. 
Figures B & C. The superficial zone (SZ) of the OCP with a score of 9. Cell clusters are 
predominant. However, there are few remaining single cells as indicated by the arrow in figure B. 
Figure C demonstrates the excessive surface fissuring, with the surrounding clusters of cells. Scale 
bar = 200 µm.  
Figures D & E. The deep zone (DZ) of the OCP with a score of 9. Through figure D it can be seen 
that the majority of the chondrocytes in this region are located within clusters. In figure E, as well 
as clusters, there are a greater proportion of cells orientated in the typical columnar arrangement 
(indicated by the arrows). Vascular and cellular invasions are also apparent, together with great 
tidemark duplication as indicated by the red star in figure D. Scale bar = 200 µm. 
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Score 10: 
 
 
Figure 2.13. A representative osteochondral plug from tibial plateau with an overall score of 10.  
 
Figure A. Low power view of a Masson’s stained OCP with an overall score of 10. The residual 
overlying cartilage is minimal. The subchondral bone is thick and contains blood vessels and bone 
marrow cavities. Scale bar = 1.5mm. 
Figures B & C. The remaining cartilage and tidemark from the OCP with a score of 10. 
Chondrocytes are all located within clusters as indicated by the arrows. The articular surface is 
highly fissured. Figure B shows an accumulation of cells located below a deep fissure. Scale bar = 
200 µm.  
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Score 11: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.14. A representative osteochondral plug from tibial plateau with an overall score of 11.  
 
Figure A. Low power view of a Masson’s stained OCP with an overall score of 11. There is a very 
thin covering of cartilage over two thirds of the OCP. The subchondral bone has numerous blood 
vessels near the articular surface. There is an abnormal pocket of cells (imaged in figure C). Scale 
bar = 1.5mm. 
Figure B. The remaining articular cartilage from the OCP with a score of 11. The surface is 
fissured. Multiple tidemarks are illustrated by the red star. There is evidence of vascularisation and 
cellular breeches at the tidemark as indicated by the arrow. Scale bar = 200 µm.  
Figure C. An abnormal pocket is evident as outlined by the X’s. There appears to be a highly 
cellular region extending from the surface into the bone or vice versa. Large regions of marrow 
cavity surround the abnormal pocket. Arrow indicates tidemark duplication. Scale bar = 200 µm.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
86 
 
Score 15: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.15. A representative osteochondral plug from tibial plateau with an overall score of 15.  
 
Figure A. Low power view of a Masson’s stained OCP with an overall score of 15. There is no 
overlying articular cartilage. Large marrow cavities reside within the subchondral bone. Scale bar 
= 1.5mm. 
Figure B. A cellular pocket extending from the surface into the bone. Cells located within lacunae 
are characteristic of chondrocytes. Vascular channels can be seen within the bone. Scale bar = 200 
µm.  
Figure C. A highly cellular region of a marrow cavity extending towards the surface of the 
articulating bone is indicated by the red star. A vascular channel can also be seen between the 
surface of the bone and the highly cellular cavity. Scale bar = 200 µm.  
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Score 16: 
Figure 2.16. A representative osteochondral plug from tibial plateau with an overall score of 16.  
 
Figure A. Low power view of a Masson’s stained OCP with an overall score of 16. There is no 
overlying articular cartilage. The bone area is more dense than in the lower score as a result of 
smaller marrow cavities. Scale bar = 1.5mm. 
Figure B. A vascular/marrow cavity within the bone. Arrows are indicative of vascular channels. 
A cellular region sits within the bone cavity. Scale bar = 200 µm.  
 
 
 
Score 17: 
 
Figure 2.17. A representative osteochondral plug from tibial plateau with an overall score of 17.  
 
Figure A. Low power view of a Masson’s stained OCP with an overall score of 17. There is no 
overlying articular cartilage and the bone is very dense. Scale bar = 1.5mm. 
Figure B. A higher power image of the bone. Vascular channels are indicated by the arrows. The 
size of the cavity is smaller in relation to the lower scores. Scale bar = 200 µm.  
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2.4.2. Scoring of osteochondral plugs 
 
Having assembled all of the scores for the OCPs (table 2.3) it was possible to examine data 
between parameters. For each patient, several OCPs were excised representing the 
topographically different regions within the medial and lateral compartments. Using the 
overall scores obtained from each OCP, a mean sum of overall scores was calculated for 
each patient in order to give an indication of the severity of the tibial plateau as a whole. 
Figure 2.18 demonstrates the relationship between patient age and the mean sum of overall 
scores obtained for the patient. The blue line indicates the positive regression line which 
suggests that as age increases, the severity of OA also increases. Pearson’s correlation test 
showed a significant correlation between the two parameters (p<0.05).  
 
Using the mean sum of scores, differences in sex were examined in order to ascertain 
whether or not sex is a variable factor affecting the severity of OA. The mean sum of 
scores in the females ranged from 4.3 to 9.3. In the males this was slightly higher ranging 
from 6 to 13.75, however this difference was not statistically significant when tested using 
a student t-test (figure 2.19).  
 
Figure 2.20 is a box plot comparing scores obtained from medial and lateral OCPs. It can 
be seen that despite the range of scores being similar, the median in the medial side is 8, 
which is higher than the median in the lateral side which is 5. This suggests that as a 
whole, the medial side is more severely affected than the lateral side. Using the Mann-
Whitney test statistical significance was confirmed (p<0.02).  
  
 
 
 
 
 
 
89 
 
908070605040
15.0
12.5
10.0
7.5
5.0
Age
M
ea
n 
su
m
 (
0-
17
)
Scatterplot of patient age vs overall score of OCP
 
 
Figure 2.18. A scatter-plot illustrating the relationship between the patient age and the mean sum 
of scores obtained through the scoring system (n=10). Blue line indicates the trendline. Pearson’s 
correlation test confirmed that there is a significant relationship between the parameters (p<0.05). 
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Figure 2.19. A box-plot showing the distribution of mean overall scores obtained from OCP’s 
between female (n=5) and male (n=5) patients. The midline of the box-plot is representative of the 
median value (f=7.67, m=8.33), the second and third quartiles are displayed as a box and the first 
and third quartiles as whiskers. Student t-test confirmed that there were no statistical differences 
between these two groups (p>0.05).  
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Figure 2.20. A box-plot comparing the differences in overall scores of OCPs excised from the 
medial (n=23) and lateral (n=16) tibial condyles. The midline of the box-plot is representative of 
the median value (l=5, m=8), the second and third quartiles are displayed as a box and the first and 
third quartiles as whiskers. Mann Whitney test was used to confirm that the differences between 
the two groups was significant (p<0.02). 
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Moving on more specifically to the parameters used for scoring the OCPs, figures 2.21 and 
2.22 are scatter graphs showing the relationship of scores obtained when looking solely at 
the cartilage parameters, or solely at the bone parameters, in relation to the score obtained 
when combining both the cartilage and bone. In these graphs the adjusted score represents 
the score as a percent of the maximum possible score. This was calculated in order to keep 
constant the overall score; without a percentage of the total it would be unfair to compare a 
score out of 17 to a score out of 10 as it is for the cartilage parameters alone. Figure 2.21 
shows the relationship between scores obtained with and without bone factors. The blue 
line indicates the trend line which suggests that as the combined cartilage and bone score 
increases, the cartilage parameters alone also increase at a similar rate. These findings 
were confirmed using Spearman’s rank correlation coefficient where p<0.01. This 
suggests that by including the bone based parameters does not significantly alter the score 
which would have otherwise been achieved using solely the cartilage based parameters. 
Figure 2.22 is a similar scatter graph which shows the relationship between scores 
obtained with and without cartilage parameters. Again, a positive relationship can be seen 
between the two which was confirmed by Spearman’s rank correlation coefficient p<0.01. 
Studying this graph it can be concluded that including the cartilage parameters does not 
alter the score trend which would have otherwise been obtained from only the bone based 
scores. It can also be noted from the graph that the progression in bone scores occurs in 
line with the progression achieved when scoring the unit as a whole. In this way it can be 
said that the bone changes are just as significant and happen together with the changes 
observed in the cartilage.  
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Figure 2.21. A scatter-plot demonstrating the relationship of scores (n=39) when comparing those 
obtained using only the cartilage parameters to the scores obtained using both the cartilage and the 
bone parameters. Blue line is indicative of the trendline. Spearman’s rank correlation coefficient 
confirmed that the two variables showed a significant correlation (p<0.01). 
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Figure 2.22. A scatter-plot demonstrating the relationship of scores (n=39) when comparing those 
obtained using only the bone parameters to the scores obtained using both the bone and the 
cartilage parameters. Blue line is indicative of the trendline. Spearman’s rank correlation 
coefficient confirmed that the two variables showed a significant correlation (p<0.01). 
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2.4.3. Correlations between histological parameters 
 
Using the whole data set correlation coefficients were produced. Cartilage thickness was 
significantly and negatively correlated with percentage bone area, tidemark integrity, 
surface integrity and cartilage morphology (p<0.05). The cartilage thickness and tidemark 
integrity showed the greatest correlation coefficient (results not shown). 
 
Bone area was also significantly correlated with all parameters. The percentage of bone 
correlated negatively with the cartilage thickness and demonstrated positive correlations 
with the tidemark, surface and morphology parameters. Pearson’s and Spearman’s rank 
correlation coefficients in all cases produced a significant p<0.05 value. Figure 2.23 
illustrates the negative regression line produced when correlating the percentage of bone to 
the cartilage thickness.  
 
The bar charts seen in figures 2.24 to 2.26 demonstrate frequencies of the categorical 
parameters in relation to the categorical bone scores. Looking specifically at figure 2.24 it 
is evident that with increasing bone score there is an increasing number of samples that 
had a tidemark score of 4 (highest score). The low tidemark scores (scores 0 and 1) are 
abundant in the lower bone score categories. It is also possible to suggest that the bone 
scores appear to become higher (suggesting a more diseased state) prior to the changes to 
the tidemark. In other words, with the increasing bone scores, there remains an abundance 
of lower tidemark scores whilst also seeing an increase in the numbers of higher tidemark 
scores. It is only when the state of the bone appears at its worst (score 3) that the lower 
tidemark scores reduce. As mentioned, this may indicate that changes to the subchondral 
bone precede the tidemark changes. Interestingly, there is a lack of tidemark score 3 in the 
highest bone score category. A possible reason for this may be that once changes do begin 
to occur in the tidemark, it then deteriorates rapidly and, as a consequence, falls into the 
highest scoring category rather than score 3. Data were computed using the crosstabulation 
method on SPSS, showing statistical significance when analysed using Spearman’s rank 
correlation for ordinal variables (p<0.01). 
 
Figures 2.25 and 2.26 show similar trends when compared to figure 2.24. When the bone 
achieves the highest score (score 3), the most frequent score obtained for the surface 
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integrity and cartilage morphology is also the highest score. In figure 2.25, the low surface 
integrity scores are restricted to the low bone scores. As the state of the bone progresses, it 
seems that the changes to the surface are variable in that there are samples whose surface 
integrity deteriorates at what seems to be a relatively similar rate to the bone. However, 
there are also many samples whose bone scores are high but whose surface scores remain 
low. It is important to note however, that data in figure 2.26 did not generate a significant 
correlation despite following the general trend (p>0.05).  
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Figure 2.23. A scatter-plot showing the correlation between the amount of bone (%) and 
the cartilage thickness (mm) within the whole data set (n=39). Blue line is indicative of the 
trendline. Pearson’s and Spearman’s correlation tests demonstrate a significant difference 
between the parameters (p<0.01). 
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Figure 2.24. Frequency bar charts showing tidemark integrity scores obtained relative to 
the bone scores within the whole data set (n=39). Lower scores are indicative of a more 
normal state. Spearman’s rank correlation for ordinal variables suggest a significant trend 
(p<0.05). 
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Figure 2.25. Frequency bar charts showing surface integrity scores obtained relative to the 
bone scores within the whole data set (n=39). Lower scores are indicative of a more 
normal state. Spearman’s rank correlation for ordinal variables suggest a significant trend 
(p<0.01). 
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Figure 2.26. Frequency bar charts showing cartilage morphology scores obtained relative 
to the bone scores within the whole data set (n=39). Lower scores are indicative of a more 
normal state. Spearman’s rank correlation for ordinal variables did not suggest a 
significant trend (p>0.05). 
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2.4.4. Using the scoring system to distinguish ‘mild’ and ‘severe’ samples of OA 
 
Obtaining a score between 0 and 17 represents the overall state of tissue, as the more 
‘normal’ the sample, the lower the score. The system was tested to see whether or not 
these overall scores could be used to distinguish between ‘mild’ from ‘severe’ OA 
samples. Within the data set, as previously mentioned, the overall scores ranged from 2 to 
17, and the mean of all scores was 8.26. Based on this observation, the overall scores were 
used to group the milder cases from the more severe cases of OA. Scores between 0 and 8 
were categorised under ‘mild OA’ and scores between 9 and 17 were categorised under 
‘severe OA’. Figure 2.27 illustrates the difference between the two groups. It can be seen 
that in the mild category, the median score is 6 where as in the severe category the median 
is 16. The difference between the two groups was shown to be statistically significant 
(p<0.01) when analysed using a Mann-Whitney test for non-parametric data.  
 
Using these two separate groups, the individual parameters were analysed to see whether 
the overall sum was accurate in distinguishing mild from severe OA groups. Table 2.4 
shows the breakdown of frequencies within the individual categorical parameters, enabling 
us to assess whether scores obtained through the scoring system was representative of 
individual parameters (figures 2.28 – 2.32). 
 
For cartilage thickness and bone area, the continuous data was used rather than the 
categorical data (figures 2.28 and 2.29). The median cartilage thickness in the mild group 
was 1.91mm, whereas in the severe group the majority of the samples were denuded 
resulting in a thickness of 0mm. This demonstrates a great difference between the two 
groups which was statistically confirmed using a Mann-Whitney test (p<0.01). This result 
confirms that the overall scores obtained from the scoring system can be used to 
distinguish 2 significantly different groups (mild and severe); in this case within the 
cartilage thickness parameter. Similarly, figure 2.29 illustrates the bone area box-plot. The 
median bone area within the mild group was 48 percent, compared to the median within 
the severe OA group which was 66 percent. Student t-tests confirmed that the two groups 
were significantly different (p<0.01).   
 
The categorical parameters are represented in figures 2.30 to 2.32. Figure 2.30 shows the 
tidemark integrity scores within the mild OA and the severe OA groups. The mode in the 
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mild group is 1, whereas the mode in the severe group is 4. This pattern of results is 
consistent within the other parameters namely, surface integrity and cartilage morphology 
as shown in figures 2.31 and 2.32. Mann Whitney tests carried out on all sets of data 
confirmed that the mild and severe OA groups could be classed as two significantly 
different groups based on the scores obtained (p<0.01). 
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Figure 2.27. A box-plot showing the differences in overall scores for the mild OA group 
compared to the severe OA group. The midline of the box-plot is representative of the 
median value (m=6, s=16), the second and third quartiles are displayed as a box and the 
first and third quartiles as whiskers. Mann Whitney test shows that the difference between 
these two groups is significant (p<0.01).    
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Table 2.4. Frequency table summarising the distribution of scores within each parameter, 
between the ‘mild OA’ and the ‘severe OA’ groups. 
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Figure 2.28. A box-plot showing the differences in cartilage thickness (mm) between the 
mild and severe OA groups. The median in the mild group is 1.91 mm and in the severe 
group is 0.00mm. Mann Whitney test shows that the difference between these two groups 
is significant (p<0.01). Suspected outliers are represented by an asterix (*). 
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Figure 2.29. A box-plot showing the differences in bone area (%) between the mild OA 
group compared to the severe OA group. The median in the mild group is 48.02 and 66.02 
in the severe group. Student t-test shows that the difference between these two groups is 
significant (p<0.01).    
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Figure 2.30. A box-plot showing the differences in tidemark integrity (TI) in the mild OA 
group compared to the severe OA group. The median in the mild group is 1 and 4 in the 
severe group. Mann Whitney test shows that the difference between these two groups is 
significant (p<0.01).    
Severe OAMild OA
90
80
70
60
50
40
30
20
%
 b
on
e 
ar
ea
Bone area (%) in mild vs severe regions of OA
101 
 
SI severeSI mild
4
3
2
1
0
Su
rf
ac
e 
in
te
gr
it
y 
sc
or
e 
(0
-4
)
Surface integrity scores in mild vs severe OA
 
Figure 2.31. A box-plot showing the differences in surface integrity (SI) in the mild OA 
group compared to the severe OA group. The median in the mild group is 1 and 4 in the 
severe group. Mann Whitney test shows that the difference between these two groups is 
significant (p<0.01).    
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Figure 2.32. A box-plot showing the differences in cartilage morphology (CM) in the mild 
OA group compared to the severe OA group. The median in the mild group is 1 and 3 in 
the severe group. Mann Whitney test shows that the difference between these two groups 
is significant (p<0.01).    
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2.4.5. Variability 
 
Inter- and intra-observer variability was examined in order to assess the validity and 
reproducibility of the results. Studying the inter-observer results, figure 2.33 illustrates the 
sum of scores of the 10 OCPs. It can be seen that the combined scores range between 64 
and 71. The standard deviation for individual OCPs should not be regarded as relevant 
information as this is based on the varying scores of the different plugs. What should be 
observed, however, is how the standard deviation varies between OCPs as this is what 
gives the indication on how much variation there was between the OCPs. This information 
is also summarised in table 2.5. One way ANOVAs confirmed that there was no 
significant variation between observers.  
 
Figure 2.34 shows the mean scores of OCPs scored by the different observers, ranked in 
order of severity. In this case, the error bars demonstrating standard deviations are 
indicative of the variation that each OCP obtained. It is evident through looking at this 
chart that there was greatest variation in the lowest score (SD=1.13), and that with 
increasing scores and, therefore, more diseased tissue. There was no variation between 
observer scores (indicated by the fact that SD=0).  
 
Intra-observer variability results show very similar trends when compared to the 
inter-observer results. Relating to figure 2.35 which illustrates the combined sum of scores 
achieved on the 3 separate occasions, it can be seen that there is a smaller range of scores 
(64-67). The range of standard deviation is also smaller indicating that intra-observer 
scoring demonstrate more reproducibility than the inter-observer scoring.  
 
Similar to figure 2.34, figure 2.36 shows that within the intra-variability scores, there is 
greater variability in the lowest scores OCP, and that the highest scores show no variation 
(SD=0). In 60 percent of the OCPs, there was no variation in the overall score obtained on 
the 3 separate occasions.  
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2.4.5.1. Inter-observer  
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Figure 2.33. A Bar chart illustrating the combined overall scores obtained between 
observers. The combined scores ranged between 64 and 71 when grading 10 OCPs. Error 
bars are indicative of standard deviation. One way ANOVA confirmed that there was no 
significant difference between observer scores (p=0.99). 
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Figure 2.34. A bar chart showing the mean scores of OCPs scored on 7 occasions by 
different people, ranked in order of severity. The error bar shows the standard deviation 
(SD) of scores, indicating the level of variability between observers for each OCP. OCPs 
G-H show no error bars as the SD was 0. 
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OCP Observer MEAN SD 
  1 2 3 4 5 6 7     
A 0 1 2 2 0 2 3 1.43 1.13 
B 2 3 3 3 2 2 4 2.71 0.76 
C 3 3 3 1 3 3 3 2.71 0.76 
D 4 3 3 3 3 4 4 3.43 0.53 
E 5 5 5 6 6 6 7 5.71 0.76 
F 6 7 7 5 7 7 6 6.43 0.79 
G 11 11 11 11 11 11 11 11.00 0.00 
H 11 11 11 11 11 11 11 11.00 0.00 
I 11 11 11 11 11 11 11 11.00 0.00 
J 11 11 11 11 11 11 11 11.00 0.00 
TOTAL 64 66 67 64 65 68 71   
SD 4.27 4.09 3.95 4.20 4.33 3.94 3.57   
 
Table 2.5. Summary of inter-observer scores for 10 OCPs. The mean score for each OCP 
is shown, as well as the total combined score achieved from each observer. SD = standard 
deviation.  
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2.4.5.2. Intra-observer 
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Figure 2.35. A Bar chart illustrating the combined overall scores obtained on three 
separate occasions by the same observer. The combined scores ranged between 64 and 67 
when grading 10 OCPs. Error bars are indicative of standard deviation. One way ANOVA 
confirmed that there was no significant difference between observer scores (p=0.99). 
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Figure 2.36. A bar chart showing the mean scores of OCPs scored on 3 occasions by 
myself, ranked in order of severity. The error bar shows the standard deviation (SD) of 
scores, indicating the level of variability between scores obtained throughout the 3 
occasions. OCPs C, E and G-J show no error bars as the SD was 0.  
 
106 
 
OCP Occasion  MEAN SD 
  1 2 3     
A 0 1 2 1.0 1.0 
B 2 3 3 2.7 0.6 
C 3 3 3 3.0 0.0 
D 4 3 3 3.3 0.6 
E 5 5 5 5.0 0.0 
F 6 7 7 6.7 0.6 
G 11 11 11 11.0 0.0 
H 11 11 11 11.0 0.0 
I 11 11 11 11.0 0.0 
J 11 11 11 11.0 0.0 
TOTAL 64 66 67   
SD 4.27 4.09 3.95   
 
Table 2.6. Summary of intra-observer scores for 10 OCPs. The mean score for each OCP 
is shown, as well as the total combined score achieved from each observer. SD = standard 
deviation.  
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2.5. Discussion 
 
The relationship between the overlying cartilage and the subchondral bone has been 
observed for decades. Radin et al., (1986) stated that “the health and integrity of the 
overlying articular cartilage depends on the mechanical properties of its bony bed, and that 
alterations of the bony bed occur before the cartilage changes”. Despite this heavily sited 
article and the abundance in literature emphasising the involvement of the subchondral 
bone in and throughout the course of OA, the articular cartilage remains in the spotlight 
when assessing the severity of diseased tissue. The cartilage is not only isolated from all 
other tissues to be used as the sole tool for judgement, but the cartilage is also stripped 
from its core; the subchondral bone, to which it is directly anchored. The process of 
detaching the cartilage from the bone has been questioned by many; a recent study by 
Amin et al., (2009) addressed this issue and went on to suggest that the condition of the 
underlying bone significantly influenced chondrocyte survival in the overlying cartilage. 
So the question to be raised is ‘why is the subchondral bone overlooked when its 
involvement is so widely accepted?’.  
 
A new scoring system: a histological view 
 
The purpose of this new scoring system was not only to incorporate the subchondral bone, 
but also to obtain overall scores for the graded tissue that was indicative of the diseased 
state. Figures 2.5 to 2.17 demonstrate the increasing scores, mapping out stages in the 
progression of OA. The range of possible scores obtained from this scoring system is 0-17, 
however within these data sets the lowest obtained score was 2. As the patients who 
underwent total knee replacement surgery were diagnosed with OA, it would be surprising 
to find normal (score=0) OCPs, as this would suggest that the tissue was unaffected by the 
disease and surgery would, therefore, be unnecessary. Relating once again to the range of 
scores, another interesting point to note was that within the OCPs, scores 12-14 were 
absent. As briefly discussed in the results section, this could indicate that once the 
degradation has reached a certain point, the changes occur at a much quicker rate and so 
there are fewer intermediate points. 
 
Addressing specifically the changes within the cartilage morphology, it appears that in 
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general, cell clustering was a feature throughout all stages of the disease where cartilage 
was present, varying between OCPs but not following any general trend. It could be said 
that clusters were larger and/or more abundant in more severe OCPs but this was not 
always the case. It is widely discussed in the literature that clustering of chondrocytes is 
indicative of mitotic activity resulting in cell proliferation, however it has also been 
proposed that clustering may be a result of cellular migration (Kouri et al., 1996, Morales, 
2007). It would be interesting to know whether the chondrocyte clusters resulted from cell 
migration, or cell proliferation as this would give an indication of the mechanisms 
involved in the changes that occur. The typical structured organisation of cartilage was 
also ambiguous as there were some severe cases where there was evidence of an organised 
matrix, as well as some milder cases with little structural organisation. Based on this 
finding, it could be argued that the overall cartilage morphology does not necessarily 
represent the overall state of disease within OCPs. This theory however, challenges many 
of the current scoring systems as they are heavily weighted on the cartilage structure and 
morphology (Collins and Mc, 1960, Mankin et al., 1971).  
 
The cartilage surface integrity as well as the tidemark integrity do appear to follow a 
general trend based on the histological sections, in that the higher scores show more severe 
changes. Having said that, duplication of the tidemark and/or multiple tidemarks do not 
seem to represent the severity as a whole, as they were seen sporadically throughout the 
OCPs. 
 
The OCP of score 7 (figure 2.10) showed in interesting feature within the articular 
cartilage which can be seen outlined by X’s. As aforementioned, there is a region which 
appears to be encapsulated by a circular fibrous covering, containing an unfamiliar variety 
of components. Further analysis confirmed that within this pocket vascular channels had 
accumulated in this area. This is intriguing as articular cartilage is renowned for its 
avascular structure. The question to be raised is ‘where did this accumulation originate 
from’? It could be a result of down-migration from the synovial fluid, or it could be up-
migration from the subchondral bone via invasions through the tidemark. The fibrous 
covering also appears to be partly detached from the surrounding tissues suggesting that it 
is a separate unit residing within the articular cartilage. The assumption that could be made 
is that a repair response is occurring within the tissue, however, the problem that this raises 
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relates to the process that occurs in endochondral ossification. Following vascularisation, 
mineralisation occurs leading to collagen type X production and eventual terminal 
differentiation and ossification. This would be detrimental to the cartilage whose structure 
and function is aimed to enable low-friction movement. 
 
The OCP of score 8 (figure 2.11) could be referred to as an anomaly. Despite a relatively 
smooth articular covering, the characteristics of the tissue are hugely altered when 
compared to the normal composition of articular cartilage. Clinically, this could be 
misleading as the articular surface is often examined prior to TKRs by arthroscopy, and 
the surface of this OCP is relatively smooth with no fissures or fibrillation. Within the 
cartilage, there are regions (which are indicated by the red stars), which resemble hyaline 
cartilage, representing a very small portion of the tissue as a whole. In saying so, it appears 
that another cell type has taken over the tissue and the hyaline-like areas are the ‘last 
standing’ areas. A question to ask, is ‘given time would those remaining regions also have 
been displaced’? The invading fibrous connective tissue appears to be the result of a repair 
response, and there is evidence of cellular infiltration totally destructing the tidemark. It 
could be hypothesised that the invading cells are mesenchymal stem cells (MSC’s) which 
are being triggered into producing a repair tissue. As well as the cellular influx, 
vascularisation was also apparent, and this could follow on as a consequence of the MSCs 
entering the area. The non-characteristic cartilage and vascularisation brings to mind the 
thought that the repair tissue being formed may be a ‘pannus-like’ tissue. Pannus is an 
inflammatory response normally seen in rheumatoid arthritis, however, a pannus-like 
tissue has previously been reported in OA (Shibakawa et al., 2003). This is important to 
note as it may signify cross-relations between rheumatoid and osteoarthritis, and also 
supports reports which state that OA does in fact have an inflammatory response.  
 
With regards to the ‘pannus-like’ tissue, there were other OCPs with small, highly cellular, 
fibrous regions (scores 4, 7, and 10; refer to figures 2.7C , 2.10B and 2.13B respectively). 
Although these regions are insignificant in comparison to the OCP in score 8 (figure 2.11), 
they may be indicative of an early stage in the process. In the figures mentioned, the 
regions in question were indicated with a black arrow.  
 
Moving through the scores to the more severe cases, it could be suggested that within the 
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scoring system, scores 9-10 represent the time frame in which the last of the cartilage 
remains. That said, the cartilage is highly fissured, and the tissues possess few of the 
characteristics that normal articular cartilage should. The subchondral bone appears to 
have thickened, and at this point one could assume that the cartilage was doing little in 
terms of transmitting the high compressive/tensile forces which would be imposed on the 
weight bearing joint. Scores 11 through to 17 are representatives of the remaining 
underlying bone. The increasing scores show the progression from a relatively porous 
bony area with pockets extending to the surface, to a more compact structure with few 
marrow cavities.  
 
Analysing the differences in patient data 
 
OA is a degenerative joint disease commonly characterised by progressive erosion of the 
articular cartilage. The correlation between increasing age and prevalence of OA has been 
heavily documented (Aigner et al., 2007) and there has been evidence to show that age-
related changes in the function of chondrocytes may contribute to the development and 
progression of OA (Buckwalter and Mankin, 1997). In saying that, results from these data 
sets adhere to this general trend. It is important to note however, that the scatter graph in 
figure 2.18 represents the age at which the patient underwent TKR, and this does not 
indicate the initial age at which the patient was diagnosed with OA. In terms of gender 
differences in OA, there is mixed information in the literature as some authors have found 
no differences (Davis et al., 1988), whereas others have described a 1.5-4 times higher risk 
in women than in men (Tsai and Liu, 1992). The data sets used in the present study (figure 
2.19) showed no significant gender differences; this could, however, be verified by 
increasing the patient number in the study. 
 
In relation to compartmental differences, there was significant evidence in this study to 
suggest that the medial compartment is more severely affected than the lateral 
compartment. This is in line with previous findings by Ledingham et al., (1993) who found 
that the medial compartment disease was 4 times more common than the lateral.  
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Relevance of bony parameters as components in OA scoring 
 
Scoring systems to date focus largely on the state of the hyaline cartilage when assessing 
the severity of OA. In this scoring system, the subchondral bone and tidemark integrity 
were added as components to assess the articular unit as a whole. In doing so, scatter 
graphs were produced so that it was possible to see the impact of the bone based scores 
when they were added to the cartilage scores. Similarly, we tested to see whether or not 
adding the cartilage based scores to the bone scores made a difference to the overall output 
(figures 2.21 and 2.22). In both cases, it was found that there was a significant correlation 
between the two scores. This not only suggests that the changes to the bony parameters are 
happening congruent to the cartilaginous changes, but potentially, suggests that the bony 
parameters alone may be sufficient to assess the severity of OA, as the score obtained 
when grading only with the bone parameters correlated to the score obtained when 
assessing the unit as a whole. This could open a pathway for clinicians in assessing the 
severity of changes in OA prior to TKRs, as a less invasive method of examination using 
imaging techniques such as MRI.  
 
Correlating the histological parameters 
 
Correlating the histological parameters established that the bone area was a parameter that 
serves as an indicator as well as any of the other parameters, the difference being that the 
bone area can be assessed quantitatively. The bone area correlated negatively with the 
cartilage thickness, and positively with the tidemark and surface integrity parameters. This 
ties in with the hypothesis of the subchondral bone involvement in OA, as the changes 
occur parallel, or possibly even prior, to the changes in the other parameters, based on the 
finding that while the bone scores appeared to be high, there were still high frequencies of 
low-scoring cartilage parameters (refer to figure 2.25). Interestingly, there was not a 
significant trend found when comparing the bone score to the cartilage morphology score. 
This was not surprising as, histologically, it was shown that there were large variations in 
the cartilage at all levels of severity. However, it does challenge the current scoring 
systems which rely largely on the assessment of the cartilage morphology. 
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Using the scoring system to distinguish between ‘mild’ and ‘severe’ OA 
 
Using the mean as the midpoint to distinguish between the milder and the more severe OA 
samples, the overall sum was successful in generating two significantly different states of 
severity. This was further confirmed by studying individual parameters. The difference 
between the cartilage thickness was more apparent than the difference between the bone 
area within the two groups. However, the mechanisms involved differ between the two 
and, therefore, it is not possible to conclude that the cartilage is being affected to a greater 
extent. The important point to note is that the changes within the bone parameter were 
significant and that these differences did correlate with the mild/severe group as 
categorised through the overall sum.  
 
The qualitative parameters which include the tidemark, the articular surface and the whole 
cartilage morphology, as previously mentioned, showed similar trends in that there was a 
significant difference in the distribution of scores obtained in the mild versus the severe 
samples. This re-established the point that the scores assigned when assessing the tissue as 
a whole do indeed match up with scores from the individual qualitative parameters, and 
that the scoring system can successfully separate the milder cases from the more severe 
cases.  
 
On a separate note, the parameters were assigned based on the fact they are not influenced 
by the fixation and staining process. Most current scoring systems incorporate matrix 
staining as a variable to be assessed, based on the level of proteoglycan staining achieved. 
It is well documented however, that proteoglycan leaching is often associated with fixation 
methods and so the reliability of the staining is questionable (Pousty et al., 1975). In 
addition, matrix staining is not consistent throughout the articular cartilage; the distribution 
differs between the surface and deep layers and so the question of staining intensity 
becomes subjective. For these reasons we have chosen to omit matrix staining from our 
new scoring system.  
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Variability 
 
Inter- and intra-observer variability was tested, indicating the precision of the 
measurements and also the reproducibility of the results. The results showed that there was 
greater consistency within intra-observer scores when compared to inter-observer scores, 
however the scores as a whole did not reveal great variation. The trend that was observed 
in both the inter- and intra-observer variabilities was that the lowest overall scores (i.e. the 
milder cases which may be verging on normal) demonstrated the most variation. The 
severe cases were less sensitive as there was no variation in the inter- and intra-observer 
scores. A reason for this may be due to the ambiguous nature of the initiation and early 
progression of the disease.   
 
Conclusion and clinical relevance 
 
The involvement of subchondral bone in OA has been a topic of much discussion in the 
past decades, however it has been greatly ignored in scoring systems. Here we have 
incorporated this ‘bystander’ into the assessment process and have shown that there are 
significant correlations between changes to this parameter compared to other more 
commonly used parameters. Inter- and intra-observer variability confirmed that this 
scoring system provides a promising new devise for the histopathological assessment of 
OA.   
 
In order for the devised scoring system to be more widely accepted it should undergo a 
validation process. As such, it would be interesting to score the same tissue samples using 
the Mankin scoring system to establish whether the results obtained through this scoring 
system differ from what would be achieved through currently validated scoring systems. It 
would be of interest to show that despite the different parameters, the result is not radically 
different from what would have otherwise been obtained. One may then ask ‘why bother 
going to the effort when the end result is no different?’. The answer to this question is that 
this scoring system highlights changes in the bone that occur congruent to the more widely 
recognised changes in surrounding tissues, and by validating this scoring and showing the 
progressive bone changes, a diagnostic tool may be developed providing a more robust 
method for earlier identification of the disease process.  
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Within this study, the location of the OCPs excised was based on the topography, where 
the tibial plateaux were mapped and classified into regions of varying cartilage integrity. It 
would be of interest to carry out a similar study limiting the analysis to specific anatomical 
sites within the joint, as this would provide further insight into the locations of the 
observed progressive disease changes. As a means of further enhancing the scoring 
system, it would also be beneficial to include the use of molecular targets such as 
denatured type II collagen epitopes. Hollander et al., (1994) developed an immunoassay to 
detect denatured type II collagen in osteoarthritis and demonstrated its significant increase 
particularly in the superficial zone of OA cartilage. As such, it would be interesting to 
incorporate this technique into the new scoring system to add greater value and further 
distinguish it from previous methods. 
 
Confirming the relationship between the subchondral bone changes with the overlying 
hyaline cartilage changes is an exciting prospect as it opens doors for clinical translation. 
We can hypothesise that quantifying subchondral bone will give the clinician an indication 
of hyaline cartilage degradation. This will ultimately assist the clinician in identifying 
cartilage damage or deterioration, thereby facilitating the early diagnosis and the ability to 
monitor OA in a minimally invasive way. 
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Chapter 3: 
Correlating disease severity with expression of matrix markers, 
proliferation and stem cell markers in osteoarthritic tissue 
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3.1. Introduction 
 
As previously outlined, OA is a disease characterised by a loss of articular cartilage 
components, accompanied by remodelling and a repair attempt carried out by the resident 
cells. Despite the array of knowledge which has been elucidated from studies throughout 
the decades, studies commonly focus on the comparative differences between normal or 
early stage OA and end stage diseased specimens giving little insight into the progressive 
changes that occur as the disease develops (Ostergaard et al., 1999, Ostergaard et al., 
1997).  
 
3.1.1. Matrix markers 
 
Early in development, the cartilage anlagen is predominantly made up of collagen type I, 
and together with the process of chondrogenic differentiation, there is a gradual transition 
from type I to type II collagen synthesis (von der Mark, 1980). As such, type I collagen is 
often referred to as a developmental marker within articular cartilage.  
 
In osteoarthritic cartilage, type I collagen is re-expressed and it is, therefore, regarded as a 
factor involved in the pathogenesis of the disease (Goldwasser et al., 1982, Nerlich et al., 
1993, Miosge et al., 2004). Type I collagen is also associated with fibrocartilage which is 
referred to as a form of repair tissue following disease or injury within hyaline cartilage 
(Miosge et al., 1998).  
 
Collagen type IIA is temporarily expressed early in chondrogenesis as a procollagen prior 
to collagen type II synthesis, and it is thought to have roles other than purely structural 
(Nah and Upholt, 1991, Oganesian et al., 1997, Sandell et al., 1991). Expression of this 
protein in later stages of cartilage maturation and under pathological conditions have been 
observed by several authors, however the expression in these stages aren’t clearly 
understood. In osteoarthritic cartilage, the expression of type IIA procollagen has led to the 
assumption that OA chondrocytes reverse their phenotype towards a chondroprogenitor 
phenotype whilst undergoing hypertrophic changes (Aigner et al., 1999, Nah et al., 2001). 
Despite the acceptance of collagen type IIA in osteoarthritic cartilage, human studies 
predominantly compare end-stage of the disease to normal specimens and, as such, 
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information regarding the progressive expression of collagen type IIA throughout the 
progression of the disease is not known.  
 
Together with the detection of collagen type IIA in osteoarthritic cartilage is the detection 
of collagen type X, a marker for terminally differentiated hypertrophic chondrocytes. A 
study by Nah et al., (2001) demonstrated that in the same upper zone of osteoarthritic 
cartilage where type IIA labelling is evident, collagen type X was also detected. Both 
collagens type IIA and X were absent from the corresponding regions in normal, mature 
articular cartilage. There are several other studies which have shown the presence of type 
X collagen in diseased cartilage (Girkontaite et al., 1996, Walker et al., 1995); however, 
Rucklidge et al., (1996) detected collagen type X labelling in the surface of normal, human 
articular cartilage and it is therefore difficult to draw any solid conclusions from the 
literature. Type X collagen is more commonly renowned for its presence in the deep zone 
and the zone of calcified cartilage in normal articular cartilage where the cells may become 
involved in mineralisation; and this labelling has been shown to be consistent in 
osteoarthritic cartilage (Nah et al., 2001, Rucklidge et al., 1996, von der Mark et al., 1992).  
 
3.1.2. Proliferation marker: Proliferation cell nuclear antigen 
 
Proliferation cell nuclear antigen (PCNA) is an essential component for eukaryotic 
chromosomal DNA replication, and is, therefore, often used as a marker for cell 
proliferation (Paunesku et al., 2001). Chondrocytes in normal articular cartilage have a 
stable phenotype when compared to immature or growth plate cartilage; however, as 
Pfander et al., (2001) describes; “the possible expression of proteins which are normally 
produced by chondrocytes during various stages of differentiation in growth plate 
cartilage, by chondrocytes in OA cartilage could lead to the altered functional activities 
and loss of their ability to maintain a functional articular cartilage matrix.” As such, PCNA 
which is undetectable in normal human articular cartilage, has been shown to be present in 
moderately affected OA cartilage, as well as in clusters (chondrones) in severely affected 
OA cartilage (Pfander et al., 2001).  
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3.1.3. Stem cell markers 
 
Stem cells in synovial joints are mesodermal by origin, and, as such, are referred to as 
mesenchymal stem cells (MSCs). Unlike hematopoietic stem cells however, there is no 
single marker for MSCs at present and thus combinations of cell surface molecules are 
often employed to identify the cells. According to the International Society for Cellular 
Therapy (ISCT), MSCs are characterised by their adhesion potential in monolayer culture, 
their tripotent differentiation potential in vitro, and the expression of surface markers 
CD73, CD90 and CD105 (Dominici et al., 2006). The ISCT have also defined certain 
surface markers, including CD45 and CD 34 which MSCs should lack. In addition to the 
cell surface markers listed, many other publications have employed other surface markers 
to identify progenitor cells in in vitro and in vivo studies including CD44, CD90, CD166; 
as well as Stro-1 and Notch-1 (Artavanis-Tsakonas et al., 1999, Baron, 2003, Dennis et al., 
2002, Diaz-Romero et al., 2005, Simmons and Torok-Storb, 1991).  
 
Stro-1 is a cell surface protein most widely known for its expression by bone marrow 
stromal cells (Simmons and Torok-Storb, 1991). Work by Dennis et al., (2002) 
demonstrated that a subset of Stro-1 positive cells were capable of differentiating into 
multiple mesenchymal lineages. As such, Stro-1 is regarded as a valuable marker for the 
identification of human bone marrow stromal precursors, and more generally, a 
mesenchymal progenitor cell marker. A recent study by Grogan et al., (2009) identified 
Stro-1 positive cells within normal and increased activation in OA cartilage. Karlsson and 
Lindahl (2009) have hypothesised that the increased activation of certain cell surface 
markers, including Stro-1, in OA cartilage could indicate signalling from a regenerative 
response, and a sign of activated progenitor cells.  
 
Notch-1 
 
The notch signalling pathway plays a crucial role during cell fate assignment, cell 
differentiation and proliferation, and also in maintaining a stem cell population in many 
tissues throughout life. Notch receptors are 300-kDa transmembrane proteins with a large 
extracellular domain containing epidermal growth factor repeats essential for ligand-
receptor interactions. In mammals, there are four Notch homologues (Notch 1-4) that 
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interact with ligands of the Notch receptor, namely Jagged 1 & 2, and Delta 1,3 & 4 (Sassi 
et al., 2011).  
 
The Notch activation cascade is initiated by cleavage of the receptor in the trans-Golgi 
network. Through cell-cell contact, the active Notch receptor can then bind with one of its 
ligands (Gering and Patient, 2010). The canonical pathway consists of a series of 
cleavages which lead to the release of the intracellular domain of the receptor, which then 
interacts in the nucleus with the transcription factor CSL (CBF1, Su [H], Lag-1) to 
regulate the expression of downstream target genes including HES and HERP (Iso et al., 
2003, Schweisguth, 2004). Other studies including Matrinez Arias et al., (2002) however, 
have also suggested that CSL-dependent signalling does not mediate all functions of 
Notch, and that there is also a CSL-independent signalling pathway. 
 
Extensive research has implicated the Notch pathway in numerous cell fate decisions 
throughout development; and in particular its role in limb development and 
chondrogenesis (Artavanis-Tsakonas et al., 1999, Austin et al., 1995, Conlon et al., 1995, 
Jiang et al., 1998, Williams et al., 2009). Prior to birth, data suggest that the presence of 
Notch is required for cell differentiation and proliferation, whilst during the late stages of 
development and post-birth, the expression of Notch instead allows the terminal 
differentiation and maturation of chondrocytes; favouring the process of endochondral 
ossification. As summarised by Sassi et al., (2011); “One of the most relevant hypotheses 
is that Notch may act as an on/off switch, either enabling maturation of the articular 
cartilage by promoting cell proliferation or acting as a terminal differentiation potential 
leading to bone formation.” 
 
More recent studies have demonstrated that the Notch signalling pathway also promotes 
the maintenance of a progenitor cell phenotype; a hypothesis supported by Dowthwaite et 
al., (2004), who showed that Notch was expressed on the surface of articular cartilage of a 
7-day-old calf by a progenitor cell population. The authors describe how these cells exhibit 
increased colony forming efficiencies compared with chondrocytes not expressing Notch, 
suggesting a primordial role for the receptor in controlling the clonality of the surface zone 
chondrocytes. Studies by McCarthy et al., (2011) have also confirmed similar findings in 
chondroprogenitors isolated from equine cartilage. 
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In relation to human cartilage, studies have demonstrated the presence of chondrocytes in 
the surface zone of the articular cartilage which positively label for Notch-1 in healthy and 
OA specimens, which has raised the issue of involvement of the Notch signalling pathway 
in the pathogenesis of OA, especially with regards to the changes that the chondrocytes 
undergo during the process (Grogan et al., 2009, Karlsson et al., 2008, Ustunel et al., 2008, 
Williams et al., 2010).  
 
It was, therefore, the aim of this study to correlate disease severity with the expression of 
various matrix, stem cell and proliferation markers in order to determine patterns of 
change that occur as the OA progresses. The scoring system devised in the previous 
chapter was used to identify specimens at varying stages of disease progression. 
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3.2. Materials 
Material Catalogue 
number 
Supplier 
 
Procollagen type IIA (003-02) 
antibody 
 
 
Ab17771 
 
Abcam, UK 
 
Dako pen 
Mouse immunoglobulins 
PCNA (PC-10) antibody  
 
 
S2002 
X0931 
M0879 
 
Dako, UK 
 
Aggrecan (5C5) antibody 
 
 
ALX-803-311-
R100 
 
 
Enzo Life Sciences, UK 
 
DPX mounting medium 
Haemalum (Mayer) 
Methylated spirit industrial 0.89 
S.G. 74 O.P. 
Polysine adhesion glass slides 
Xylene 
 
LAMB/DPX 
LAMB/170-D 
M/4450/17 
 
MNJ-800-010F 
X/0200/17 
 
Thermo Fisher Scientific, 
UK 
 
Type X collagen antibody 
 
Gift 
 
Klaus von der Mark 
 
 
Stro-1 antibody 
 
 
MAB1038 
 
R & D Systems Europe Ltd, 
UK 
 
 
Notch-1 (M-20) antibody 
 
 
SC-6015 
 
Santa Cruz Biotechnology, 
Inc, USA 
 
 
Chondroitinase ABC from Proteus 
vulgaris 
Hyaluronidase from Streptomyces 
hyalurolyticus 
Hydrogen peroxide, 30% (w/w) 
Phosphate buffered saline  
Proteinase K from Tritirachium 
album 
Toluidine blue 
Tween® 20 
Type I collagen (COL-1) antibody 
 
C2905 
 
H1136 
 
H1009 
P4417 
P6556 
 
89640 
P1379 
C2456 
 
 
Sigma Aldrich, UK 
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Table 3.1. Materials and suppliers. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Antigen unmasking solutions 
R.T.U Vectastain Universal Quick 
Kit 
DAB Peroxidase Substrate Kit,  
3,3’-diaminobenzidine 
 
 
H-3300 
PK-7800 
 
SK4100 
 
 
Vector Laboratories, UK 
 
Safranine O Gurr 'Certistain' 
 
 
343122N 
 
VWR – Jencons, 
Leicestershire, UK 
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3.3. Methods 
 
3.3.1. Source of material 
 
Osteochondral plugs (OCPs) from tibial plateaux were excised and processed as described 
in Chapter 2.3.2 – 2.3.4. This included fixation and decalcification of the tissue prior to 
wax embedding and sectioning at 8μm. 
 
3.3.2. Scoring  
 
The OCPs were scored using the scoring system that was outlined in Chapter 2 
incorporating the articular cartilage and the subchondral bone. A possible score between 0 
and 17 was obtained, indicating the degree of change seen within the tissue -higher scores 
represent more severe changes. The tissue sections were then ranked according to overall 
score. 
 
The scores of the OCPs ranged from 2-17; in order to see progressive changes in the tissue 
sections, representatives from score 2, 4, 6, 8, 10, 11, 16 and 17 were analysed. As there 
were no OCPs scored between 12 and 15 it was not possible to include them. For this 
reason it was decided that ‘score 11’ should be presented. Score 17 is important as it is the 
highest possible score. 
 
3.3.3. Immunohistochemistry: peroxidase labelling  
 
Tissue sections were dewaxed and rehydrated as above. Indirect immuno-histochemistry 
was then performed in a light-proof, humidified chamber. Using a ‘DAKO’ pen, a 
hydrophobic ring was drawn around the tissue sections in order to retain solutions on the 
slide. Sections were subsequently rinsed in 0.1M PBS containing 0.01% Tween 20 (PBS-
T), a wetting agent used to increase penetration and permeability of the antibody. For 
subsequent washes PBS-T was used. At this point, certain primary antibodies required 
antigen retrieval techniques. Where required these are outlined in table 3.2. Sections that 
did not require pre-treatment were maintained in PBS until required. Endogenous 
peroxidise activity was blocked with 0.3% hydrogen peroxide in distilled H20 for 5 
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minutes. Sections were then rinsed. The following steps utilised the R.T.U Vectastain 
Universal Quick Kit in which reagents (excluding primary antibodies) are contained and 
instructions outlined. Briefly, tissue sections were incubated in prediluted normal horse 
serum for 20 minutes. This step is species-specific; appropriate to the species in which the 
secondary antibody was raised in order to block any non-specific binding to epitopes on 
the secondary antibody. Following incubation, excess serum was tipped off and primary 
antibodies diluted in PBS-T were directly applied and incubated; either at room 
temperature for one hour, or at 4°C overnight. Sections were subsequently washed in PBS 
(three changes of 5 minutes) and then incubated for 15 minutes in prediluted biotinylated 
pan-specific universal secondary antibody at room temperature. Following further washes, 
sections were incubated in a streptavidin/peroxidase complex for 5 minutes. Sections were 
washed again and developed using a 3,3’Diaminobenzidine (DAB) substrate kit, for 2 to 3 
minutes. Subsequently, slides were rinsed in distilled H20 and immersed in filtered 
Mayer’s haematoxylin for 90 seconds and then washed under running water. The slides 
were then dehydrated in graded alcohols, cleared in xylene and mounted in DPX. Specific 
antibodies, incubation times, concentrations and temperatures are summarised in table 3.2.  
 
 
3.3.3.1. Controls 
 
Negative controls 
Primary antibody was omitted and:  
- replaced with isotype specific immunoglobulins to demonstrate that the secondary 
antibody is binding specifically to the primary antibody.  
- replaced with PBS to confirm that the secondary antibody is not binding 
non-specifically to the tissue.  
 
Where possible positive controls were also used to demonstrate that the antibodies were 
reactive and specific to their antigens.  
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3.3.3.2. Primary antibody concentration 
 
It was essential that the primary antibodies were optimised by antibody titration so that the 
best possible results could be obtained.  
 
3.3.4. Microscopy 
 
Labelling was viewed using a Leitz DMRB Leica (Leitz, Wetzlar, Germany) light 
microscope and images were captured using a moticam 2000 (Motic China Group Co. 
Ltd.) and subsequently processed using Adobe Photoshop. 
 
3.3.5. Quantification of immunolabelling 
 
Determining the percentage of immunolabelled cells involved systematic counting of 
positive and negative cells in three 400 x 530µm grids (20x field), starting from the 
cartilage surface down. The average of the three counts was used for statistical analysis. 
Comparisons between different scores were made via one-way analysis of variance 
(ANOVA) followed by Fishers A Priori and Student t-tests to test between individual 
means (Minitab16). P values less that 0.05 were considered significant. 
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Table 3.2. Primary antibodies including antigen retrieval methods used and dilution 
factors. M – Monoclonal, P – Polyclonal. 
 
 
Primary 
antibody P/M Detects Antigen retrieval IgG 
Incuba-
tion time 
Optimal 
working 
dilution/ 
concent-
ration 
       
Type I M Collagen type I 
Chondroitinase 
(0.25U/ml) & 
hyaluronidase 
(2U/ml). 1h30min 
@ 37°C 
 
Mouse  1 hour 1:800 
Procollagen 
type IIA M 
Procollagen 
type IIA 
Chondroitinase 
(0.25U/ml) & 
hyaluronidase 
(2U/ml). 1h30min 
@ 37°C 
 
Mouse 1 hour 1:300 
3.3μg/ml 
Type X M Type X collagen 
Proteinase K 
(2μg/ml) 1h @ 
37°C followed by 
Chondroitinase 
(0.25U/ml) & 
hyaluronidase 
(2U/ml). 30min 
@ 37°C 
 
Mouse 1 hour 1:3 dilution 
5C5 M Aggrecan 
Hyaluronidase 
(2U/ml) 1hr30 @ 
37°C 
 
Mouse 1 hour 1:100 
M-20 P Notch-1 None Goat Overnight 
 
10μg/ml 
 
PC-10 M 
Proliferating 
cell nuclear 
antigen 
Antigen 
unmasking 
solution (1:100). 
Bring to boil and 
put over sections 
for 1 min. Rinse 
in cold water 
 
Mouse Overnight 5μg/ml 
STRO-1 M Human Stro-1 None Mouse Overnight 
1:50 
10μg/ml 
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3.4. Results 
 
3.4.1. Collagen type I  
 
Collagen type I was detected in all OCPs to varying degrees of intensity. Regionally, there 
was a trend observed in which the extracellular matrix protein was mostly restricted to the 
superior aspects of the OCPs; emerging from the surface zone and extending into the 
middle zone. In figure 3.1A illustrating an OCP of score 2, type I collagen labelling is 
detected predominantly in the surface zone, accompanied by regions of hypercellularity, 
and the intensity of the label is gradually reduced inferiorly. As such it appears that a 
reparative process has been activated through which chondrocytes are altering the ECM. 
Looking at the detectable labelling in scores 2 and 4 compared to scores 6 & 8, it appears 
that collagen I is more widespread in the lower scores. In the OCP of score 6 (figure 3.1C) 
there is clear delineation approximately 300µm below the articular surface where type I 
collagen labelling diminishes. Similarly, in the OCP of score 8 (figure 3.1D), within the 
deep fissures type I collagen labelling in the interterritorial matrix is more sparse. Having 
said that, it can be seen in figure 3.1D that despite the reduction of ECM labelling, there is 
evidence of cellular up-regulation within individual cells as well as cell clusters. In most 
cases, there was no apparent labelling in the deep zones of the various OCPs as 
demonstrated through figure 3.1H. The ‘anomalous’ OCP is described below. 
 
Figures 3.1E and F show collagen type I label in an OCP which achieved score 10. Within 
this OCP, an abundance of collagen type I was seen throughout the entire tissue. Mid-zone 
chondrocytes labelled positively and deep zone labelling surrounds the pericellular matrix. 
The fibrous orientation of the fibres within this OCP is also highlighted through the 
collagen type I labelling, particularly in the surface zone. There appears to be a lack of 
cellular presence in the surface zone of this OCP as demonstrated by the empty lacunae in 
the surface zone. Associated with subchondral remodelling is the increased synthesis of 
type I collagen which can be seen surrounding cell clusters in regions which may have 
originated from the bone marrow spaces.  
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Through figure 3.1G (score 11) it can be seen that inferior to the tidemark in the region of 
calcified cartilage, there is collagen type I labelling which appears reduced in the 
neighbouring bone.  
 
3.4.2. Procollagen type IIA 
 
The overall distribution of procollagen type IIA labelling throughout OCPs of varying 
scores was comparable to that seen when labelling for collagen type I. In the OCPs of 
scores 2 through to 6 (figures 3.2A-C), the surface zones labelled positively throughout the 
ECM, whereas the middle and deep zones elicited no signs of detectable procollagen type 
IIA synthesis. There was evidence of cellular labelling as demonstrated in figure 3.2C in 
some but not all chondrocytes, regardless of whether they were in clusters. Figure 3.2D 
demonstrates the fissured surface containing many chondrocyte clusters in an OCP 
achieving score 8. Upon procollagen type IIA labelling, it could be said that there was a 
lack of definitive cellular and extracellular labelling found.  
 
Figures 3.2E to H highlight the major features seen in the ‘anomalous’ OCP of score 10 
labelled for procollagen type IIA. The surface and middle zones can be seen in figure 3.2E. 
Figure 3.2F illustrates a higher power image of the cells in the mid-zone through which it 
can be seen that there is a high percentage of positively labelled cells. It appears that the 
surface zone cells comprise large lacunae, which are absent in the population of cells in the 
middle zone perhaps suggesting that there may be a heterogeneous population of cells 
within the OCP. Similar to the images seen in figure 3.1, the fibrous orientation of the 
cartilage is highlighted through the procollagen type IIA label. Figure 3.2G is a low power 
image demonstrating the changes in procollagen type IIA distribution between the 
different regions. There is an arched delineating line that spans through the middle zone, 
inferiorly towards the deep zone on the left of the image. Superior to this line, the ECM 
has labelled positively, and inferiorly there is a reduction in labelling. Having said that, 
through the central aspect of the non-labelled region there is a zone of cells which appear 
to be approaching from the subchondral region, showing more positive labelling than the 
surrounding matrices. This region is shown at a higher power in figure 3.2H. A distinct 
change in cellular morphology was also observed, as chondrocytes surrounding this region 
appear to be larger and rounder than the cells within the unidentified region of cells.  
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Figure 3.2I portrays an OCP of score 11 showing procollagen type IIA labelling within the 
thin region of remaining articular cartilage.  
 
3.4.3. Aggrecan 
 
Aggrecan labelling is a distinctive feature of articular cartilage as it is typically highly 
abundant in the ECM. Indeed, in this study it was widely distributed throughout the OCPs 
of varying scores. Figures 3.3A to C show aggrecan labelling detected in and OCP of score 
2. Figures 3.3A and B are images of separate regions along the surface, highlighting the 
presence of atypical regions within low scoring tissue. It can be seen in figure 3.3B that 
there is a surface pocket lacking aggrecan, suggesting reduced tissue integrity. Figure 3.3C 
confirms the presence of aggrecan in the middle and deep zones.  
 
With scores increasing between 2 and 8, the pattern of labelling is continued. Aggrecan 
was detectable throughout all regions in OCPs of scores 4 and 6 as shown in figures 3.3D 
to H. One notable observation however, was that the labelling shifted from predominantly 
extracellular, as seen in figures 3.3A - C to both cellular and extracellular in the higher 
scores. Between scores 6 and 8 it was noted that there were various regions in which 
aggrecan labelling diminished; particularly on the surface of the fissures in the OCP of 
score 8 as seen in figure 3.3I.  
 
Figures 3.3K to P demonstrate the results of aggrecan labelling in the OCP which achieved 
score 10; previously described for its unusual collagen I and collagen type IIA labelling. A 
low power image can be seen in figure 3.3K where remarkable changes in aggrecan 
distribution throughout the tissue was observed. Superiorly in the surface region, aggrecan 
labelling is reduced when compared to the intensity of label seen in the neighbouring 
middle region, as illustrated in figures 3.3M and N. However, similar to the procollagen 
type IIA labelling previously described, there is an imaginary line spanning through the 
middle zone and progressing inferiorly delineating the regions of positive and negative 
ECM labelling. The chute-like structure which was previously mentioned for apparent 
procollagen type IIA label also appears to have heavily labelled for aggrecan as seen in 
figure 3.3P. The region inferior to the middle zone shows a distinct lack of extracellular 
aggrecan labelling, despite eliciting cellular labelling as illustrated in figure 3.3O.  
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3.4.4. Collagen type X 
 
In articular cartilage, collagen type X is usually restricted to the deep zones and the zone 
of calcified cartilage where terminal differentiation occurs. In the OCPs examined, 
between scores 2 and 8 there were no unusual differences observed and results are shown 
in figures 3.4A to C. Figure 3.4D portraying an OCP of score 10 demonstrates evidence of 
increased label extending into the middle zone. It is also apparent in this image that the 
tidemark is not linear and has been breached by cell clusters arising from the subchondral 
bone, a possible contributing factor to the altered type X collagen expression.  
 
Figures 3.4E to I demonstrates the anomalous type X labelling which was detected in the 
OCP of score 10, highlighting the extent of remodelling and terminal differentiation 
occurring within this OCP. The distinguishable zones observed previously were 
maintained; type X collagen synthesis was noticeably up-regulated in the region spanning 
between the middle zone and the subchondral bone; diminishing to the left of the image. 
As such, the region which lacked aggrecan labelled positively for type X collagen. 
Interestingly, however, the chute-like structure previously observed was not apparent when 
labelling for type X collagen. Higher power views of specific areas are shown in figures 
3.4F to I. Within figure 3.4F, a region lacking type X collagen can be seen neighbouring a 
region with extensive labelling. A population of invading cells can be seen in the right side 
of the image, shown in higher power in figure 3.4H. Figure 3.4G shows the surface region 
lacking type X collagen expression. An interesting observation was that at the presumptive 
tidemark, the overlying tissue appears to have detached from the bone on which it sits, and 
this detachment can be seen throughout the majority of the OCP when looking at figure 
3.4E. In addition, looking at the left side of figure 3.4I where there is no apparent 
detachment, it appears instead that cells are arising from the bone and spreading through 
the overlying tissue in a fan-like manner.  
 
3.4.5. PCNA 
 
Figures 3.5A to D demonstrate the presence of proliferating cells in OCPs of varying 
scores. It can be seen that the labelled cells vary from individual cells to cell clusters, 
predominantly at the surface and surrounding fissure edges. Interestingly, however, no 
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PCNA labelling was evident in the lowest scoring OCP. As a general trend, middle and 
deep zones showed no PCNA labelling within chondrocytes, other than in the anomalous 
OCP of score 10 (figures 3.5C and D). Through the low power image, it can be seen that 
the demarcation of labelled regions follows a similar pattern to what was seen previously 
with the procollagen type IIA and aggrecan labelling. As such, whether in the surface, 
middle or deep zones, a great proportion of the cells have labelled positively for PCNA, 
whereas the counterpart elicits virtually no positive labelling.  
 
Figure 3.6 shows the percentage of total cells in the surface zone that labelled positively 
for PCNA, as an average of 3 random snapshots. What is clear initially by looking at the 
histogram is that the lower score (score 4) has a significantly reduced proportion of 
labelled cells when compared to the higher scores, and this was confirmed using one way 
ANOVA and Student t-tests. Between scores 6 and 10 there was no significant difference 
between the proportion of labelled cells as they all ranged between 55 and 65 percent. 
Another interesting point to note is that the error bars are the greatest at score 6, suggesting 
the greatest variation. With increasing severity, the error appears to reduce in size 
suggesting that the high proportion of labelled cells is more consistent throughout the 
surface of the tissue. 
 
In line with the increased proportion of labelled cells in the surface zone was a general 
trend that became apparent, in that there was also a general increase in the sheer number of 
cells with increasing scores. This ties in with the finding that there is increased PCNA 
labelling in OCPs of higher scores.  
 
3.4.6. Stro-1 and Notch-1 
 
Similar to the pattern seen in PCNA labelling, Stro-1 and Notch-1 was localised in OCPs 
of varying scores as shown in figures 3.7 and 3.9 respectively. Individual cells and cell 
clusters were shown to have labelled positively. In these OCPs, Stro-1 labelling was 
restricted to a region approximately 200µm from the surface (figure 3.7C), whereas Notch-
1 labelling extended further, into the middle zone (figures 3.9B to D). There was no label 
detected for either Stro-1 or Notch-1 in the OCP with the lowest score (score 2).  
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Figures 3.7D to G illustrate the Stro-1 labelling detected in the anomalous OCP of score 
10. In this particular case, the area containing positively labelled cells extends beyond the 
surface zone. It can be seen in figure 3.7G that the Stro-1 labelled region corresponds with 
the previous findings, spanning throughout the width of the tissue. Again there is a clear 
demarcation between the non-labelled and the labelled regions as shown in figure 3.7E. 
Interestingly, it was observed that upon Stro-1 labelling, dendritic-like cells with long 
‘tails’ could be seen particularly in the middle zone (figure 3.7D). Cellular invasions 
highlighted in figure 3.7F also labelled extensively for Stro-1.  
 
Notch-1 labelling in the anomalous OCP of score 10 showed a similar pattern to the Stro-1 
labelling however, the transition between the labelled and non labelled regions was not as 
clearly defined. As such, the cells in the ‘non-labelled’ region in the Stro-1 did show signs 
of Notch-1 labelling albeit to a lesser extent (figure 3.9D).  
 
Figures 3.8 and 3.10, similar to figure 3.6 show the percentage of total cells in the surface 
zone that labelled for Stro-1 and Notch-1 respectively, as averages of 3 random snapshots. 
Looking specifically at figure 3.8, the histogram relating to Stro-1 it can be seen that there 
is no apparent trend in the proportion of cells labelled between the varying scores, and this 
observation was confirmed statistically using the one way ANOVA test. The proportion of 
labelled cells in the surface zone as a whole ranged between 67 and 81 percent, with 
varying degrees of standard error in accordance to the variability seen. On the other hand, 
Notch-1 labelling in the surface zone did show significant difference between the varying 
scores, as confirmed using one way ANOVAs and Student t-tests (figure 3.10). Score 4 
showed a significantly reduced proportion of labelled cells (approximately 48 percent) 
when compared to higher scores, and score 6 elicited the highest proportion of labelled 
cells, at 97 percent. The higher scores (8 and 10) also comprised a large proportion of 
labelled cells when compared to score 4, at approximately 85 percent. Notably, the greatest 
variation seen in Notch-1 labelling was in the score 10, where the error levels are over 
double those from the other scores.  
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Figure 3.1. Type I collagen labelling in OCPs of varying scores. 
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Figure 3.1. Type I collagen labelling in OCPs of varying scores.  
 
Figure A. Surface region of OCP with score 2. Collagen type I labelling throughout the 
ECM, with more intense labelling superficially. No cellular label apparent. 
Hypercellularity in the surface zone is indicative of a repair process. Scale bar = 100µm. 
 
Figure B. Surface region of OCP with score 4. Collagen type I label evenly distributed 
throughout imaged area. There is evidence of cellular labelling in the superficial cells. 
Scale bar = 100µm.  
 
Figure C. Surface region of OCP with score 6. Collagen type I label in the surface only. A 
visible reduction can be seen on entering the mid zone. A lack of cellular and pericellular 
labelling was observed. Scale bar = 100µm. 
 
Figure D. Surface region of OCP with score 8. Weak collagen type I labelling can be seen 
in the interterritorial matrix. Evidence of cellular labelling in individual cells as well as 
cell clusters. Scale bar = 100µm. 
 
Figures E & F. Type I collagen labelling in an OCP of score 10. Figure E illustrates the 
surface zone extending into the mid zone, whilst figure F demonstrates the deep zone with 
evidence of subchondral bone remodelling. ECM labelling is apparent throughout the 
regions. Cellular labelling is restricted to the mid and deep zones. Scale bar = 100µm. 
 
Figure G. Type I collagen labelling in an OCP of score 11. A thin layer of articular 
cartilage covering the subchondral bone labelled positively for collagen type I. Label is 
also apparent in the calcified cartilage and bone regions. Scale bar = 100µm.  
 
Figure H. The deep zone of an OCP demonstrating an absence of type I collagen labelling 
in this region. Multiple tidemarks can be seen. Scale bar = 100µm. 
 
Figure I. Negative control showing no non specific labelling of type I collagen in the 
surface region. Scale bar = 100µm.  
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Figure 3.2. Procollagen type IIA labelling in OCPs of varying scores.  
 
 
Figure A. Procollagen type IIA labelling in an OCP of score 2. Label apparent throughout 
the matrix. Increased label intensity is apparent in the surface zone and in the pericellular 
matrix region. Scale bar = 100µm. 
 
Figure B. Procollagen type IIA labelling in an OCP of score 4. Labelling can be seen in 
the ECM of the surface zone extending into the mid zone. Evidence of cellular labelling in 
the surface zone chondrocytes. Scale bar = 100µm. 
 
Figure C. High power view of procollagen type IIA labelling in the surface zone of an 
OCP of score 6. Cellular labelling evident in some but not all cells. Interterritorial matrix 
labelling observed in the most superficial regions. Scale bar = 50µm. 
 
Figure D. Fissured surface of an OCP with score 8 labelled for procollagen type IIA. 
There is an absence of labelling in the superficial region. Very weak labelling was detected 
in the mid zone. Cellular labelling was apparently absent. Scale bar = 100µm. 
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Figures 3.2. E – H. Procollagen type IIA labelling in an OCP of score 10.  
 
Figure E. Demonstrates the surface and mid zones where label was detected in the matrix 
regions. Cellular labelling is evident in the middle zone chondrocytes, and was largely 
undetectable from the surface zone. The fibrous nature of this tissue sample can also be 
seen. Unlabelled cells appear to have large surrounding lacunae which are absent from the 
labelled cells. Scale bar = 200µm. 
 
Figure F. High power image of the cells in the mid zone as seen in Figure E. Cellular and 
territorial matrix labelling apparent in some cells. Scale bar = 50µm.  
 
Figure G. Low power image demonstrating the overall distribution of detectable 
procollagen type IIA labelling. There is a line delineating a region of positive labelling 
seen in the mid/surface zones, which extends through to the deep zones on the left. Within 
the deep zone there is also a region of positively labelled cells forming a chute-like 
structure coming from the subchondral region. Scale bar = 400µm.  
 
Figure H. High power image demonstrating the chute-like feature highlighted in Figure G. 
Weak labelling is apparent and there is evidence of cellular labelling. Cells in this region 
appear to be different in shape and size. Scale bar = 100µm. 
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Figure 3.2. Procollagen type IIA labelling in OCPs of varying scores.  
 
Figure I. Procollagen type IIA labelling in an OCP of score 11. Positive labelling is 
evident within a thin region of remaining articular cartilage. Labelling is also evident in 
the calcified cartilage and bone regions. Scale bar = 100µm. 
 
Figure J. Demonstrates the absence of procollagen type IIA labelling in the middle/deep 
zones. Scale bar = 100µm. 
 
Figure K. Negative control showing no non specific labelling of procollagen type IIA in 
the surface region. Scale bar = 100µm. 
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Figure 3.3. Aggrecan labelling in OCPs of varying scores. 
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Figure 3.3. Aggrecan labelling in OCPs of varying scores. 
 
Figures A – C. Aggrecan labelling in an OCP of score 2. The surface zone is 
demonstrated in Figures A & B. Figure A shows the typical distribution of labelling (scale 
bar = 100µm) and figure B shows an atypical region where pockets in the surface show a 
distinct lack of labelling (scale bar = 50µm). Figure C confirms the presence of aggrecan 
labelling in the mid-deep zones (scale bar = 200µm). 
 
Figures D-F. Aggrecan labelling in an OCP of score 4. The surface zone shoes positive 
cellular and extra cellular labelling as seen in figures D and E. Territorial labelling was 
evident in chondrocytes from the middle zone as seen in Figure D. Positive labelling also 
evident in the deep zone as seen in figure F. Scale bar (figures D & F) = 200µm. Scale bar 
(figure E) = 50µm. 
 
Figures G & H. Aggrecan labelling in an OCP of score 6. Figure G illustrates the 
superficial and mid zones and figure H the deep zones. Labelling in the interterritorial 
matrix appears reduced throughout, with exception of the surface zone. However, there 
also appears to be increased production of aggrecan as seen by the intense label 
immediately surrounding the chondrocytes. Scale bar = 200µm.  
 
Figures I & J. Aggrecan labelling in an OCP of score 8. Figure I illustrates the superficial 
and mid zones and figure J the deep zones. Matrix breakdown resulting in fissures 
extending into the mid zone is confirmed by a marked reduction of aggrecan labelling in 
the superficial zone. Inferiorly, aggrecan labelling was observed in the deep regions and 
surrounding the chondrocytes. Scale bar = 200µm. 
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Figure 3.3. K. A low power image of aggrecan labelling in an OCP of score 10. An 
unusual distribution of aggrecan spans the OCP as a result of marrow invasions and 
subchondral remodelling. High power images on following page. Scale bar = 400µm.  
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Figures 3.3. L – P. Higher power images of figure 3.3 K, an OCP of score 10 labelled for 
aggrecan. 
 
Figure L. A region extending from the surface to the mid zone illustrating. There is reduced 
labelling in the articular surface accompanied inferiorly by a region of more pronounced labelling. 
The deep region elicits a lack of extracellular labelling, despite evidence of cellular and pericellular 
labelling. Scale bar = 200µm. 
 
Figure M. The surface zone of an OCP of score 10 demonstrating chondrocytes with large 
lacunae. Aggrecan label is detectable in the extracellular label. Scale bar = 50µm. 
 
Figure N. Mid zone of an OCP of score 10 highlighting the increased intensity of labelling 
compared to the surface zone (figure M). The chondrocytes appear to be immersed between a thick 
fibrous matrix, and lack the typical lacunae as seen in figure M. Scale bar = 50µm. 
 
Figure O. A region where the deep zone appears to be terminally differentiating and remodelling, 
forming a part of the subchondral bone as a result of endochondral ossification. Scale bar = 50µm. 
 
Figure P. A highly labelled region spreading from the subchondral bone through the deep zone 
and towards the middle zone. The cells within this region appear to be smaller than the cells from 
the surface and middle zones. Scale bar = 100µm.   
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Figure 3.4. Type X collagen labelling in OCPs of varying scores.  
 
Figure A. Tidemark and calcified cartilage in an OCP with score of 2. A number of type X 
positive cells in the calcified cartilage region. Scale bar = 100µm. 
 
Figure B. Superior to the tidemark, territorial labelling of type X collagen was detected 
surrounding individual cells and cell clusters in an OCP of score 4. Inferior to the 
tidemark, positively labelled cells are also evident. Multiple tidemarks can also be 
observed. Scale bar = 100µm. 
 
Figure C. Territorial labelling of type X collagen extends further into the deep zone in an 
OCP of score 6. Multiple tidemarks observed with increased type X labelling in this 
region. Scale bar = 100µm.  
 
Figure D. Heightened type X collagen labelling in the deep zone of an OCP of score 10. 
Non-linear tidemark is observed together with cellular invasions emerging from the 
subchondral region and breaching the tidemark. Scale bar = 100µm.  
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Figures 3.4. E – I. Type X collagen labelling in the corresponding OCP of score 10. 
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Figures 3.4. E – I. Type X collagen labelling in the corresponding OCP of score 10. 
 
Figure E. A low power image of type X collagen labelling in the corresponding OCP of 
score 10. An inverse relationship with the pattern of aggrecan labelling was observed. A 
region of extensive remodelling below the surface zone can be seen. Cellular and vascular 
invasions from the underlying bone are prominent. There is a clear boundary in the mid 
zone where the type X collagen labelling terminates. Scale bar = 400µm.  
 
Figure F. The transition between the region with no type X labelling and the region of 
extensive type X labelling. Cellular invasions on the left side of the image are 
accompanied by regions of no collagen type X (figure H). The fibrous nature of the ECM 
is highlighted by the type X labelling. Scale bar = 100µm.  
 
Figure G. A high power image of the surface region demonstrating the lack of detectable 
type X collagen. Scale bar = 100µm.  
 
Figure H. A high power image of figure F highlighting the transition zone where bone 
formation has proceeded following type X collagen formation in the presumptive deep 
zone of articular cartilage. The cellular invasions can be seen protruding further into the 
deep zone. Scale bar = 50µm.  
 
Figure I. A high power image of the deep zone. Extensive remodelling in the cartilage 
resulting in the total detachment of the cartilage from the underlying bone. Marrow 
invasions breaching through the cartilage appear to fan out in an organised arrangement, 
presumably attempting to repair the damaged cartilage. Scale bar = 100µm.  
 
Figure J. Demonstrates the presence of type X collagen in the underlying bone of 
confirming the continued remodelling in the latter stages of the disease. Scale bar = 
200µm.  
 
Figure K. Negative control showing no non-specific binding of type X collagen in the 
deep regions. Scale bar = 100µm.  
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Figure 3.5. PCNA labelling in OCPs of varying scores.  
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Figure 3.5. PCNA labelling in OCPs of varying scores. 
 
Figure A. Individual cells and cell clusters in the surface of articular cartilage in an OCP 
of score 6. Within the cluster there are positively and negatively labelled cells. Scale bar = 
50µm. 
 
Figure B. A high number of chondrocyte clusters on the fissured articular surface labelling 
positively for PCNA, accompanied by a small number of cells that exhibit no labelling. 
Scale bar = 100µm.  
 
Figure C. PCNA labelling in an OCP of score 10. The distribution of positively labelled 
cells can be spanning the surface zone of the articular cartilage. Inferiorly there is a lack of 
detectable PCNA. Scale bar = 200µm. 
 
Figure D. A low power image of PCNA labelling in the corresponding OCP of score 10. 
Positively labelled cells are located in the regions lacking collagen type X and eliciting 
positive aggrecan labelling. On the right side of the image, this region is restricted 
superiorly, and spans through the mid zone and into the deep zone on the left side of the 
image. Scale bar = 400µm. 
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Score No. positive Total no. % positive Standard Error 
4 5.33 32.33 16.94 1.08 
6 10.00 22.00 57.15 17.61 
8 26.00 42.33 64.56 10.78 
10 59.67 98.33 62.33 6.07 
 
 
Figure 3.6. Histogram and corresponding table showing the percentage of total cells that 
labelled positive for PCNA in the superficial zone of OCPs of varying scores. 
 
Data are expressed as the mean (n=3) ± SE of the percentage of total cells which show 
cell-associated labelling. Score 4 showed a significantly reduced proportion of labelled 
cells when compared to the higher scores as confirmed by one way ANOVA and Student 
t-tests (p<0.05).   
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Figure 3.7. Stro-1 labelling in OCPs of varying scores. 
 
Figures A & B. Stro-1 labelling in an OCP of score 4. Figure A is a high power image of 
chondrocyte clusters in the surface of articular cartilage demonstrating positive cytoplasmic 
labelling for Stro-1. Scale bar = 50µm. Figure B demonstrates the transition from the positively 
labelled surface zone cells to the negatively labelled middle zone cells. The cells in the mid zone 
are individuals or pairs where as in the surface there is a balance between individual cells and cell 
clusters. Scale bar = 100µm.  
 
Figure C. Stro-1 labelling in an OCP of score 6. A similar pattern of labelling is seen whereby the 
surface layer of cells show detectable PCNA. The middle and deep zones lack detectable PCNA. 
Scale bar = 200µm. 
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Figure 3.7. Stro-1 labelling in an OCP of score 10. 
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Figure 3.7. D – G. Stro-1 labelling in an OCP of score 10. 
 
 
Figure D. Stro-1 labelling in the surface and middle regions of the corresponding OCP of 
score 10. Abundant Stro-1 labelling can be seen in the majority of the cells. Dentritic-like 
cells are evident. Scale bar = 100µm. 
 
Figure E. Demonstrates the distribution of positively labelled cells and the distinct 
transition in the mid zone to non Stro-1 expressing cells. The presence of dentritic-like 
cells is further emphasised in this image. Scale bar = 200µm. 
 
Figure F. Cellular invasion protruding from the underlying bone presents positively for 
Stro-1 label. Blood vessels are also evident in this frame. Scale bar = 200µm.  
 
Figure G. A low power image of Stro-1 labelling in the corresponding OCP of score 10. 
The distribution is comparable to that seen in the PCNA labelling (figure 3.5D). Scale bar 
= 400µm.  
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Score No. positive Total no. % positive Standard Error 
4 16.33 20.67 79.13 4.02 
6 11.33 17.33 67.41 9.21 
8 28.67 36.00 80.85 3.51 
10 91.00 117.33 76.46 9.53 
 
 
Figure 3.8. Histogram and corresponding table showing the percentage of total cells that 
labelled positive for Stro-1 in the superficial zone of OCPs of varying scores. 
 
Data are expressed as the mean (n=3) ± SE of the percentage of total cells which show 
cell-associated labelling. One way ANOVAs and Student t-tests suggested that there was 
no significant difference in the proportion of labelled cells between the varying scores 
(p>0.05).   
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Figure 3.9. Notch 1 labelling in OCPs of varying scores.  
 
Figure A. High power of a cluster of cells in the articular surface showing cytoplasmic 
labelling of varying degrees. Scale bar = 50µm.  
 
Figure B. Distribution of Notch 1 labelling across the articular surface. Cells are 
negatively and positively labelled regardless of whether they are in clusters. Scale bar = 
100µm. 
 
Figure C. Notch 1 labelling in an OCP of score 8 illustrating the abundance of positively 
labelled cells and cell clusters. Notch 1 labelled cells extend beyond the surface zone into 
the middle zone. Scale bar = 200µm. 
 
Figure D. Notch 1 labelling in the corresponding OCP of score 10 elicits similar labelling 
to that seen in figure 3.7 of Stro-1, however the transition between the labelled and non 
labelled zones was not as clearly defined. Labelling extends inferiorly to the lower aspect 
of the image. Dendritic-like cells evident. Scale bar = 200µm. 
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Score No. positive Total no. % positive Standard Error 
4 9.33 19.33 47.61 1.32 
6 18.67 19.00 97.44 2.56 
8 24.00 28.00 84.54 3.06 
10 55.67 66.33 84.75 6.84 
 
 
Figure 3.10. Histogram and corresponding table showing the percentage of total cells that 
labelled positive for Notch-1 in the superficial zone of OCPs of varying scores. 
 
Data are expressed as the mean (n=3) ± SE of the percentage of total cells which show 
cell-associated labelling. Score 4 showed a significantly reduced proportion of labelled 
cells when compared to the higher scores as confirmed by one way ANOVA and Student 
t-tests (p<0.05). Score 6 showed a significantly greater proportion of labelled cells when 
compared to scores 4 & 8 as confirmed by one way ANOVA and student t-tests (p<0.05).  
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3.5. Discussion 
 
The purpose of this study was to map out changes in ECM components relative to disease 
severity in osteochondral plugs excised from tibial plateaux. Research into osteoarthritis 
often focuses on end stages and the differences between the state of tissue ‘before’ and 
‘after’ the disease, however, there is little insight into the progressive changes that occur as 
the disease develops. Is there one common factor that precedes the changes that follow? 
There are several studies that do look into relative changes in gene expression between 
normal and/or early stage OA compared to late stage OA (Brew et al., 2010, Martin et al., 
2001, Young et al., 2005), however, gene expression does not necessarily relate directly to 
protein synthesis; just because a gene is present or even up-regulated it does not signify 
that it is activated.  
 
As such, using the scoring system devised in the previous chapter, a range of different 
scores were assessed using antibodies to localise synthesis of major ECM proteins, stem 
cell and proliferation markers. The aim was to reveal changes and identify trends within 
the shifting tissue, giving an insight into the mechanisms behind the changes that occur 
throughout this mysterious disease. Whilst displaying the results the choice was made not 
to omit the ‘anomalous’ OCP which achieved an overall score of 10. The reason for this 
was because despite it being an anomalous result within the small study which was carried 
out, it may indeed be representative of processes that occur more widely and are not 
recognised or distinguished from the usual changes which are more commonly reported. It 
is, therefore, imperative that a similar study is carried out on a larger scale so that one can 
verify whether or not an ‘anomalous result’ is indeed anomalous on a greater scale. 
Similarly, many of the trends observed throughout this study would be more heavily 
supported in a study of greater magnitude, as inevitably variation and inconsistencies are 
two of the common hindrances encountered when doing osteoarthritic studies on human 
patients.  
 
Collagen type I production was evident in all of the OCPs to varying degrees of intensity. 
In OCPs of lower grade (lesser extent of severity), where the surface zone often remained, 
labelling was restricted to this region. This is concurrent with previous reports which 
suggest that collagen type I labelling is evident as an independent layer residing in the 
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superficial region of normal articular cartilage (Pfander et al., 1999, Teshima et al., 2004). 
As such, it is not uncommon to find collagen type I labelling in normal articular cartilage, 
supporting the case that lower grade OCPs from this study resemble normal, un-diseased 
hyaline cartilage.  
 
Interestingly, collagen type I labelling in the surface zone was often accompanied by 
regions of hypercellularity in the form of cell clusters, in low scoring OCPs. This could, 
therefore, be indicative of cellular changes preceding ECM changes in the early phases of 
cartilage degradation in OA.  
 
Converse to the general consensus, in this study the trend lent towards a reduction in type I 
collagen in the ECM, with increasing severity of the tissue. Previous reports have 
suggested that a thicker band of type I collagen is seen in OA cartilage (Pfander et al., 
1999), and there is great ongoing speculation regarding the presence of type I collagen 
formation in cartilage repair tissue. The question addresses the issue of whether the type I 
collagen-rich tissue is the end-product of the repair mechanism; producing a 
fibrocartilagenous tissue in place of the original hyaline cartilage, or if the presence of type 
I collagen is merely a moment captured in time, of a long process that recapitulates early 
cartilage development.  
 
This question fails to be answered as the integrity of the tissue as a whole diminishes, 
resulting in further erosion and degradation. If the type I collagen is indeed a precursor to 
type II collagen formation, it may be a case of a ‘race against time’ in that the process of 
maturation from a type-I rich tissue to a type-II rich tissue is not given enough time, and 
the degradative process occur at a more rapid rate overriding the repair process before it 
has had the chance to impact the tissue integrity. The slow rate of collagen synthesis, 
particularly in adult articular cartilage is well documented (Maroudas, 1980). 
 
As mentioned, in this study no marked increase in type I collagen was found in the ECM 
of OCPs of increasing severity. However, it was observed that there was cellular 
up-regulation in individual cells as well as cell clusters. As such, it may be that the 
changes to the ECM were not yet apparent despite the well documented mechanism of 
collagen type I activation being switched on.  
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Aside from the trend of little type I collagen which has been discussed, the OCP of score 
ten which has been termed the ‘anomalous’ OCP reared very different results when 
immunohistologically labelled for collagen type I. In this OCP, an abundance of collagen 
type I was seen throughout the entire tissue, spreading from the surface through the mid- 
and into the deep zone. The distinct fibrous features suggest a well established 
fibrocartilagenous tissue (Roberts et al., 2001). In this instance, large clusters of cells 
appear to be localised at and around the presumptive tidemark region. It may be that a 
mass infiltration of cells pierced through the tidemark as a result of subchondral 
remodelling resulting in the highly cellular type I positive tissue.  
 
Type II collagen is synthesised by chondrocytes as a procollagen which is cleaved before 
being incorporated into the forming fibril and, as such, can be used as a more direct 
measure of type II collagen synthesis (Lee et al., 1996). It was found that procollagen type 
IIA labelling in this study correlated to the regions of type I collagen synthesis. In OCPs of 
lower scores the surface zone labelled positively, yet middle and deep regions elicited no 
positive label. Cellular and extracellular procollagen type IIA therefore suggests an active 
metabolic state within the osteoarthritic tissue, particularly in earlier stages of disease 
progression. Aigner et al., (1999) proposed that procollagen type IIA could be used as a 
marker of OA as its presence is congruent with the apparent onset of the disease. 
Similarly, other studies have accrued similar results; Khan et al., (2008) demonstrated the 
presence of procollagen type IIA in bovine articular cartilage in mild lesions of OA tissue, 
whilst commenting on the reduction of labelling in overtly fibrillated tissue. These reports 
are in accordance with the findings of this study; whereby OCPs of scores higher than 8 
lacked procollagen type IIA labelling.  
 
Relating these findings to those of the collagen type I results, it would appear that the 
matched labelling is indeed indicative of the developmental state being recapitulated. If the 
type I collagen rich tissue was the end state of the repair tissue, one could assume that 
procollagen type IIA collagen would not be present. As the type II collagen precursor is 
present, the conclusion may be drawn that type I rich fibrocartilage is not the intended 
end-state of the tissue. It could instead be more a case of the equilibrium between 
degradation and synthesis being disturbed, resulting in a quicker rate of degradation and 
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thus capping the potential for the newly formed tissue to reach the desired composition and 
integrity.  
 
Procollagen type IIA labelling in the ‘anomalous OCP’ does not directly correlate to the 
collagen type I results. A demarcation between labelled and non-labelled regions was 
evident dividing the mid-zone, with a positively labelled chute-like structure extending 
from the subchondral bone. By the stature of the structure it appears as though it is an 
invasion of cells from the subchondral region; more specifically an invasion of stromal 
cells from the marrow regions. As such, these undifferentiated BMSCs have the capacity 
to differentiate into articular cartilage in vivo (Han et al., 2008), and so an unknown 
mechanism may have been activated in this case to trigger the onset of new articular 
cartilage formation in this region. It could be hypothesised therefore, that within this OCP 
two different repair mechanisms are occurring; one at the surface where the surface zone 
cells are responding like the other OCPs by recapitulating the developmental phase in a 
repair attempt, and the second mechanism is through the vast infiltration of BMSCs from 
the subchondral region.  
 
The presence of aggrecan in articular cartilage ECM endows the tissue with its 
characteristic water imbibing properties and as such, is a distinctive feature of the tissue 
(Bayliss et al., 2000). It was, therefore, expected that aggrecan would be present 
throughout the OCPs, particularly in the lower scoring specimens. Indeed, it was found 
this component was widely present throughout the matrix of the OCPs assessed. 
 
 Within the low scoring OCPs, atypical pockets along the surface of the tissue lacked 
aggrecan and cellular presence. As such, it could be hypothesised that these pockets are 
areas of weaknesses which develop into fibrillated surfaces as the disease progresses. It is 
well renowned, however, that chondrocyte clusters are a histological hallmark of OA (Lotz 
et al., 2010), particularly localised around fissured surfaces in the upper regions of the 
cartilage. Through this study, it was seen that aggrecan labelling in pockets along the 
surface occur prior to chondrocyte cluster formation and as such, it can by hypothesised 
that tissue integrity is initially compromised through aggrecan degradation, and the 
formation of chondrocyte clusters is a secondary effect. 
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Cellular labelling of aggrecan was detected in some OCPs of higher scores, which 
suggested anabolic mechanisms resulting in renewed synthesis of the macromolecule prior 
to its exportation out of the cell. This, however, was not seen in all of the OCPs of higher 
scores, and this may in part be due to OCPs being excised from patients of different ages; 
it is known that the rate of aggrecan synthesis is dependent on the age of the specimen 
from which the tissue was obtained (Bayliss et al., 1999). In the OCP of score 8, where 
large fissures extend into the mid-zone, a marked reduction of aggrecan was observed 
accompanied by typical chondrocyte clusters. This finding supports the hypothesis that 
aggrecan loss occurs initially, followed by tissue degradation prior to the formation of cell 
clusters which attempt to repair and relay new matrix (Lotz et al., 2010).  
 
In the anomalous OCP, intriguingly, substantial labelling was evident alongside regions 
that clearly lacked positive labelling in the ECM. Concurrent with the other OCPs, the 
surface zone lacked aggrecan; which became more abundant in the middle region. 
However, in this OCP, a clear separation exists between regions of the mid-zone. Inferior 
to the line, aggrecan labelling is absent in the ECM however cellular labelling was 
observed. Superior to the line the tissue was rich in aggrecan throughout the ECM. This 
discrepancy very clearly highlights the altered composition of the tissue which would 
ordinarily contain aggrecan throughout the depth of the tissue. It appears that the non-
labelling, chute-containing deep region may not be of a cartilaginous nature, and may be 
indicative of a region in which endochondral bone formation is occurring. This finding 
reinforces the well known dogma that unknown mechanisms occur throughout the 
progression of OA. Again, it is important to elucidate whether this is a unique case or if 
this is common on a grander scale. It is important to understand the difference between 
what is occurring in this case compared to ‘traditional’ OA, as it also highlights the issue 
that perhaps patients are being misdiagnosed; perhaps this is a different disease which has 
not been detected and thus categorised as OA.  
 
The chute-like structure seen in this OCP which labelled positively for collagen type I and 
procollagen type IIA also demonstrated substantial aggrecan labelling. This again 
reinforces the view that infiltrating cells emerged from the subchondral region in an 
attempt to produce a hyaline-like repair tissue in response to the tissue damage.  
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Despite literature reporting the increased presence of type X collagen in OA cartilage 
(Walker et al., 1995), as whole OCPs between scores 2 and 8 showed no distinctive pattern 
or difference. This highlights the issue that, in many cases, the patterns of change that 
evolve in articular cartilage as a result of OA, are not always consistent with one another 
and vary from patient to patient. These inconsistencies, in part, are why assessing the 
severity of OA has become a subjective issue.  
 
With regards to inconsistencies, the ‘anomalous’ OCP of score 10 did indeed present with 
remarkable type X labelling extending beyond the zone of calcified cartilage and deep 
regions of the tissue. Having said that, concomitant with the findings with regard to this 
OCP, a distinct line can be seen separating the labelled and non-labelled regions. This 
further amplifies the evidence to suggest that within this OCP, hyaline cartilage has been 
replaced by a region in which endochondral bone formation is occurring. As type X 
collagen is a marker of hypertrophic chondrocytes which form prior to angiogenesis and 
subsequent mineralisation (Kronenberg, 2003), it fits the hypothesis that this region is no 
longer a region of hyaline, articular cartilage.   
 
Upon further examination using CD34 to identify endothelial cells of blood vessels, it was 
observed that indeed, on the right aspect, the noted cellular invasions were accompanied 
by blood vessels, further supporting the suggested theory.  
 
Upon type X collagen labelling in this OCP, the chute-like region which was previously 
distinguishable, could not be seen. It was previously suggested that these cells may have 
originated as BMSC from the bone marrow region. Studies have demonstrated that 
BMSCs, when chondrogenically induced in vitro, present with type X collagen (McCarthy 
et al., 2011) and as such, it is understandable that this previously identifiable region does 
not stand out under these conditions. 
 
Typically, chondrocytes in mature articular cartilage have low mitotic activity when 
compared to other cell types, and an increase in proliferative cells may be suggestive of a 
reparative attempt (Pfander et al., 2001). Concurrent to this, in our study, it was shown that 
in the lowest scoring OCP no mitotic activity in the form of PCNA labelling was detected. 
OCPs of score 4 plus did show evidence of PCNA labelling, agreeing with other studies 
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that report of increased mitotic activity in OA specimens (Hellio Le Graverand et al., 
2001, Pfander et al., 2001).  
 
Quantitative investigation (figure 3.6) suggested that there was a marked increase in 
PCNA in OCPs achieving a score of 6 or more, although no obvious trend between these 
higher scores (6 to 10) in relation to relative numbers of labelled cells was noted. More 
specifically, between the scores of 6 and 10, the proportion of labelled cells in the surface 
of the tissue ranged between 55 and 65 percent. Interestingly, error bars were greatest at 
score 6, suggesting the greatest level of variation at this score. With increasing severity, 
error levels reduced in size suggesting that the high proportion of labelled cells was more 
consistent throughout the surface of more severely diseased tissues.  
 
A review by Lotz et al., (2010) also confirmed the consensus that PCNA labelling, and 
more generally, cell proliferation is increased with OA. Unfortunately, however, within 
this study there was no progressive trend that was observed, in that PCNA labelling did not 
steadily increase with increasing severity and, as such, it is difficult to use this information 
to further decipher mechanisms of disease progression.  
 
Relating back to the ‘anomalous’ OCP, cells which labelled positively for PCNA were 
present throughout the hyaline-cartilage like tissue yet absent in the inferior region 
demonstrating endochondral bone characteristics. As such, hypercellularity throughout 
certain regions of the tissue is accounted for due to the actively proliferating cells; 
however, the phenomenon which segregates the two congruent regions of tissue is not 
explained. Migratory cells have been reported in OA cartilage (Khan et al., 2009, Koelling 
et al., 2009) which may have played a role in creating this divide between the tissue but 
again it is difficult to elucidate the mechanisms behind this change.  
 
The labelling of stem cell markers Stro-1 and Notch-1 was examined qualitatively and 
quantitatively. Qualitative data confirm previous findings of increased synthesis of the two 
putative stem cell markers within OA (Grogan et al., 2009), however particularly within 
Stro-1, no pattern was observed between increasing severity of disease within tissue and 
Stro-1 positive cells. In addition, the volume of labelled cells within the surface zone was 
significant in that over 65 percent of cells demonstrated positive (Stro-1) label. These were 
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not only individual cells, but also cell clusters, and interestingly, within clusters it was 
seen that there were, at times, a mixture of labelled and unlabelled cells. Numerically, the 
proportion of labelled cells is remarkably high which brings into question the reliability of 
Stro-1 as a marker for stem/progenitor cells. Studies by Giurea et al., (2006) have shown 
that alongside the articular cartilage, Stro-1 positive cells are also significantly increased in 
the neighbouring synovium and this may have a cascade effect onto the exposed fibrillated 
surface of the articular cartilage. Concurrent with this, Grogan et al., (2009) agree that 
despite demonstrating clear involvement in the process of OA, Stro-1 should not be used 
as a sole representative indicator of stem cells within human articular cartilage. 
 
Notch-1 has been shown to promote the maintenance of a progenitor cell phenotype in 
normal articular cartilage (Dowthwaite et al., 2004). However, in diseased articular 
cartilage, its reliability as a stem cell marker has also been questioned (Grogan et al., 
2009). Within this study, the lack of Notch-1 labelling in the lowest scoring OCPs was 
accompanied by an increase in labelling in OCPs of score 4, suggesting that there is a 
progressive correlation between severity of disease and Notch-1. Having said that, within 
OCPs of scores 6 and above, no distinct trend was detected; once OCPs reached a 
‘threshold’ level, Notch-1 labelling was notably elevated in relation to OCPs of low 
scores. With over 80 percent of the surface/mid zone cells of OCPs with severe OA 
labelling positively for Notch-1, it again brings to light the issue of whether or not Notch-1 
can be used generally as a sole marker for stem cells within articular cartilage. These 
results do, however, confirm that Notch-1 signalling is dysregulated in OA, although we 
have been unable to make any direct correlations between severity of OA and Notch-1 
labelling due to variability seen within the results.  
 
As a whole, the aim of this study was to map out progressive changes in OCPs of varying 
scores. As such, no obvious trend or direct correlation was found. This reinforces the fact 
that there are clearly many unknown mechanisms involved in OA which may interact at 
varying degrees not only within different people but also within different joints of one 
particular person. It is important to remember that OA is a disease that not only affects the 
articular cartilage, and that mechanisms of disease progression may be intricately 
intertwined between contributing factors from the surrounding environment.      
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Oxygen tension is one environmental factor that several authors have shown to have an 
effect on cartilage homeostasis. More specifically, studies have demonstrated that 
chondrocytes favour hypoxic conditions when compared to normoxic (≈20%) conditions 
(Buckley et al., 2010), and so a vicious cycle may generate when a fibrillated surface 
begins to form in the early stages of OA. The increased surface area results in increased 
exposure to the joint capsule and its constituents. The detrimental effects of the increased 
oxygen levels may be due to the fact that chondrocytes are not usually exposed to high 
levels of oxygen being an avascular tissue, and as a result the change/increase in oxygen 
alters the metabolism of the cells. Similarly, molecular oxygen is required for the 
production of nitric oxide and other reactive oxygen species (ROS) which also have been 
shown to be involved in the pathogenesis of OA (Khan et al., 2008, Pelletier et al., 2000, 
Yudoh et al., 2005, Ziskoven et al., 2010). Furthermore, a study by Altindag et al., (2007) 
suggested that decreased collagen metabolism may also be related to oxidative stress, 
which would further enhance the degradative cycle resulting in compromised tissue 
integrity alongside deranged cells.  
 
Previous studies have demonstrated the presence of cytokines and MMPs in the 
neighbouring subchondral bone and synovial fluid, which not only further contribute to the 
web of mechanisms leading to the progression of OA, but also are indicative of the pro-
inflammatory condition of OA pathology (Hulejova et al., 2007, Scanzello et al., 2009). 
This is of importance as it was evident in this study that the ‘anomalous’ OCP of score 10 
could perhaps be a case of a misdiagnosed specimen. Indeed many of the features seen 
within this OCP could be linked to rheumatoid arthritis (RA), a chronic, systemic 
inflammatory disorder (Allard et al., 1988). Within RA, a typical feature is pannus; a 
‘cloth-like’ soft tissue which appears as an invasive granulation tissue covering the 
articular cartilage, and tissue described in the OCP of score 10 did indeed bear great 
resemblance to this archetypal pannus. Several reports in the literature do report of a 
pannus-like tissue evident in OA cartilage (Shibakawa et al., 2003, Yuan et al., 2004); 
however, its occurrence is not heavily documented. A more recent article by Furuzawa-
Carballeda et al., (2008) linked the similarities between pannus in OA and RA by 
describing similar metabolic characteristics and pro-inflammatory cytokine responses. As 
such, these similarities highlight issues that clinicians face when diagnosing a patient and 
prescribing relevant treatments, in that many diseases present in comparable ways. 
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Similarly, as each case is unique and symptoms of the disease vary between patients, the 
need for a deeper understanding of OA is further emphasized. Misdiagnosing patients as a 
result of similarities between diseases could be of further detriment and as such it is 
imperative that mechanisms are understood in order to be able to improve on diagnostic 
tools.  
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Chapter 4: 
Isolation and characterisation of chondroprogenitor cells in 
osteoarthritic articular cartilage 
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4.1. Introduction 
 
Chondroprogenitor cells are cartilage derived stem cells that originate from pluripotent 
MSCs. They have a limited replicative capacity and restricted differentiation potential to 
certain lineages. The terms progenitor cell and stem cell are often used interchangeably 
however and it is important that their differences are recognised. True stem cells 
(introduced in Chapter 1) are undifferentiated cells with endless self-renewal capacity and 
the potential for multi lineage differentiation. According to the International Society for 
Cellular Therapy (ISCT), MSCs are further characterised by their adhesion potential in 
monolayer culture and their differentiation potential into chondrocytes, osteocytes and 
adipocytes in vitro (Dominici et al., 2006). The ISCT has also listed several markers that 
MSCs should exhibit or lack. Markers that MSCs should exhibit include CD105, CD73 
and CD90, whereas CD45 and CD34 are amongst the markers that MSCs should lack.  
 
As outlined in Chapter 1, surgeons have begun to implement cell therapies for articular 
cartilage repair using chondrocytes and/or MSCs as these are natural and logical choices 
for repair applications. However, chondrocytes pose problems due to the limited capacity 
of donor sites to provide the necessary quantities for ACT (Andriamanalijaona, 2010), as 
well as donor site morbidity, chondrocyte dedifferentiation in vitro and other major 
impediments that have been encountered from this treatment (Csaki et al., 2008). 
Treatments using MSCs offered a promising progression, following their use with a 
variety of techniques including intra-articular injections and matrix assisted therapies. 
However, it has come to light that foreign, undirected MSCs may have little influence on 
the repair or regeneration of cartilage leading to ambiguous results (Murphy et al., 2003, 
Im et al., 2001, Jiang et al., 2003). Furthermore, evidence of fibrocartilage formation has 
superseded hyaline cartilage formation in several cases, and integration problems have also 
been apparent, suggesting that there is room in the market for an improved technique. An 
added challenge that has been raised with regards to MSCs is their tendency to 
demonstrate type X collagen expression during in vitro chondrogenesis (Barry et al., 
2001). While type X collagen is usually used as a marker for hypertrophic chondrocytes, 
Pelttari et al., (2006) revealed that upregulation of type X collagen during in vitro 
chondrogenesis leads to strong matrix calcification accompanied by vascular invasion –a 
process similar to that occurring during endochondral ossification which ultimately leads 
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to the development of new bone. Therefore, the predisposition of MSCs towards 
osteogenesis and matrix calcification is an unfavourable aspect of using MSCs to produce 
a hyaline like repair tissue in articular cartilage defects (Andriamanalijaona, 2010). 
 
More recent advancements in cell therapies for articular cartilage repair have moved onto 
investigating the potential of using a population of native cells to repair defective cartilage. 
These cells may offer a source of cells that would not be accompanied by ‘baggage’ in the 
form of problems that surgeons currently face when treating damaged or diseased hyaline 
cartilage: donor site morbidity, genetic instability and poor integration. As such, if and 
when the native cells and methods of activation are fully understood, the prospects of 
regenerative processes are high. 
 
In view of using a native cell source, work in our laboratory demonstrated the presence of 
a stem/progenitor cell population in bovine articular cartilage in 2004 (Dowthwaite et al., 
2004b). Successful isolation of these chondroprogenitors was achieved using a differential 
adhesion assay described by Jones and Watt in 1993 involving rapid adhesion to 
fibronectin (Jones and Watt, 1993). Fibronectin plays a major role in regulating many 
cellular processes including adhesion and migration, regulation of cell growth, 
differentiation and homeostasis (Pierschbacher and Ruoslahti, 1984). In their original 
article, Jones and Watt showed that a subpopulation of human epidermal keratinocytes 
were epidermal stem cells; distinguishable by their adhesive properties and high levels of 
α5β1 integrins, and these cells correlated to the cells with the highest colony forming 
efficiencies (CFEs). The fibronectin adhesion assay outlined by Jones and Watt was 
pursued by Dowthwaite et al., (2004) who enzymatically digested cartilage to release the 
resident chondrocytes and investigated the adhesion and CFEs using a bovine model. The 
authors investigated relative differences in chondrocytes from different zones and found 
that the chondroprogenitor cell population was localised to the surface zone where the 
cells not only exhibited significantly higher CFEs but the mean number of cells per colony 
was also significantly increased in the cohort. 
 
Progressing from the work carried out by Dowthwaite et al., (2004), Williams et al., 
(2010) and McCarthy et al., (2011) investigated the possibility that a sub-population of 
chondroprogenitor cells may reside within normal human and equine articular cartilages 
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respectively. Williams et al., (2010) demonstrated that it was possible to isolate and 
expand clonal cell lines using determined growth medium to supplement the cells in vitro. 
This cohort of cells elicited a restricted differential potential during chondrogenic 
induction in a 3D pellet culture system as well as demonstrating further multipotent 
differentiation capacity. 
 
These results are of major interest due to the potential for therapy and implications to 
clinical practise. Traditionally, chondrocytes that are enzymatically released and cultured 
in monolayer at low densities undergo phenotypic modulation, whereby synthesis of 
cartilage specific macromolecules are down-regulated and the cells acquire a fibroblast-
like morphology. Given the right conditions and a chondrogenically permissive 
environment; chondrocytes are able to retain their chondrogenic potential (and 
redifferentiate or re-establish the original phenotype) up to 7 population doublings and 
sometimes beyond depending on medium additives. Due to the relatively low numbers of 
resident chondrocytes in articular cartilage, this tends to pose a problem when large 
numbers of cells are required to fill an articular defect. As a result, several research groups 
have focussed on the use of growth factors and 3D culture systems to maintain 
chondrogenic potential of cells (Benya and Shaffer, 1982, Jakob et al., 2001, Li et al., 
2004, Wolf et al., 2008). As Williams et al., 2010 summarises “Although these 
modifications, to some extent, have proved successful they would be unsuitable as a 
method of expanding cells for use in cell-based repair therapies and as such, monolayer 
culture is a limiting factor for chondrocyte efficacy. Additionally, when chondrocytes are 
used in cell based tissue engineering, the resulting repair tissue is unpredictable and often 
fibrocartilagenous.” A way to overcome this cell source limitation is to use a cell type that 
maintains its inherent proliferative capacity and possesses the ‘developmental repertoire’ 
of the native tissue. As such, the identification and characterisation of this cartilage 
progenitor population resident in normal human cartilage of varying ages presents a 
potential cohort of cells suitable for advancing cell based tissue repair therapies for 
cartilage defects.  
 
In support of data presented by Dowthwaite et al., (2004), Williams et al., (2010) and 
McCarthy et al., (2011) not only demonstrated the presence of a congruent 
chondroprogenitor population resident in equine articular cartilage; but also compared the 
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chondroprogenitor cells to bone marrow-derived stromal cells (BMSCs) as potential cell 
sources for cartilage repair in the horse. Results were promising as data from this paper 
suggested that the chondroprogenitor cells may be considered superior to BMSCs in 
producing a functional repair tissue. The article demonstrated that following 3D 
chondrogenic induction, collagen type X labelling was not detected in the progenitor cell 
pellets whereas distinct labelling was evident in the BSMC pellets. This study reiterates 
the problem highlighted earlier regarding the tendency of MSCs to undergo terminal 
differentiation with an endochondral phenotype, potentially limiting the cartilage repair 
processes; and conversely presents the articular cartilage progenitor cells as a more viable 
cell source.  
 
Work highlighted thus far focuses on progenitor cells within normal articular cartilage. 
However, with repair and regeneration in mind several research groups have directed their 
work towards looking into progenitor cells within osteoarthritic cartilage. As described in 
Chapter 1, there are many conservative and invasive surgical methods that are currently 
used which may either be palliative, or result in inconsistent results; and as such, no single 
treatment has been established as truly successful one. Total joint replacements are often 
used in patients where the tissue is deemed irrecoverable, however, this procedure does not 
rectify the problem; it provides an alternative solution through an invasive procedure that 
does not last a life-time and incurs many other implications. A native source of progenitor 
cells within diseased articular cartilage, therefore, presents with high prospects of 
regenerative processes; however this requires a deeper understanding of said cells and 
mechanisms of activation.  
 
Alsalameh et al., (2004) was the first to describe the presence of a mesenchymal 
progenitor cell population in human osteoarthritic cartilage, using flow cytometry to 
demonstrate a significant increase in CD105+/CD166+ cells compared to the primary cell 
cultures from normal cartilage. Fickert et al., (2004) published an article shortly after 
Alsalameh et al., which was agreeable despite using a different selection of CD markers 
(CD9+, CD90+ and CD166+) to conclude that within human osteoarthritic cartilage, there 
are cells with mesenchymal progenitor cell characteristics. More recently, Koelling et al., 
(2009) has described the presence of migratory chondrogenic progenitor cells within 
human osteoarthritic cartilage which are believed to be migrating in response to 
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chemoctactic signals. A review by Khan et al., (2009) suggests that despite being present, 
these cells fail to receive local differentiation cues and thus, retain their native phenotypic 
state within OA cartilage instead of differentiating into fully committed chondrocytes.  
 
The purpose of this study was to elucidate whether or not it is possible to isolate progenitor 
cells from human OA cartilage using the established Jones & Watt/Dowthwaite method of 
isolation and to examine whether these clonally derived populations had the potential for 
chondrogenic induction. Further investigations were carried out in order to establish the in 
vitro expansion potential of these cells and to determine their plasticity potentials into 
osteogenic and adipogenic lineages. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 4.2. Materials 
Material Catalogue 
number 
Supplier 
 
anti-CD105 FITC Conjugate 
anti-CD166 R-PE Conjugate 
 
 
326-040 
393-050 
 
 
Ancell, USA 
 
 
40µm mesh cell strainer 
 
 
352340 
 
BD Falcon™, UK 
 
CellTrics 30 µm filters 
 
04-004-2326 
 
Partec, UK 
 
 
Dulbecco’s modified eagles medium 
Dulbecco’s modified eagles medium 
F12 + glutamax 
Fetal calf serum  
Gentamicin 
L-glutamine 200mM 
Hepes buffer 
Insulin transferrin selenium 
Rabbit serum 
Trypsin-EDTA 0.05% 
 
 
41965-062 
31331-093 
 
10106-169 
15750-045 
25030-024 
15630-056 
41400-045 
16120107 
25300-062 
 
Gibco, UK 
 
SafeView Nucleic Acid Stain 
 
NBS-SV1 
 
 NBS Biologicals Ltd, UK 
 
 
Low Molecular Weight DNA 
Ladder 
Quick-Load 1 kb DNA Ladder 
 
 
N3233S 
 
N0468 
 
New England Biolabs, UK 
 
 
Human FGF - basic 
Human TGF - β2 
 
 
100 - 18B 
100 – 35B 
 
Peprotech, UK 
 
Agarose 
GoTaq® Flexi DNA Polymerase 
M-MLV Reverse Transcriptase, 
RNase H Minus 
Random primers 
Recombinant RNasin Ribonuclease 
Inhibitor 
Set of dATP, dCTP, dGTP, dTTP 
TBE Buffer 
 
 
 
 
V3125 
M8301 
M5301 
 
C1181 
N2511 
 
U1240 
V4251 
 
Promega, USA 
 
  
Table 4.1. Materials and suppliers. 
 
 
 
 
Pronase from Streptomyces griseus 
 
 
11 459 643 001 
 
Roche, UK 
 
Accutase 
Albumin from bovine serum 
L-Ascorbic acid 2-phosphate 
Cloning rings 
Collagenase from clostridium 
histolyticum 
Dexamethasone 
Dimethyl sulfoxide  
Fibronectin from bovine plasma 
Formalin solution, neutral buffered, 
10% 
D-(+)-Glucose  
β-Glycerophosphate disodium salt 
hydrate 
Indomethacin 
Insulin solution, human 
3-Isobutyl-1-methylxanthine 
Β-Mercaptoethanol  
Oil Red O 
Paraformaldehyde 
Phosphate buffered saline 
Silver nitrate 
Sodium carbonate 
Sodium thiosulfate pentahydrate 
Water (RNase free) 
 
 
A6964 
A8022 
A8960 
C7983 
C0130 
 
D8893 
D5879 
F1141  
HT501320 
 
G6152 
G9422 
 
I7378 
I9278 
I7018 
M3148 
O9755 
P6148 
P4417 
S6506 
S2127 
S7143 
W4502 
 
Sigma Aldrich, UK 
 
 
Ethanol 
Propan-2-ol 
Sodium hydroxide 
 
 
E/0650DF/17 
P/7500/15 
S/4920/60 
 
Thermo Fisher Scientific, 
UK 
 
 
Paraffin wax 
 
298682F 
 
VWR – Jencons, 
Leicestershire, UK 
 
 
RNase-free DNase set 
RNeasy Mini Kit 
Qiashredder 
 
 
79254 
74104 
79654 
 
Qiagen, UK 
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4.3. Methods 
 
4.3.1. Tissue digestion & chondrocyte isolation 
 
Following TKRs, tibial plateaux (TPs) were immediately transported in saline solution to 
the laboratory. Under sterile conditions, cartilage was excised from the TPs by fine 
dissection using a scalpel, ensuring where possible, that no other tissues (meniscus, 
ligament or osteophyte) were included in the digestion process. The cartilage was collected 
in a sterile 50ml tube and the chondrocytes were released from their matrix by sequential 
enzyme digestion using 70U ml-1 pronase in supplemented Dulbecco’s Modified Eagles 
Medium F12 (DMEM/F12) plus Glutamax, [DMEM/F12 + Glutamax with 100mg ml-1 
Gentamicin, 50µg ml-1 L-ascorbic acid 2-phosphate, 1mg ml-1 glucose, 2mM L-glutamine 
and 5% foetal calf serum (FCS)], for 30 minutes at 37˚C on a roller. Subsequently, the 
pronase was removed and replaced with 300U ml-1 collagenase (type I) in supplemented 
media for 3 hours at 37˚C on a roller. Following digestion, the chondrocytes were passed 
through a 40µm mesh cell strainer to ensure that any undigested tissue was eliminated, and 
the remaining cell suspension was centrifuged at 2000 rpm x g for 5 minutes. The 
supernatant was then removed and the pellet was re-suspended in supplemented 
DMEM/F12 without FCS and counted using a haemocytometer.  
 
4.3.2. Fibronectin adhesion assay to isolate cartilage progenitor cells 
 
Studies by Jones and Watt in 1993 demonstrated a method to identify epidermal stem cells 
using differential adhesion to fibronectin in vitro. Since then, Dowthwaite et al., 2004 
expanded on this method and utilised fibronectin in an in vitro adhesion assay to identify 
bovine articular cartilage progenitor cells. This method is now an accepted method to 
isolate articular cartilage progenitor cells, and Williams et al., in 2010 described the 
presence of these cells within human articular cartilage. In this chapter, the fibronectin 
adhesion assay was utilised to see whether cartilage progenitor cells were evident in 
diseased articular cartilage. 
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Chondrocytes were re-suspended at a concentration of 4000 cells ml-1 in supplemented 
DMEM/F12 and seeded onto 6-well plates that had been pre-treated with fibronectin 
(10µg ml-1 in PBS containing 1mM MgCl2 and 1mM CaCl2) for 24 hours at 4˚C. Cells 
were incubated for 20 minutes at 37˚C, after which the media and non-adherent cells were 
removed. Fresh media (DMEM/F12 + 10% FCS) was then added to the dish and the cells 
were incubated and maintained in culture in a humidified chamber containing 5% CO2 at 
37˚C. Twenty four hours later, the media was changed once again to ensure that any 
non-binding cells were removed.  
 
4.3.3. Colony isolation 
 
Colonies consisted of clusters of 32 plus cells derived from an initial cell adhering as a 
result of the fibronectin assay. The bottom of the tissue culture plastic was marked in order 
to locate the colonies and allow for colony isolation. Subsequently, the media was 
removed and dishes were washed with serum-free media. Sterile polystyrene cloning rings 
were then dipped into Vaseline using sterile forceps and placed over the marked colony. 
One hundred microlitres of trypsin-EDTA was then added to the cloning ring, and the dish 
was placed at 37˚C for 3-5 minutes until the cells had rounded. The cells were then lifted 
by gentle pipetting and added to 1ml supplemented DMEM/F12 + 10% FCS containing 
1ng ml-1 TGF-β2 and 5ng ml-1 FGF-2 in a fresh 24-well plate. 
 
4.3.4. Expansion in monolayer culture 
 
The cultures were maintained in a humidified CO2 incubator at 37˚C, and supplemented 
media (DMEM/F12 + 10% FCS containing 1ng ml-1 TGF-β2 and 5ng ml-1 FGF-2) was 
changed 3 times a week. Once the cells reached confluence, they were washed in serum-
free media and incubated in trypsin-EDTA for 6-8 minutes at 37˚C. The lifted cells in 
trypsin were then transferred to a 50ml centrifuge tube and an equal volume of 
DMEM/F12 + 10% FCS was added to the tube in order to deactivate the trypsin. The cell 
suspension was then centrifuged at 2000 rpm x g for 5 minutes. The supernatant was 
removed and the pellet was re-suspended and counted so that population doublings (PDs) 
could be monitored, using the following formula: 
 
PD =  [log (N) – log (N0)] / 0.301 
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Where N is the number of cells recovered at the end of the passage and N0 is the number 
of cells initially plated. Day 1 was considered the day in which the cells were initially 
plated and the initial number of cells was 1. PDs were analysed using Microsoft Excel.  
 
If there was a surplus of cells, they were frozen down in 100µl dimethyl sulfoxide 
(DMSO) and FCS making the total volume up to 1ml in a sterile microcentrifuge tube, and 
stored at -80˚C until necessary. 
 
4.3.5. Pellet cultures  
 
In order to establish the chondrogenic potential of the cells 3D pellet cultures were 
generated. Confluent flasks were washed in serum-free media before being trypsinised for 
6-8 minutes at 37˚C. The cell suspension was then transferred to a centrifuge tube and 
equal volumes of DMEM/F12 + 10% FCS added. The cell suspension was centrifuged at 
2000 rpm x g for 5 minutes, the supernatant removed and the pellet re-suspended and 
counted. Half a million cells were added to a sterile 1.5ml Eppendorf tube containing 
chondrogenic media (DMEM/F12 + Glutamax with 2% FCS, 100mg ml-1 Gentamicin, 
50µg ml-1 ascorbic acid, 1mg ml-1 L-glucose, 2mM L-glutamine, 1% hepes, and 
supplemented with 1% insulin transferring selenium (ITS), 0.1µM dexamethasone and 5ng 
ml-1 TGF-β2). The Eppendorf tube containing cells was then centrifuged at 2000 rpm x g 
for 5 minutes and incubated at 37˚C. Pellets were fed every second day for either 3 weeks 
or 6 weeks after which they were processed for analysis.  
 
4.3.6. Processing pellets for paraffin wax embedding 
 
Following the incubation period, the pellets were washed in PBS and then fixed in 4% 
paraformaldehyde or 70% ethanol for 20 minutes. The pellets were dehydrated in graded 
alcohols (70%, 95% and 100% x 2) with changes of 20 minutes each before being cleared 
in xylene (one change of 20 minutes), infiltrated with paraffin wax at 56˚C for one hour 
and finally embedded in paraffin wax. Following embedding, the pellets were sectioned as 
outlined in Chapter 2.3.4. 
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4.3.7. Pellets for RNA extractions 
 
Following the incubation period the pellets were washed in sterile PBS. Three hundred and 
fifty microlitres of Buffer RLT containing 10µl ml-1 β-mercaptoethanol from the Qiagen 
RNeasy Mini Kit was then added to the Eppendorf tube and the pellet was disrupted by 
gentle pipetting. The lysed pellet was then either immediately used or was stored at -80˚C 
until needed.  
4.3.8. Phenotypic plasticity  
 
Osteogenic differentiation 
 
Pellet cultures were established as described above. Osteogenic differentiation medium 
comprised DMEM + 10% FCS, 10mM β-glycerophosphate, 10nM dexamethasone and 
0.1mM L-ascorbic-acid-2-phosphate, 500mg ml-1 Gentamicin and 1% Hepes. Pellets were 
incubated at 37˚C and 5% CO2 and media was changed every second day for either 3 or 6 
weeks, after which they were processed as above.  
 
von Kossa staining for calcium mineral deposits 
 
Once pellets were embedded and sectioned, they were dewaxed using xylene (2 changes of 
2 minutes) and rehydrated through the graded alcohols (see Chapter 2.3.5). The sections 
were washed for a further 2 minutes in order for the von Kossa silver impregnation 
technique to be carried out. The sections were stained with fresh 5% aqueous silver nitrate 
for 30 minutes under bright light, and then rinsed 3 times in distilled water. Subsequently, 
the stain was developed using 5% sodium carbonate in 10% neutral buffered formalin 
solution (NBFS) for 5 minutes. Sections were then rinsed in distilled water again before 
being fixed in 5% sodium thiosulphate for 2 minutes. Examination and images were 
recorded using the Leitz DMRB light microscope.  
 
Adipogenic differentiation 
 
Adipogenic differentiation was induced in monolayer cultures using a modified protocol 
described by Koch et al., (2007). In brief, cells were seeded in 6-well plates at 5 x 104 per 
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well and cultured until sub-confluent, at which point they were treated with DMEM + 10% 
FCS containing 10µg ml-1 insulin, 1µM dexamethasone, 100µM indomethacin, 500µM 3-
isobutyl-1-methyl xanthine (IBMX) and 15% normal rabbit serum. The medium was 
changed every 48 hours for 6 days after which the cells were either fixed for 10 minutes 
with 10% NBFS and stained with Oil red-O for the presence of lipid droplets, or washed in 
PBS and lifted using Buffer RLT using the method described above, for RNA extraction. 
 
Oil red-O staining for adipogenic differentiation  
 
Following fixation in 10% NBFS, the cells were rinsed and maintained in PBS whilst fresh 
Oil red-O was prepared (0.3% Oil red-O in 60% isopropanol) immediately prior to 
staining. (A stock solution of 0.5% Oil red-O was made up in 100% isopropanol and then 
diluted in distilled water). The stain was added to the plates for 1 hour at room temperature 
before being washed thoroughly in distilled water, examined using a Nikon Eclipse TS100 
microscope and imaged using a Nikon E4500 camera.  
 
4.3.9. Histological stains 
 
Sections were dewaxed using xylene (two changes of 2 minutes) and rehydrated through a 
series of graded alcohols (two changes of 2 minutes in 100%, followed by one change of 2 
minutes in 95% and 70%). The sections were then washed in running water for a further 2 
minutes before being stained with either safranin O (2 mins) or toluidine blue (1 min). 
Following staining, sections were washed in running water for 2 minutes (or until water 
was clear). Toluidine blue stained sections were air-dried overnight and mounted under 
coverslips using DPX the following day. Safranin O stained sections were dehydrated in 
graded alcohols (one change of 1 minute in 70% and 95%, followed by two changes of 2 
minutes in 100%), cleared in xylene (two changes of 2 minutes) and mounted under 
coverslips using DPX.  
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4.3.10. Immunohistochemistry 
 
Immunoperoxidase labelling was carried out as described in Chapter 3 using antibodies 
against collagens type I, II and X, and aggrecan. A summary table of antibodies and 
concentrations is shown in table 3.2.  
 
4.3.11. Total RNA extraction using the RNeasy Mini Kit (Qiagen) 
 
The protocol used for extracting RNA was from the RNeasy Mini Handbook supplied 
within the RNeasy Mini Kit (materials supplied). 
  
A simple outline of the protocol that was used is described below.  
 
Initially, the cells were lysed in 350µl of Buffer RLT containing 10µl ml-1 
β-mercaptoethanol. The lysate was then transferred onto a QIAshredder spin column in a 
2ml collection tube and centrifuged for 2 minutes at maximum speed (13,000 rpm x g). 
Three hundred and fifty microlitres of 70% ethanol was then added to the homogenized 
lysate, and mixed well by pipetting. Seven hundred microlitres were transferred into an 
RNeasy spin column placed in a 2ml collection tube and centrifuged at 10,000 rpm x g for 
15 seconds. To eliminate genomic DNA contamination, additional On-column DNase 
digestion steps were carried out. Three hundred and fifty microlitres of Buffer RW1 was 
added to the spin column and centrifuged for 15 seconds at 10,000 rpm x g. Ten 
microlitres of DNase I stock solution was added to 70µl Buffer RDD and placed directly 
on the RNeasy spin column membrane and left for 15 minutes at room temperature. 
Subsequently, 350µl Buffer RW1 was added to the spin column and centrifuged for 15 
seconds at 10,000 rpm x g. Five hundred microlitres of Buffer RPE were then placed onto 
the RNeasy column and centrifuged for 15 seconds at 10,000 rpm x g. Another 500µl of 
Buffer RPE was added to the RNeasy column and centrifuged for a further 2 minutes at 
10,000 rpm x g. After every step, the flow-through was discarded. To elute the total RNA, 
the RNeasy column was transferred to a new 1.5ml collection tube, and 30µl of RNase-
free water was placed onto the RNeasy silica-gel membrane and centrifuged for 1 minute 
at 10,000 rpm x g. The total RNA was stored at -80°C. 
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4.3.12. Estimation of RNA concentration and purity 
 
Total RNA was quantified by measuring the absorbance at 260nm and 280nm in a 
NanoDrop ND-100 Spectrophotometer associated with Nano-Drop 3.0.1 software 
(NanoDrop Technologies, UK) against a blank of molecular biology grade water. The ratio 
of absorbance provides an indication of the purity of the RNA with respect to 
contaminants that absorb in the UV spectrum such as proteins. Pure RNA has an A260/A280 
ratio of ~2.0. 
 
4.3.13. Complimentary DNA synthesis 
 
Total RNA was reverse transcribed to prepare complimentary DNA (cDNA). The mass of 
RNA used was kept constant where possible at 100ng. Reverse transcription was carried 
out in a 50µl volume and reagents were from Promega, UK. Total RNA was mixed with 
10µl 5x M-MLV RT buffer, 1µl random hexamers, 1µl deoxyribonucleotide triphosphate 
(dNTPs) (at 20mM), 1µl rRNasin RNase inhibitor and 0.5µl M-MLV reverse transcriptase. 
RNase free water was added to make the reaction volume up to 50µl. The mixtures were 
placed in RNA-free dome cap tubes and incubated for 10 minutes at 25˚C, 60 minutes at 
48˚C and a further 10 minutes at 95˚C on a Techne TC-3000 thermal cycler (Techne, 
Cambridge, UK). Samples were then held at 4˚C before being stored at -20˚C until the 
cDNA was required. 
 
4.3.14. Reverse transcriptase polymerase chain reaction (RT-PCR) 
 
Standard PCR amplification of cDNAs of interest was carried out in a reaction containing 
2.5mM MgCl2, 200nM of each forward and reverse primer, GoTaq Flexi buffer, pH8.5 and 
1 unit of GoTaq Flexi DNA polymerase in the presence of 200µM dNTPs (reagents from 
Promega, UK). Reaction volumes were scaled to a 12.5µl with the following quantities. 
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Table 4.2. Reaction volumes for reverse transcriptase polymerase chain reaction 
(RT-PCR). 
 
Samples were initially denatured at 95˚C for 3 minutes and then amplified for 40 cycles at 
95˚C for 30 seconds, primer specific annealing temperature (Tm) for 30 seconds, and the 
extension phase was held for 30 seconds at 72˚C (refer to table 4.3 for annealing 
temperatures). A final extension was held at 72˚C for 10 minutes. Samples were then 
stored at 4˚C prior to the analysis of products by agarose gel electrophoresis.  
 
4.3.15. Agarose gel electrophoresis 
 
Nucleic acid was resolved on 2% (w/v) agarose gels containing SafeView nucleic acid 
stain at 5µl 100ml-1 prepared in 1x Tris Borate EDTA (TBE) buffer. DNA ladders were 
run alongside the products. Gels were visualised and documented using a transilluminator 
on a Bio-Rad Gel Doc 2000.  
 
 
 
 
 
 
Reagent Volume (µl) 
5x GoTaq buffer 2.50 
MgCl2 (25mM) 1.25 
Forward primer (10µM) 0.25 
Reverse primer (10µM) 0.25 
dNTPs (10mM each) 0.25 
GoTaq Polymerase 0.06 
dH2O/cDNA 7.94 
TOTAL 12.50 
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Gene of 
interest 
Primers (5’-3’) 
Annealing 
temp 
(˚C) 
Product 
size 
(bp) 
18S 
Ribosomal 
RNA 
Fwd - GCA ATT ATT CCC CAT GAA CG 
Rev – GGC CTC ACT AAA CCA TCC AA 
60 125 
 
Sox 9 
 
Fwd - AAT CTC CTG GAC CCC TTC AT  
Rev – GTC CTC CTC GCT CTC CTT CT 
62 198 
 
Notch-1 
 
Fwd - GAG GCG TGG CAG ACT ATG C 
Rev - CTT GTA CTC CGT CAG CGT GA 
60 117 
Lipoprotein 
lipase 
(LPL)  
Fwd - AGG AGC ATT ACC CAG TGT CC 
Rev - CCA AGG CTG TAT CCC AAG AG 
60 130 
 
Osteonectin 
 
Fwd - AAA TAC ATC CCC CCT TGC CT (Exon 
6/7) 
Rev - CCA GGA CGT TCT TGA GCC AG 
(Exon 7) 
60 78 
 
Osteocalcin 
 
Fwd - GGC AGC  GAG GTA GTG AAG AG 
(Exon 3) 
Rev - GAT CCG GGT AGG GGA CTG (Exon 4)  
60 73 
 
Table 4.3. Summary table of primer sequences for specific genes used for generating PCR 
products. Annealing temperature and product size also included in table.   
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4.4. Results 
 
4.4.1. Chondroprogenitor cell isolation and expansion 
 
4.4.1.1. Morphology 
 
Chondroprogenitor cells were successfully isolated from osteoarthritic tibial plateaux and 
cultured until clonally derived primary cell lines were established. The number of days 
required for colonies to form ranged from 8 days up to 14 days; after which they were 
disregarded. The morphological appearance of the colonies formed showed a large degree 
of variation. Figures 4.1 A-H demonstrates the differences in these variations. Differences 
seen related to the size of the colony (figure 4.1A compared to H), how condensed the 
cells within the colonies were (figure 4.1C compared to E), and also to the size and shape 
of the cells within the colonies. It was observed that larger cells often correlated with the 
looser colonies and smaller cells with the tighter ones. The cell shape typically seen was 
fibroblast-like, however flatter cells with numerous protrusions were also identified, as 
were spindle-like cells.  
 
Using cloning rings, colonies were isolated to enable clonal cell lines to be expanded 
independently. Figures 4.2 A-C are representatives showing the typical appearance of the 
expanded chondroprogenitor cell lines isolated from osteoarthritic tissue. Figure 4.2A 
demonstrates the cells at sub-confluence and Figure 4.2B is a representative photograph of 
the cells at confluence. These images are from cells at population doubling (PD) 28-30. 
Figure 4.2C illustrates a clonal cell line at over 60PDs and it can be seen that the cells 
retain a similar morphology at this late stage. It was generally observed that the cells had a 
tendency to increase in size with longer culture periods.  
 
Crucially, it was noted that many cell lines would initially proliferate and pass the point of 
colony formation, after which mitotic activity was curbed and proliferation ceased. 
Morphological changes in the cells were apparent at this stage and representatives of 
unsuccessful cell lines are shown in figures 4.3 A & B.  
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4.4.1.2. Population doublings 
 
Growth kinetics of the clonally derived chondroprogenitor cells lines from 9 tibial plateaux 
were investigated (figure 4.4). It was observed that there was a large amount of 
heterogeneity between the different cell lines from the different patients; however, 
different cell lines from the same patient appeared to adopt similar proliferation rates. A 
large number of cell lines did not survive past the initial phase of exponential growth (up 
to 20 PDs), which in certain cases resulted in limited cell lines being analysed per patient. 
From the chart (figure 4.4) it can be seen that after the initial surge, the tendency was for 
proliferation rates to slow. In some cases this reduction eventually plateaued, however, in 
other cases, following the initial reduction in growth rate, a second surge was apparent 
where proliferation rates increased again. The furthest that any of the cell lines were 
expanded to was to 67.4 PDs and this was achieved in 157 days.  
 
As previously mentioned, many of the chondroprogenitor cell lines that initially appeared 
to be proliferating normally showed a sudden arrest in their proliferation. Based on the 
number of cell lines initially cultured passed 20PDs, a substantial 48% of these failed to 
reach 30PDs (figure 4.5). As such, of the initial clonally derived chondroprogenitor cell 
lines originally cultured, only 14 successfully reached 30 PDs from 6 different patients 
(figure 4.6). The time taken to reach 30 PDs ranged between 34 and 75 days and this 
significant difference highlights the heterogeneity in cells isolated and cultured in the same 
way, from different patients. Interestingly, the clonal variation (variation between clones 
from the same patient) was less pronounced and no statistical significance was found 
between these cells.  
 
Seven cell lines from 4 different patients were successfully cultured to 40 PDs and the 
time taken to reach this stage ranged between 50 and 98 days; as such, the retarded cell 
lines were slower by 2-fold (figure 4.7) highlighting again that there is a distinct difference 
in cell behaviour and proliferation rates under the same conditions. The diminishing 
numbers and lack of consistency again highlights the heterogeneity throughout the 
chondroprogenitor cell lines isolated from osteoarthritic tibial plateaux.  
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Comparisons of PDs per day can be seen in figures 4.8 and 4.9. PDs per day allows for a 
direct measure of proliferation rate within a defined amount of time. Using the cell lines 
that reached 40 PDs, PDs per day up to 30 PDs and up to 40 PDs were investigated in 
order to establish whether or not the rate of proliferation slowed in the latter stages of 
culture. Figure 4.8 allows for a direct comparison between the two time points to be 
visualised and it can be seen that in most cases (6 out of 8) the PDs per day up to 30 PDs 
were slightly greater than those up to 40, this trend suggesting that the cell proliferation 
slows after extended periods in culture. There were 2 anomalies noted however; in one 
case the PDs per day increased after 30 PDs, and in the second instance, PDs per day did 
not appear to change after 30 PDs were reached. The PDs per day up to 30 PDs ranged 
from 0.42 to 0.88, and the PDs per day up to 40 PDs ranged from 0.41 to 0.79. For both of 
those data sets however, the initial phase of exponential growth was included and as such, 
this phase is likely to have the greatest impact on PDs per day. Consequently, figure 4.9 
illustrates the PDs per day for the duration between 30 and 40 PDs thus eliminating the 
early phase so that a comparison can be made to how the rates really differ in the former 
and latter stages of culture. Between 30 and 40PDs, the rate of PDs per day ranged 
between 0.29 and 0.81. Statistically, there was no significant difference observed due to 
the varied behaviours of the different cell lines - some cell lines showed a reduction in 
proliferation whereas others demonstrated an increase in proliferation. As such, no 
definitive conclusion can be drawn as to whether the proliferation rates slow in later stages 
of culture; more so each cell line has its own behavioural pattern.  
 
A linear regression line was plotted in order to establish whether or not there was a 
relationship between proliferation rates (PDs per day) and patient age. This dot plot was 
based on the cell lines that surpassed 30 PDs and the dots represent cell lines rather than 
individual patients. Interestingly it was found that proliferation rates were higher in cell 
lines of older patients (P<0.05 using Pearsons correlation test), however a low R2 value 
brings to question the significance of the regression line.   
 
4.4.2. Chondrogenic 3D pellet formation 
 
Chondroprogenitor cells were chondrogenically induced into 3D pellets containing 5x105 
cells (figures 4.11 A-E). These pellets were smooth and iridescent, resembling a typical 
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hyaline cartilage surface. The pellets formed varied in size between clonal cell lines and 
between patients but were typically between 600µm and 1.0mm. Figures 4.11 A-C 
illustrate pellets from clonal cell lines from 3 separate patients, expanded to 24-26 PDs. 
Despite varying slightly in size their physical appearance is comparable. Figure 4.11 D 
illustrates a pellet formed following expansion in culture to 60PDs. Again the difference 
observed was in size (500µm) however it cannot be assumed that this difference is due to 
the long culturing period. When forming the pellets for each clonal cell line, a minimum of 
3 replicates were maintained. As such, it was apparent that within one particular cell line, 
the resultant pellets were homologous to one another (figure 4.11 E). The size and gross 
appearance of the pellets were consistent within the clonal cell lines. In terms of gross 
morphology, it was noted on several occasions that outgrowths sporadically formed off the 
main pellet. Although not featured in figure 4.11 they are apparent in several of the 
sectioned pellets for histology and immunohistochemistry.  
 
4.4.2.1. General histology 
 
The ECM present in pellets was visualised by safranin O and toluidine blue staining 
(figure 4.12 & 4.13 respectively). Four pellets were imaged to illustrate the variation 
between clonal cell lines from different patients after culturing the cells in monolayer for 
24-26 population doublings (A – D). Figure 4.12/13 E represents a pellet formed after 
culturing in monolayer for 35 PDs and figure F illustrates a pellet formed following 
extended culture in monolayer, furthering 60 PDs. In all cases GAG deposition was 
evident, to greater or lesser extents. In the PD24-26 pellets, safranin O was most abundant 
in pellet A and, incidentally, the pellet also appears to be more intact; a coherent pellet 
with a retained structure when removed for analysis. In pellet C it can be seen that there 
are areas that lack GAG deposition particularly around the centre of the pellet, and 
similarly this pellet appears to have the least amounts of integrity. The pellets from PD 35 
and 60 (E & F) demonstrated GAG deposition again, to differing degrees.  
 
Toluidine blue staining (figure 4.13) demonstrated very similar results however it appears 
to have been a more sensitive stain as there are regions that elicit positive toluidine blue 
stain that apparently lacked GAG deposition when looking at the safranin O results. 
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Having said that, pellet C maintained its apparently poor ECM, as was found with the 
safranin O.  
 
In all cases, safranin O and toluidine blue staining for sulphated GAGs was most abundant 
around the periphery of the pellet, where an apparently more fibrous outer coating appears 
to surround the pellet. 
  
4.4.2.2. Immunohistochemistry 
 
The sectioned pellets were labelled with a panel of antibodies to ECM components. These 
were carried out on pellets formed from cells expanded to PD 24-26, 35 & 60 and cultured 
in 3D for 21 days. To see whether time influenced expression of ECM components, pellets 
were cultured for 21 and 41 days respectively. These pellets originated from cells 
expanded to 24-26 PDs.  
 
All pellets labelled for collagen type II (figure 4.14). Although it is not possible to quantify 
labelling, it is apparent that labelling is more continuous in pellets A and C, compared with 
E and G, and this also correlates with the integrity of the pellets assessed. Pellets I and K, 
formed from later PDs do not show any marked difference in the level of collagen type II 
labelling. Looking at the pellets that were cultured for different lengths of time (M-S), no 
distinct differences were detected in the first pellet (M/O) however the longer culture 
period did appear to yield more collagen type II in the second pellet (Q/S). As such, 
culturing the pellets for longer periods of time did not elicit a distinct response on the 
resultant tissue.   
 
Aggrecan labelling was not consistent throughout the pellets (figure 4.15). In certain 
pellets, labelling was evident throughout the tissue and, in particular, around the periphery 
(pellet A). However, in other pellets (pellet C) despite having a sound histological 
appearance, very little aggrecan was detectable. Pellets with less integrity demonstrated 
lower levels of aggrecan particularly in the core of the pellet (E and G). No major 
difference was found in pellets cultured from cells at later PDs; the trend that was 
generally observed was that the more aggrecan detected, the more intact the pellet, 
regardless of PDs at the point of pellet formation. Similar to the collagen type II result, the 
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effect of incubation time on aggrecan expression appeared to be cell-line specific as in one 
instance the 6 week incubation time made no difference and in the other pellet an increase 
in aggrecan expression was observed (figure 4.15 M-S). 
 
Collagen type I expression was evident in the ECM of all the pellets (figure 4.16). In some 
pellets it was more prominent in the core when compared to the periphery (pellets A and 
G). No distinct pattern, however, was observed in relation to the distribution of type I 
collagen and there more no marked difference in expression between the 3 and 6 week 
cultures.  
 
Labelling for type X collagen demonstrated the greatest variation between the pellets 
(figure 4.17). Some demonstrated a distinct lack of type X collagen, whereas in other 
pellets from different clonal cell lines, the ECM component was detected (pellet A). This 
is interesting as it demonstrates clear heterogeneity between the pellets. Pellet G represents 
the pellet cultured from cells expanded to 60 PDs and it is evident that in that particular 
case extended culturing did not increase the propensity of type X collagen expression. 
Pellets I to O demonstrate no marked effect of 3 versus 6 week incubation times whilst in 
pellet culture.   
 
4.4.3. Plasticity  
 
Following adipogenic induction, the cells adopted different morphologies in that they 
developed projections and resembled a more dendritic phenotype when compared to the 
controls (figures 4.18 and 4.19). Histological examination using oil red O revealed the 
presence of numerous lipid vacuoles surrounding the cells. This was consistent between all 
the clonal cell lines (figure 4.18 A-C). No lipid vacuoles formed in the corresponding 
controls (figure 4.19). Real-time reverse transcriptase polymerase chain reaction (RT-
PCR) analysis of the expression of mRNA for lipoprotein lipase (LPL), a member of the 
lipase gene family found in adipose tissue, in cultures exposed to adipogenic treatment 
verified the histological observation seen within the clonal cultures. Figure 4.23 B 
illustrates the absence of LPL in the chondroprogenitor cultures (C) compared to the 
positive bands seen in the adipogenic cultures (A). 
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Osteogenic differentiation was induced in a similar 3D pellet culture system used for 
chondrogenic induction. Gross morphology of the osteogenic pellets after 3 weeks closely 
resembled that of the chondrogenic pellet. The smooth, white structures are pictured in 
figure 4.20. Sectioned pellets were stained using the von Kossa technique to demonstrate 
deposits of calcium, indicative of a mineral rich matrix. Results were cell-line specific as 
varying levels of deposits were apparent after the 3 week incubation time (figure 4.21). 
Pellet A showed abundant staining throughout the pellet, pellet B showed signs of mineral 
deposits particularly in the core region of the pellet; and pellet C apparently lacked any 
calcium deposits after 3 weeks. Pellet D however is the same clonal cell line as pellet C, 
cultured under the same conditions for 6 weeks rather than 3, and here it was evident that 
after 6 weeks the mineral deposits formed and were abundant throughout. No positive stain 
was detected in any of the corresponding controls (figure 4.22). RT-PCR was carried out 
in order to demonstrate gene expression of osteogenic markers, however no particular gene 
was found to be exclusive to the osteogenic pellets whilst being absent from the 
chondrogenic pellets.  
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Figure 4.1. Comparative morphology of chondroprogenitor cell colonies isolated from 
osteoarthritic cartilage.  
Pictured colonies were cultured between 8 – 14 days in conditioned medium. Cells 
displayed a typical fibroblast-like phenotype of dedifferentiated chondrocytes. Colonies 
varied both in size and density. Scale bars: A-B = 200µm; C-E = 400µm, F-G = 500µm, H 
= 700µm. 
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Figure 4.2. Representative images of chondroprogenitor cells expanded in monolayer 
culture at sub-confluent stages (A) and at confluence (B).  
Cells cultured passed 60PDs retained they typical fibroblast-like morphology (C) 
throughout the extended culture period.  
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Figure 4.3. Representative images of chondroprogenitor cell lines that failed to continue 
proliferating.  
Cell morphology became altered; they adopted either a long thin appearance (A) or an 
irregular, straggly appearance (B). In all cases, these ‘unsuccessful’ cells showed a greater 
affinity to each other; clustering together forming networks of non-proliferating cells.  
 
 
 
 
 
191 
 
0 
10 
20 
30 
40 
50 
60 
70 
0 20 40 60 80 100 120 140 160 180 
P
op
ul
at
io
n 
do
ub
lin
gs
 (P
D
s)
 
Days in culture 
Population doublings of clonally derived chondroprogenitor cell lines 
K2 MA Cl2 gf 
K3 Lat Cl1 
K3 Lat Cl2 
K3 Lat Cl4 
K3 Med Cl1 
K3 Med Cl2 
K3 Med Cl3 
K3 Med Cl4 
K1 mcl1 
K2LP Cl1 
K6 OA Cl2 
K6 OA Cl3 
K6 OA cl4 
K19 Cl1 
K19 Cl2 
K19 Cl3 
K19 Cl4 
K28 Cl1  
K28 Cl2 N 
K28 Cl3  
K29 Cl 1 
K29 Cl 4 
k32 cl2 
K32 cl 4 
K32 cl 5 
k35A Cl1  
k35A Cl5 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.4. Chart to illustrate population doublings of clonally derived primary chondroprogenitor cell lines isolated from human osteoarthritic knee 
cartilage. 
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Figure 4.5. Pie chart displaying the proportion of cell lines that were successfully 
expanded passed 30 PDs.  
 
Fifty-two percent of the total number (n=27) successfully reached 30PDs.  
 
 
Figure 4.6. Dot plot representing the range of number of days in culture before clonally 
derived chondroprogenitor cell lines reached 30 population doublings.  
 
One-way ANOVAs confirmed that there was a statistical significance (P<0.001) between 
days taken to reach 30PDs in different patients. No significance was found between clones 
of the same patient, however this does not consider the cell lines that failed to reach 
30PDs.  
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Figure 4.7. Dot plot representing the range of number of days in culture before clonally 
derived chondroprogenitor cell lines reached 40 population doublings.  
 
One way ANOVAs confirmed a significant difference (P≤0.001) between days taken to 
reach 40PDs in different patients. 
 
 
Figure 4.8. Dot plot demonstrating the rate of population doublings per day up to 30 
(blue) and 40 (red) PDs in clonally derived chondroprogenitor cell lines reaching this 
proliferative stage. 
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Figure 4.9. Dot plot demonstrating the rate of population doublings specifically between 
30 and 40PDs in clonally derived chondroprogenitor cell lines.  
 
A paired t-test was used to establish whether or not there was a difference between 
proliferation rates at 0-30 PDs and 30-40PDs; as such no difference was found (p>0.05). 
 
 
Figure 4.10. Dot plot demonstrating the correlation between population doublings per day 
in relation to patient age in clonal cell lines that reached 30 PDs.  
 
Pearson’s correlation test demonstrated a positive relationship (p<0.05).  
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Figure 4.11. Photomicrographs of the gross morphology of chondrogenic pellets.  
Cell lines from different patients were used (A-C) displaying consistent characteristics. 
The major difference observed was size related. After long term expansion (beyond 
60PDs) cells maintained the capacity to form pellets (D). Replicates within cell lines 
demonstrated consistency in pellet size (E).  
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Figure 4.12. Photomicrographs of chondrogenic pellets stained with Safranin O for GAGs. 
Varying amounts of GAG was observed in pellets from clonal cell lines derived from 
different patients at PD 24-26 (A-D). Detectable GAG was particularly evident around the 
periphery of the pellet. GAG was also evident in pellets formed after longer culture 
periods; at PD 35 (E) and PD 60 (F). Scale bars: A-C, E-F = 50µm (insert = 100µm), D 
=100µm (insert = 200µm).  
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Figure 4.13. Photomicrographs of chondrogenic pellets stained with toluidine blue.  
Varying amounts of GAG was observed in pellets from clonal cell lines derived from 
different patients at PD 24-26 (A-D). Detectable GAG was particularly evident around the 
periphery of the pellet. GAG was also evident in pellets formed after longer culture 
periods; at PD 35 (E) and PD 60 (F). Scale bars: A-F = 50µm (insert = 100µm). 
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Figure 4.14. Collagen type II expression in chondrogenic pellets formed from 
chondroprogenitor cells isolated from osteoarthritic tibial plateaux.  
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Figure 4.14. Collagen type II expression in chondrogenic pellets formed from 
chondroprogenitor cells isolated from osteoarthritic tibial plateaux. 
A-H: Pellets from cells expanded to PD 24-26. I-J: Pellets from cells expanded to PD 35. 
K-L: Pellets from cells expanded beyond 60PDs. Collagen type II labelling was evident 
throughout the sectioned tissue. 
M-R: Pellets incubated for 3 (M+ P) or 6 (O+R) weeks. Collagen type II labelling evident 
in pellets at both time periods. In P/R there is an increase in intensity of the stain in the 6 
week pellet.  
Control pellets displayed on the right side (B, D, F, H, J, L, N, and Q). 
Scale bars: A-D = 150µm (insert = 300µm). E, G, I-K = 100µm (insert = 200µm). F, H, L 
= 200µm.  
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Figure 4.14. Collagen type II expression in chondrogenic pellets formed from 
chondroprogenitor cells isolated from osteoarthritic tibial plateaux. 
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Figure 4.15. Aggrecan (5C5) expression in chondrogenic pellets formed from 
chondroprogenitor cells isolated from osteoarthritic tibial plateaux. 
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Figure 4.15. Aggrecan (5C5) expression in chondrogenic pellets formed from 
chondroprogenitor cells isolated from osteoarthritic tibial plateaux. 
A-H: Pellets from cells expanded to PD 24-26. I-J: Pellets from cells expanded to PD 35. 
K-L: Pellets from cells expanded beyond 60PDs. Aggrecan labelling was evident 
throughout the sectioned pellets. 
M-T: Pellets incubated for 3 (M+ Q) or 6 (O+S) weeks. Aggrecan was detected in pellets 
at both time periods. No consistent pattern relating to expression in relation to incubation 
time was observed. 
Corresponding control pellets displayed on the right side (B, D, F, H, J, L, N, P, R and T). 
Scale bars: A-L = 100µm (insert = 200µm). M-T = 150µm (insert = 300µm). 
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Figure 4.15. Aggrecan (5C5) expression in chondrogenic pellets formed from 
chondroprogenitor cells isolated from osteoarthritic tibial plateaux. 
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Figure 4.16. Collagen type I expression in chondrogenic pellets formed from 
chondroprogenitor cells isolated from osteoarthritic tibial plateaux. 
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Figure 4.16. Collagen type I expression in chondrogenic pellets formed from 
chondroprogenitor cells isolated from osteoarthritic tibial plateaux. 
A-H: Pellets from cells expanded to PD 24-26. I-J: Pellets from cells expanded to PD 35. 
K-L: Pellets from cells expanded beyond 60PDs. Collagen type I labelling was detected in 
all pellets.  
M-S: Pellets incubated for 3 (M+ P) or 6 (O+R) weeks. Collagen type I labelling evident 
in pellets at both time periods. 
Control pellets displayed on the right side (B, D, F, H, J, L, N, Q and S). 
Scale bars: A-D, I-L = 100µm (insert = 200µm). E-H, M-S =150µm (insert = 300µm).  
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Figure 4.16. Collagen type I expression in chondrogenic pellets formed from 
chondroprogenitor cells isolated from osteoarthritic tibial plateaux. 
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Figure 4.17. Collagen type X expression in chondrogenic pellets formed from 
chondroprogenitor cells isolated from osteoarthritic tibial plateaux. 
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Figure 4.17. Collagen type X expression in chondrogenic pellets formed from 
chondroprogenitor cells isolated from osteoarthritic tibial plateaux. 
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Figure 4.17. Collagen type X expression in chondrogenic pellets formed from 
chondroprogenitor cells isolated from osteoarthritic tibial plateaux. 
A-F: Pellets from cells expanded to PD 24-26. G-H: Pellets from cells expanded beyond 
60PDs. Collagen type X labelling was not consistent between pellets. Pellet A displays 
positive labelling whereas no detectable collagen type X is seen in pellet E. No collagen 
type X was observed in the pellets formed following extended expansion (60+ PDs) in 
monolayer (G).  
I-P: Pellets incubated for 3 (I + M) or 6 (K + O) weeks. No marked difference in collagen 
type X expression was observed between the different incubation times.  
Control pellets displayed on the right side (B, D, F, H, J, L, N, and P). 
Scale bars: A – H, O - P =100µm (insert = 200µm). I - N =150µm (insert = 300µm).  
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Figure 4.18. Photomicrographs of monolayer cultures following adipogenic induction in 
clonally-derived cell lines from several patients.  
Cells were stained using oil red-O to highlight lipid vacuole formation.  
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Figure 4.19. Photomicrograph of monolayer culture demonstrating comparative control 
following adipogenic induction.  
Lipid formation is absent in chondroprogenitors when treated with oil red-O. 
 
 
 
 
 
 
 
 
 
 
 
212 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.20. Photomicrograph of osteogenic pellets from clonally derived cell lines from 
different patients (A-C).  
Gross morphology of the pellets showed a smooth white surface similar to chondrogenic 
pellets previously displayed. Variation was found in pellet size from different clonal cell 
lines and patients however, consistency in size was seen within replicates from a particular 
cell line (C). 
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Figure 4.21. Photomicrographs of sectioned osteogenic pellets stained using the von 
Kossa technique for mineral deposits.  
Great variation was found between pellets from different cell lines; in certain pellets 
(represented by A) strong positive labelling was detected throughout the pellet, in other 
pellets (B) evidence of mineral deposits were detected particularly in the core of the pellet; 
and there was a third category of pellets which demonstrated no sign of mineral deposition 
(C), following a 3-week incubation period. The experiment was repeated where pellets 
were incubated for 6 weeks to test whether changes observed were time dependent. Image 
D is from the same cell line as image C- after 3 weeks no mineral deposition was detected, 
however, after 6 weeks mineral deposition was abundant. This result however was not 
consistent and in some cases no difference in deposition could be detected. Scale bars: A 
& D = 150µm (insert = 300µm), B-C = 100µm (insert = 200µm).  
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Figure 4.22. Photomicrograph of a sectioned pellet representing a comparative control 
following von Kossa staining.  
No positive labelling was detected signifying no detectable mineral deposits in control 
pellets. Scale bar: 150µm (insert = 300µm). 
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Figure 4.23. Expression of sox 9, notch 1, LPL and 18S genes were investigated by RT-
PCR following multi-lineage induction of chondroprogenitor cells. 
Chondrogenic pellets expressed sox 9 and notch 1 genes (A) and adipogenic cultures 
expressed LPL (B). A = adipogenic cultures & C = comparative controls.  
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4.5. Discussion 
 
The presence of articular cartilage stem/progenitor cells is now a concept that has become 
increasingly accepted with various research groups reporting on their occurrence 
(Alsalameh et al., 2004a, Dowthwaite et al., 2004a, Khan et al., 2009a, Koelling et al., 
2009a, McCarthy et al., 2011a, Pretzel et al., 2011, Williams et al., 2010a). Previous work 
from our laboratory has demonstrated in normal bovine, equine and human tissue that 
these cells can be isolated and expanded in culture whilst retaining their cartilage-specific 
characteristics in vitro in permissive conditions. Other research groups have identified 
tissue-specific progenitor cells using other methods of identification including CD markers 
and migratory capacities; and using these, investigators have also demonstrated the 
existence of progenitor cells in normal and diseased, osteoarthritic tissue.  
 
Within this study we have demonstrated for the first time the presence of a progenitor cell 
population isolated from human osteoarthritic cartilage using the Jones & 
Watt/Dowthwaite method that relies specifically on α5β1 integrin interactions within a 
twenty minute timeframe.  
 
Colonies of cells formed from single cells. However, there was great variation seen in the 
time taken for the colonies to appear, in the density of colonies and in the morphology of 
the cells within the colonies. The reason for these discrepancies remains unknown and it 
was not possible to assess whether or not these early differences had implications on the 
cultures at later stages of expansion. Of the initially seeded cells that formed colonies of 
over 32 cells, three different categories were observed. There was i) a group which initially 
surpassed 32 cells and then almost immediately stopped proliferating, ii) a cohort of cells 
that reached the region of 25-30 population doublings, and iii) a group which could be 
cultured beyond 30 population doublings; in one case reaching up to 60 population 
doublings. Colonies selected for expansion were picked at random and therefore, it is 
possible that disparities in results could stem back to these early differences in colony 
morphology and it would be interesting to pursue this finding further as it may have major 
implications on the potential of the cells used for regenerative purposes. In a recent paper 
by Pevsner-Fischer et al., (2011), the author discusses the possibility that “long-term 
culture of MSCs leads to the selection of specific clones overtaking the culture. Since 
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MSCs may be a priori heterogeneous, functionally divergent MSC cultures could simply 
be an outcome of specific culture conditions that select particular type of MSCs”. This is a 
view that raises the point of certain cells taking over others within long term culture, a 
reasonable rationale, however the differences in this case were not a result of culture 
conditions as all cells were isolated and expanded in culture in the exact same conditions.   
 
Only 52% of the cell lines cultured reached 30 PDs, a substantial figure implying that 
approximately half of the chondroprogenitors isolated have the capacity to be cultured 
long term. It was also interesting to observe the varied proliferation rates following the 
initial exponential phase. Some cell lines slowed down, some remained constant, and 
intriguingly others sped-up upon reaching the 30 PD mark. Again these differences 
highlight a discrepancy in the cells isolated suggesting that despite the constant α5β1 
integrin interactions, there is heterogeneity within this cell population.   
 
Understanding the proliferation mechanisms of chondroprogenitors is an issue that has 
been addressed by Martin et al., (2005) who state that optimal proliferation rates of 
chondroprogenitor cells are achieved in the presence of 40% fetal bovine serum. However, 
this high percentage of serum results in a high level of ‘unknown’ combinations of 
substances acting on the cells; an issue that would be raised if this method was taken into 
clinical trials. Despite the acceptance of an issue in understanding the proliferation 
mechanisms, this paper does not address the issue of ‘failed cell lines’ which was 
encountered within this particular study. 
 
As a result of the differences in proliferation rates, the number of days taken for the cells 
to reach 30 (and 40) PDs varied significantly between patients. Due to the fact that the 
number of successful cell lines cultured could not be pre-determined, it was not possible to 
analyse clonal variation within patients. Evidently there were patients in which only one 
cell line reached 30 PDs and in a different patient four clonal cell lines reached 30 PDs. It 
is difficult to state at this point whether the difference was based on the patient and the 
viability of the cells within patients, or if it was a case of random selection that led to more 
viable cells being picked by coincidence and vice-versa. The trend that was observed 
however (which does not take into consideration the ‘failed’ cell lines) is that clonal cell 
lines from the same patient appear to proliferate at similar rates. An explanation for this 
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could be that there are different cohorts of cells within osteoarthritic tissue, and as such the 
‘high proliferating’ cohort behave in a similar way to each other, yet differently to the 
cohort of cells which are less viable. Understanding the differences between these cohorts 
of cells is essential as it will highly impact cell selection criteria when using them for 
reparative purposes.   
 
Indeed, heterogeneity of resident cells in articular cartilage has been documented; Kouri et 
al., (1996) described three different cell types inhabiting osteoarthritic cartilage 
specifically. Using ultra-structural studies, the authors identified i) type 1 cells which are 
single or clustered chondrocyte-like cells, ii) elongated secretory cells termed type 2 cells 
and iii) type 3 cells which are irregularly shaped cells undergoing degeneration. It is 
important at this stage to highlight that results from Dowthwaite et al, (1994), Williams et 
al., (2010) and McCarthy et al., (2011) papers specifically targeted progenitor cells 
residing in the surface zone of articular cartilage in the respective different species. As 
such, it is likely that the digested cells used in those studies contained a more uniform, 
homogeneous population of cells. In the osteoarthritic tissue used for this study, the 
topographical morphology of the tibial plateaux was so varied; certain regions were eroded 
to the bone, others were extensively fibrillated and other areas appeared morphologically 
‘normal’. As such, the typical surface zone seen in healthy articular cartilage was 
predominantly absent and as a result, any/all of the remaining cartilage was used in the 
tissue digestion for cell isolation. Undoubtedly, this ‘mixed bag’ of heterogeneic cells 
contributed to the inconsistent outcomes encountered throughout this study.  
 
Pellet cultures were established using the clonally derived cell lines isolated and expanded 
from osteoarthritic tibial plateaux. Morphologically, the pellets were consistent in terms of 
outer appearance; displaying a smooth, iridescently white surface. The size of pellets from 
different cell lines was variable. Histologically, the cells within the 3D pellets displayed a 
more rounded phenotype, characteristic of articular cartilage in situ. This is positive 
following de-differentiation that occurs when culturing cells in monolayer (Schnabel et al., 
2002). The pellets consistently formed an outer fibrous layer with fibres running parallel to 
the pellet periphery. This region bears great resemblance to capsule-like perichondrium 
which is usually devoid in articular cartilage due to the presence of the protective synovial 
membrane. Perichondrium is typically a region containing flat and tangentially aligned 
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chondrocytes, with a higher cell density than deeper regions that is actively involved in 
developmental stages (Morris, 2002). As such, as these cells have been extracted from 
their original protected niche, it is understandable that the pellets form this protective outer 
layer.   
 
The extent to which the cells have the capacity to recapitulate normal articular cartilage 
was investigated using immunohistochemistry to detect protein expression of specific 
cartilage ECM components, as well as general stains to demonstrate the level of sulphated 
GAG production within the matrix. Safranin O and toluidine blue staining demonstrated 
the presence of sulphated GAGs, particularly around the outer fibrous region of the pellets 
which, as stated, is congruous to the higher cell densities in this area. Within the central 
cores of the pellets, there was great variability between the level of GAG deposition of 
pellets processed at the same PDs, which again highlights inter-population heterogeneity. 
Both stains were highly detected in the pellets which where chondrogenically induced past 
60 PDs. This was an interesting result as it has been suggested in the literature that long 
term expansion of MSCs in culture results in a decreased ability to differentiate into 
mesodermal lineages (Digirolamo et al., 1999). 
 
The presence of sulphated GAG alone however, is not enough to state that cells are 
producing a cartilaginous matrix and as such it is imperative to refer to the 
immunohistochemistry results. Collagen type II and aggrecan (5C5) labelling was evident 
in all the chondrogenic pellets regardless of the stage at which the pellet was formed. 
Having said that, in some pellets the staining was more sparse than in others and as such, 
variability was present regardless of time in culture or point of pellet formation. This 
finding again emphasises the heterogeneity which was encountered throughout this study. 
Combined, these results supply evidence that chondroprogenitor cells excised from 
osteoarthritic tissue do have the potential to produce a cartilage-like, hyaline matrix rich in 
GAGs, aggrecan and collagen type II. However, it is also apparent that within the cohort of 
cells selected using the fibronectin adhesion assay, there are certain cells which respond 
more positively than others.  
 
Collagen type I was also detected in all of the pellets assessed. In some cases the labelling 
was restricted to the core, in other instances labelling was heightened around the periphery 
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and in other pellets, labelling was uniform throughout; demonstrating the inconsistent 
nature of the labelling observed. Interestingly, there are two approaches which could be 
seen with regards to collagen type I expression. During growth of the musculoskeletal 
system, type I collagen expression precedes collagen type II expression at the growth plate 
during endochondral ossification (Leboy et al., 1988) and so the presence of type I 
collagen may represent the anlagen phase of the mature tissue. Conversely, type I collagen 
is present in fibrocartilagenous repair tissues which provide a surface insufficient for 
weight bearing (Roberts et al., 2009). It is difficult at this point to elucidate which of the 
two scenarios is occurring as collagen type II was also present deploying a hyaline like 
resemblance, however, in the 6 week pellet cultures there was no marked reduction in type 
I collagen synthesis suggesting its continued production, rather than an initiator of type II 
collagen synthesis.   
 
The ambiguous nature of type X collagen expression found in the pellets further reinforces 
the heterogeneous nature of the tissue in question. The presence of type X collagen is 
suggestive of differentiation into terminally differentiated chondrocytes and, in some 
cases, the formation of a hypertrophic cartilage. This is a renowned phase of endochondral 
ossification in which the cartilaginous anlagen is transformed into bone (reviewed by 
Shen, 2005). It is a common phenomenon, as demonstrated by McCarthy et al., (2011) that 
bone marrow derived stromal cells have the tendency to not only produce a matrix rich in 
cartilaginous macromolecules following chondrogenic induction; but to also display 
consistent type X collagen labelling within the matrix; ultimately resulting in the 
resounding possibility that the tissue may have the tendency to terminally differentiate and 
calcify. McCarthy et al., (2011) suggested that chondroprogenitors isolated using the 
fibronectin adhesion assay (as per Dowthwaite et al., (2004)) were superior to 
conventional bone marrow derived stromal cells due to their lack of type X collagen 
expression in pellet cultures and therefore their reinstated hyaline cartilage phenotype. It is 
important to note, however, as previously mentioned that this study used only surface zone 
cells and therefore, the population of cells initially digested from the tissue was more 
homogeneous when compared to the range of cells residing in any remaining osteoarthritic 
cartilage on diseased tibial plateaux. This difference may explain the discrepancy between 
the solid findings observed in the McCarthy et al., (2011) study compared to the current 
study. As such, in accordance with McCarthy et al., (2011) it may therefore be suggested 
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that within the osteoarthritic tibial plateau, there are chondroprogenitor cells with the 
capacity to regenerate hyaline whilst being devoid of the endochondral fate of terminal 
differentiation. 
 
Heterogeneity of MSCs is an issue that has been raised many times, and a recent review by 
Pevsner-Fischer et al., (2011) considers many of the issues surrounding the topic. 
Questions that are broached in this review include “(1) Does the in vitro observed 
variability reflect the existence of MSC subsets in vivo? (2) What is the molecular basis of 
the in vitro observed heterogeneity? and (3) What is the biological significance of this 
variability?”. All of these questions are directly relevant to the results of this chapter in 
establishing at what point the heterogeneity occurred and what the significance is to this 
particular population of cells with regards to reparative strategies.  
 
The ability for the chondroprogenitors to produce multi-lineage progeny was examined as 
the cells were induced into adipogenic and osteogenic lineages. Despite the variation seen 
in the chondrogenic pellets, results were promising as all cell lines tested produced lipid 
vacuoles in monolayer cultures, and LPL gene expression was positive following 
adipogenic induction. Osteogenic progeny was however less affirmative and more 
variable. Upon von Kossa staining, evidence of mineralisation was heavily detected in 
some pellets, and absent in other pellets. It was apparent that in certain cases time was a 
factor as in one particular cell line, no mineralisation was detected after 3 weeks, however, 
deposits were abundant after 6 weeks. As such, the variable results may be a result of 
several reasons; a) particular cell lines could (or could not) be osteogenically induced and 
b) particular cell lines may have the ability to mineralise however the process may be 
delayed compared to the rate in other cell lines. Again, the fact that some cell lines were 
able to produce a positive von Kossa stain and others weren’t, highlights the heterogeneity 
within the cells obtained from osteoarthritic tissue; suggesting that there may be some 
chondroprogenitors which are more ‘viable’ than others when assessing their MSC 
characteristics. Indeed, Pittenger et al., (1999) reported heterogeneity within multi-lineage 
capacities of expanded colonies of cells isolated from bone marrow, which led to the 
distinction between mesenchymal stem cells and progenitor cells. The former had the 
capacity for tri-lineage differentiation whereas the latter displayed limited differentiation 
potentials. As such, it is possible that further classification of cells isolated using the 
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fibronectin adhesion assay is necessary to allow the most appropriate cohort of cells to be 
expanded for use within regenerative medicine.  
 
Interestingly, Pevsner-Fischer et al., (2011) discuss in their review that generally calling 
mesenchymal stem cells ‘multipotent stem cells’ does not actually reflect their true nature, 
in that there are not only inter-population heterogeneities, but also intra-population 
heterogeneities; both of which were observed in this study. A study carried out by 
Digirolamo et al., (1999) led to the suggestion that “even when derived from a single cell, 
the progeny of MSCs can be conditioned to behave differently”. Differences observed in 
this study may stem back to the point at which colonies were forming as seeding densities 
can affect cell morphologies and, to date, it is not known how these differences relate to 
cell functions and what they may signify. As such, the initial growth rates of the colonies 
and thus their proximity to other cells may therefore have been an influencing factor 
leading to heterogeneity within the expanded cell lines.  
 
As briefly mentioned previously, heterogeneity within the chondroprogenitors isolated 
from osteoarthritic tibial plateaux may be a secondary result of extended ex vivo culturing 
in monolayer, due to in vivo heterogeneity of variable phenotypes reflecting the natural 
repertoire of MSCs, or due to the detachment of the cells from their in vivo niche (Pevsner-
Fischer et al., 2011), which can result in partial differentiation consequently harvesting a 
heterogeneous mixture of cells (Wagner et al., 2010). Within diseased tissue particularly, 
as a result of tissue degradation and inflammation, it is possible that progenitor cells are 
actively involved in different functions and/or aspects of maintenance and repair and 
therefore heterogeneity of cells within the tissue may allow for appropriate selection of 
specific cell ‘types’ for different functions. “By contrast, homogeneous and rigid 
populations could be counterproductive under strong demand for tissue repair and 
immunomodulation” (Pevsner-Fischer et al., 2011). As such, it was proposed that the 
mixed populations may reflect the varied functions necessary to regulate tissue 
homeostasis and drive tissue repair, providing a possible explanation to the variation seen 
in results within this study. 
 
Methods used in this chapter relied heavily on surface markers as a means of identification 
to distinguish between chondroprogenitor cells and mature chondrocytes. It is important to 
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mention the stability of these markers following the digestion process. Unpublished work 
from our laboratory has demonstrated that cells isolated from bovine cartilage display 
altered characteristics depending on how long after the digestion process they are used. It 
would therefore also be interesting to investigate whether or not a time dependent 
difference could be observed following the digestion process in chondroprogenitors 
isolated from OA cartilage.  
 
Despite the heterogeneity and variation observed, the method of chondroprogenitor cell 
isolation used in this study in relation to other methods currently used, provides a cohort of 
cells that are specifically targeted based on their integrin receptor interactions. Therefore, 
despite a distinctive selection process occurring, varying cohorts of cells remain in which 
there may be one or more cell types that develop into the progenitor phenotype. 
Conversely, other methods of progenitor cell isolation used, for example, the Koelling 
method relies purely on cells migrating from explants cultured in vitro (Koelling et al., 
2009a). This phenomenon is not only a common occurrence in many different tissues and 
so should arguably be treated cautiously as a mechanism for isolating ‘progenitor’ cells, 
but also inevitably contains a greater selection of various cells with unknown, undisclosed 
phenotypes. 
  
The method used by Alsalameh et al., to identify progenitor cells relies on the presence of 
CD105+/166+ cells (Alsalameh et al., 2004a). However, as previously mentioned there has 
been contradicting data published with regard to these markers in normal and osteoarthritic 
cartilage, suggesting that further work would need to be carried out before this method 
became widely accepted (Grogan et al., 2009). 
 
 As such, with the rapid advancements and developments in this area of study, the need for 
a single and accepted method of isolation is essential to allow for further consistency and 
comparability to results across the board, enabling the issue of heterogeneity to be 
addressed. Indeed it would be beneficial to decipher the differences between the clonal cell 
lines and gain a greater understanding in the heterogeneity so that a sound understanding 
in the mechanisms of cells interactions are known before they are used for reparative 
techniques.  
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To further the work described in this chapter, it would be valuable to compare the same 
tissue used for scoring to the in vitro chondroprogenitor cell analysis. This would provide 
an insight into the reparative potential of OA tissue at specific stages of disease severity. 
This could provide an indication of whether the cells that adhere to the fibronectin during 
the adhesion assay all reside in less severely affected tissue, or whether these cells are 
equally or in fact more abundant in regions of tissue that are more highly affected by the 
disease. The limiting factor here however is cell numbers, as it may not be possible to 
digest sufficient cells for in vitro culturing from small sections of OA tissue. 
 
Looking forward, it would also be beneficial to seek quantitative molecular approaches to 
establish any correlations between OA severity and the chondroprogenitor cell profile. 
These could include quantitative PCR or more simply western blotting, as a means of 
providing more weight to the qualitative results obtained in this chapter.  
 
As a result of the limitations of the cohort size, differences in age and sex of the patient 
from which tissue was excised was only briefly touched upon. It would be interesting, 
given a larger cohort to further investigate the effects of age, sex and anatomical location 
on the characterisation of chondroprogenitors. Similarly, it would be useful to correlate 
factors such as pain levels and history of disease progression to see whether these are also 
contributing factors.  
 
Despite work having previously been carried out in normal human and bovine tissue 
looking into the differences between chondrocytes and chondroprogenitor cells 
(Dowthwaite et al., 2004 and Williams et al., 2010), given more time it would have been 
valuable to conclusively demonstrate that these differences remain in osteoarthritic tissue. 
Williams et al., 2010 demonstrated that chondrocytes from full depth cartilage had the 
ability to replicate the characteristics of chondroprogenitor cells up until a certain point, 
after which they were not able to be further expanded in culture or be differentiated into 
the chondrogenic pathway. Initial work of a similar tangent was carried out within this 
study, and preliminary results demonstrated that chondrocytes failed to proliferate beyond 
2 passages, however a more extensive and conclusive comparison would reiterate and 
reinforce the superiority of the chondroprogenitor cells in OA tissue compared to 
chondrocytes. 
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Chapter 5:  
A preliminary study comparing chondroprogenitor cells from normal 
and osteoarthritic tissue and an investigation of their integration 
potentials  
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5.1. Introduction 
 
One of the persisting problems with regards to cartilage repair is the issue of integration, 
principally due to the avascular nature of articular cartilage. As quoted by Khan et al. 
(2008) in a recent review, “one characteristic shared by intrinsic reparative processes and 
the new surgical therapies is an apparent lack of lateral integration of repair or graft tissue 
with the host cartilage that can lead to poor prognosis”. There are many factors that are 
known to directly and indirectly affect the process of tissue integration (figure 5.1), 
however to what extent these variables impede cartilage fusion varies and the mechanisms 
involved are yet to be fully understood. 
 
The developmental origin of the cell source is believed to be a key factor involved in 
determining the potential for tissue integration. Indeed, in early development cell sorting 
occurs as a result of differential cell affinity owing to adhesion molecules present on cell 
surfaces (Gilbert, 2000). Differences in these molecules and selective affinities allow cells 
of different embryonic germ layers to repel one another or conversely adhere to ‘like’ cells 
(Townes and Holtfreter, 1955). Throughout development, the cell surface adhesion 
molecules are dynamic and change in type, number and distribution thus allowing for the 
intricate processes of differentiation and maturation to occur (Fyfe and Hall, 1979).  
 
Experiments directed at the integrative capacities of cartilage from different embryonic 
regions date back as early as 1957, where Chiakulas et al., looked into the specificity and 
fusion of cartilage derived from mesodermal origin (using cartilage from the appendicular 
skeleton) and ectodermal neural-crest origin (using Meckel’s cartilage) in larval spotted 
salamanders. Results of this experiment demonstrated heterogeneity based on 
embryological origin, whereby two cartilages derived from the same place resulted in 
fusion, and cartilage from different embryological origins –namely femur cartilage against 
Meckel’s cartilage demonstrated a lack of fusion. Later experiments carried out by Fyfe 
and Hall reinforced this finding by showing that avian tibial chondrocytes failed to fuse 
with Meckel’s cartilage over a period of ten days, resulting in the authors conclusion that 
avian embryonic chondrocytes are not all equivalent.  
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Isogai et al., (2006) used an in-vitro culture model to compare differences in chondrocytes 
excised from bovine articular, nasoseptal, auricular and costal cartilages, looking 
specifically at neocartilage formation in cell-seeded scaffolds implanted into athymic 
mice. Results from this experiment again highlighted metabolic differences between the 
different chondrocytes and concluded that “each chondrocyte type establishes or maintains 
its particular developmental characteristics, and this observation is critical in the design 
and elaboration of any tissue-engineered cartilage model”.  
 
In support of these data, previous experiments from our lab (unpublished data) have 
demonstrated a lack of integration using skeletally mature bovine nasal and articular 
cartilages in an aggregation study. As previously mentioned however, these cartilages are 
derived from different embryonic origins, thus, using knowledge acquired from previous 
data, the hypothesis that integration would fail was proven.  
 
As such, the overall purpose of all of these cartilage-to-cartilage integration studies are to 
potentially find a cell source to be used as a tool for repair and treatment of articular 
cartilage defects. Many of the current strategies (as summarised in Chapter 1) involve the 
removal of cells from the joint periphery and culturing these in-vitro until sufficient 
numbers are achieved. These cells are viable candidates as developmentally they are 
derived from the correct lineage, however there are many problems including donor site 
morbidity and expansion potentials of these cells in-vitro. BMSCs are another pool of cells 
which have been and continue to be targeted extensively as a source of cells which are 
easily excised and originate from the same embryonic origin as articular cartilage –the 
mesoderm; however, as highlighted in the previous chapter this cell source is not optimum 
due to its tendency to terminally differentiate. 
 
In the previous chapter, progenitor cells from OA cartilage were isolated and expanded 
presenting with the potential to be targeted as a candidate for repair therapies in diseased 
articular cartilage. The purpose of this chapter was to preliminarily examine the integration 
potential of this novel cell source native to osteoarthritic cartilage. Per se, the benefits of 
these cells are that they are derived from the correct embryonic lineage, they reside within 
the tissue itself and, therefore, could be targeted for in situ regenerative techniques, and 
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they are not as ‘multipotent’ as BMSCs and therefore mechanisms of interactions with 
mature chondrocytes may be more easily channelled.  
 
In this chapter, chondroprogenitor cells from osteoarthritic cartilage are compared to 
chondroprogenitor cells isolated from normal cartilage using the fibronectin adhesion 
assay outlined in the previous chapter, in order to provide a direct comparison and 
elucidate similarities and differences between the two cell types. Integration potentials 
were examined using the clonally derived populations to see how well the two cell types 
integrate between and also within ‘like’ populations. Determining their integration 
potentials will help to understand whether or not the chondroprogenitor cells present in 
OA cartilage are similar to the population present in healthy cartilage and whether or not 
they are able to interact together to produce a tissue targetable for the development of 
future therapies for cartilage repair.  
 
 
  
 
Figure 5.1. Factors that directly or indirectly affect cartilage integration. Figure adapted 
from Khan et al., (2008). 
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5.2. Materials 
Table 5.1. Materials and suppliers. 
Material Catalogue 
number 
Supplier 
 
Glutaraldehyde (25%) 
 
 
R1012 
 
Agar Scientific, UK 
 
G3G4 anti-BrdU antibody 
 
G3G4- 
(AntiBrdUrd) 
 
Developmental Studies 
Hybridoma Bank, USA 
 
 
Penicillin-Streptomycin 
Sodium pyruvate 
 
 
15140-122 
11360-039 
 
Gibco, UK 
 
CellTracker™ Green CMFDA 
CellTracker™ Red CMTPX 
Quant-iT™ PicoGreen® dsDNA 
Assay Kit 
 
 
C7025 
C34552 
P7589 
 
Invitrogen, UK 
 
 
5-Bromo-4-Chloro-3-Indolyl β-D-
Galactopyranoside (X-Gal) 
 
 
B1690 
 
Molecular Probes, USA 
 
Iodoacetamide 
5-Bromo-2′-deoxyuridine (BrdU) 
Chondroitin sulfate sodium salt from 
shark cartilage 
Citric acid monohydrate 
N,N-Dimethylformamide 
1,9-Dimethyl-Methylene Blue 
DL-Dithiothreitol (DTT) 
Formaldehyde solution 
Formic acid 
Magnesium chloride 
Papain from papaya latex 
Potassium ferricyanide 
Potassium ferrocyanide 
Sodium phosphate monobasic 
Trypan Blue solution 
 
 
A3221 
B5002 
C4384 
 
C1909 
D4551 
341088 
43817 
F8775 
F0507 
M2393 
P3125 
P3667 
P9387 
S3139 
T8154 
 
Sigma Aldrich, UK 
 
 
Hydrochloric acid 
Sodium chloride 
 
H/1150/PB17 
S/3160/53 
 
Thermo Fisher Scientific, 
UK 
 
230 
 
5.3. Methods 
 
5.3.1. Tissue acquisition & cell culture 
 
Osteoarthritic cartilage was obtained from TKRs as outlined in Chapter 2.3.1. Cartilage 
was excised, digested and cultured using the methods described in Chapter 4.3.1. Normal 
cartilage was obtained from patients who underwent knee surgery and institutional safety 
and ethical guidelines were followed.  
 
For both tissue types, the fibronectin adhesion assay was used to isolate the 
chondroprogenitors. Normal chondroprogenitors were cultured in optimised media 
(DMEM containing penicillin 10000 µg ml−1/ streptomycin 10000 U ml−1, 0.1 mM 
l-ascorbic acid 2-phosphate, 0.5 mg ml−1 L-glucose, 100 mM hepes, 1 mM sodium 
pyruvate, 10% FCS, 1ng ml-1 TGF-β2 and 5ng ml-1 FGF-2).  
 
As a comparison, whole population of cells (chondroprogenitors and non-binders) were 
seeded into flasks at a density of 30,000 cells per cm2. Cells from OA tissue were cultured 
in OA media and cells from normal tissue were cultured in the media described above. 
PDs were monitored as outlined in the previous chapter.  
 
5.3.2. Colony forming efficiencies (CFEs) 
 
Twenty-four hours after plating cells by fibronectin adhesion assay, the number of adhered 
cells was counted in both OA and normal cultures. Between 8 and 14 days after the initial 
seeding day, clusters of more than 32 cells (defined as a colony) were counted, as this 
number represents a population of cells derived from more than 5 population doublings of 
a single cell, thereby discounting a transient amplifying cell cohort. Colony forming 
efficiencies were then calculated based on a) the initial seeding density and the number of 
colonies formed and b) the number of cells that initially adhered and the number of 
colonies formed.  
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5.3.3. Bromodeoxyuridine (BrdU) labelling of cells 
 
BrdU incorporation into cellular DNA occurs during cell proliferation in place of 
thymidine. As such, a BrdU assay was carried out in order to elucidate the extent of 
proliferation within the monoclonal cell lines from normal and osteoarthritic cartilage. 
Briefly, cells were seeded at 1.0 x 105 in 12 well plates and incubated for 24 hours at 37˚C 
in 5% CO2. At this point, 10µM BrdU was added to each well and incubated for a further 
24 hours. The cells were then washed several times in PBS prior to being fixed in 
pre-cooled 70% ethanol for 30 minutes. Subsequent immunodetection of BrdU using a 
specific G3G4 anti-BrdU mouse monoclonal antibody (at 3µg ml-1 for 1 hour at room 
temperature) allowed for labelling of cells in S-phase of the cell cycle. After several 
washes in PBS-T, cells were incubated in 3% H2O2 diluted in distilled water for 5 minutes. 
Following this procedure, cells were incubated in 4M HCl for 10 minutes. Reagents from 
the R.T.U Vectastain kit were used to carry out the remaining steps following the protocol 
as described in Chapter 3.3.4. DAB substrate was used to visualise the staining. Dishes 
were washed in distilled water before being imaged using a Nikon E4500 camera attached 
to an inverted Nikon Eclipse TS100 light microscope.  
 
5.3.4. Senescence associated β-Galactosidase (β-Gal) staining 
 
Cells were initially washed in PBS prior to being fixed in fixation solution (2% 
formaldehyde and 0.2% glutaraldehyde diluted in PBS) for 5 minutes at room temperature. 
Following fixation, cells were washed in PBS. Fresh β-Gal stain solution was made 
immediately before use and consisted of 1mg ml-1 5-Bromo-4-Chloro-3-Indolyl β-D-
Galactopyranoside (X-Gal) dissolved in N, N-dimethylformamidine. This was added to 
40mM citric acid/ sodium phosphate at pH 6.0, 5mM potassium ferricyanide, 5mM 
potassium ferrocyanide, 150mM sodium chloride and 2mM magnesium chloride dissolved 
in distilled water. Cells were incubated with β-Gal solution for 16-24 hours at 37˚C after 
which they were washed in distilled water and imaged using a Nikon E4500 camera 
attached to an inverted Nikon Eclipse TS100 light microscope. The assay produces a blue 
precipitate in cells expressing the senescence marker SA-β-Gal. 
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5.3.5. Analysis of BrdU and β-Gal staining 
 
Three photographs were taken at random (using x20 objective) in 3 wells per cell line. The 
numbers of positively stained and unstained cells were counted. The data were used to 
determine the proportion of proliferating and/ or senescent cells in each cell line. Statistical 
analysis was carried out using a Students t-test to confirm data significance.  
 
5.3.6. Biochemical analysis of pellets 
 
Three-D pellet cultures were set up using chondroprogenitors from normal cartilage and 
osteoarthritic cartilage and maintained in culture for three weeks, following the method 
described in Chapter 4.3.5. After the incubation period, pellets were maintained at -80˚C 
until required. 
 
5.3.6.1. Digestion using papain 
 
Pellets were lysed by adding 0.5ml of papain digestion buffer consisting of 300µg ml-1 
papain, 20mM sodium phosphate at pH6.8, 1mM EDTA and 2mM DL-Dithiothreitol 
(DTT) to each pellet-containing Eppendorf tube. These were placed on a hot block at 60˚C 
for one hour or until the pellet had fully lysed, after which 5µl of idoacetamide (at 100µg 
µl-1) was added to each Eppendorf tube to prevent further action of the digestion buffer. 
Aliquots of this digest were assayed for DNA and GAG content. Samples were either 
taken directly for analysis or frozen at -20˚C until required.  
 
5.3.6.2. DNA quantification using PICOGREEN 
 
A PICOGREEN kit was used to analyse the quantity of DNA extracted from each sample. 
Briefly, 1 x TE buffer was made up from the stock supplied within the kit. The reagent 
was made up by adding 5µl ml-1 Quant-IT PICOGREEN to TE buffer. Once prepared, the 
reagent was kept in the dark as it is light-sensitive. A standard curve was created using 
DNA component supplied within the kit. Standards were made at 0ng ml-1, 1ng ml-1, 10ng 
ml-1, 100ng ml-1 and 1000ng ml-1. To carry out the sample analysis, a total of 100µl of 
sample or standard (sample diluted to 1 in 5 in DNA free water) was added to each well of 
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a 96-well plate. Equal volumes (100µl) of prepared Quant-IT PICOGREEN were then 
added to each well. Plates were covered in foil and incubated at room temperature for 5 
minutes. The plates were read on a FLUOstar OPTIMA (BMG Labtech, USA) plate reader 
with excitation at 480nm and emission at 520nm using OPTIMA software version 2.00R3.  
 
The value for the concentration of DNA in each sample was divided by two as the total 
volume used was half the volume of the standard, and then multiplied by the dilution 
factor of five in order to give the actual concentration of DNA. 
 
5.3.6.3. GAG quantification 
 
A dimethylmethylene blue (DMMB) assay was used for the quantification of GAGs within 
the digest. Standards were prepared using stock chondroitin-6-sulphate (CS) at 0µg ml-1, 
10µg ml-1, 20µg ml-1, 30µg ml-1, 40µg ml-1 and 50µg ml-1 so that a standard curve could be 
plotted. DMMB reagent contained 16mg L-1 DMMB dissolved in 1 litre dH2O containing 
10ml ethanol, 29ml of 1M sodium hydroxide and 3.5ml formic acid (98%). Forty 
microlitres of standard or samples were pipetted in duplicate onto a 96-well plate, and 
200µl of DMMB was added to each well. The absorbances of the samples were read 
immediately at 525nm on a FLUOstar OPTIMA plate reader using the OPTIMA software 
specified previously.  
 
5.3.7. Integration study 
 
Chondroprogenitor cells from normal and osteoarthritic tissue were isolated and cultured 
using the methods previously described. The separate populations of cells were 
independently labelled using cell-tracker probes prior to being combined to form 
aggregates or pellets in order to determine whether patterns of cellular organisation and/or 
integration could be observed.  
 
5.3.7.1. Fluorescent cell labelling using CellTracker™ probes 
 
Cells were grown in monolayer in supplemented media as described in Chapter 4. Once 
expanded until the desired number of cells had been achieved, cells were lifted using 
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trypsin and centrifuged at 2000 rpm x g for 5 minutes. Supernatant was removed and the 
pellet was resuspended in supplemented serum-free media so that a concentration of 
1.0x106 cells per ml was achieved. Pre-warmed fluorescent cell trackers CMTPX (red) or 
CMFDA (green) were added to the suspensions at a working concentration of 5µM and 
tubes were incubated in the dark at 37˚C on a roller for 45 minutes. After this time, an 
equal volume of serum containing media was added to the tubes to inactivate the dyes. The 
tubes were then centrifuged at 2000 rpm x g for 5 minutes and washed with fresh serum 
containing media. This step was repeated once more to ensure any excess dye was 
removed. Finally, cells were resuspended into desired volumes to be split into cultures. 
Labelled cells were always kept out of direct light to protect the cell tracker dyes from 
decay.  
 
5.3.7.2. Trypan blue exclusion test of cell viability  
 
This test was used to determine whether either of the fluorescent dyes affected cell 
viability. Following cell labelling using the method described above, cells were re-plated 
in monolayer and cultured for 5 days at 37˚C in 5% CO2. The cells were then lifted using 
trypsin, centrifuged at 2000 rpm x g for 5 minutes and resuspended in serum-free media. 
Fifty microlitres of cell suspension was mixed with equal volumes of 0.4% trypan blue and 
the mixture was left to incubate for 3 minutes at room temperature. A haemocytometer 
was used to count the unstained (viable) and stained (non-viable) cells so that an overall 
percentage of viable cells could be calculated. One way ANOVAs were used to calculate 
any statistical significance between groups.  
 
5.3.7.3. Aggregate assembly for integration study 
 
Following fluorescent labelling of chondroprogenitors from OA and normal cartilage, 
mixed population aggregates were formed by combining 5 x 104 cells from each cell line 
into 15ml centrifuge tubes containing supplemented DMEM/F12 + 10% FCS containing 
1ng ml-1 TGF-β2 and 5ng ml-1 FGF-2. The tubes were placed on a roller and incubated at 
37˚C for 72 hours in the dark. Following the incubation period, aggregates were washed in 
PBS prior to being fixed in 10% NBFS for 20 minutes. Aggregates were then mounted 
under raised cover-slips using DAPI to create a concave microscope slide effect. 
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Aggregate types included i) chondroprogenitors from OA mixed with chondroprogenitors 
from normal tissue, ii) two different OA chondroprogenitor cell lines pooled together, 
termed OA polyclonal aggregates, and iii) two different normal chondroprogenitor cell 
lines combined, termed normal polyclonal aggregates. All ratios were one to one. 
Aggregates were imaged on a confocal microscope as outlined below.   
 
5.3.7.4. Pellet cultures for integration study 
 
Pellet cultures as described in Chapter 4.3.5 were established following fluorescent 
labelling of chondroprogenitors from OA and normal cartilage. Briefly, following the 
tracker labelling, pellets were formed by combining 2.5 x 105 cells from each cell line in a 
sterile 1.5ml Eppendorf tube containing supplemented DMEM/F12 + 2% FCS as well as 
1% ITS, 0.1µM dexamethasone and 5ng ml-1 TGF-β2. Eppendorf tubes were centrifuged 
at 2000 rpm x g for 5 minutes and incubated for 21 days at 37˚C with a media change 
every second day. On completion, pellets were fixed in 70% ethanol for 20 minutes and 
processed for paraffin wax embedded using the method described in Chapter 4.3.6. The 
pellets were then sectioned using a microtome as outlined in Chapter 2.3.4, and imaged 
using a confocal microscope. Pellets were set up as in the aggregate study, with combined 
OA and normal chondroprogenitor populations, OA polyclonal and normal polyclonal 
chondroprogenitor populations.  
 
5.3.7.5. Confocal microscopy and imaging  
 
Confocal microscopy was carried out on a Leica TCS SP2 AOBS Confocal Laser 
Scanning microscope (Leica, Germany) using appropriate excitation and emission settings 
for simultaneous detection of CMFDA (ex. max: 492nm; em. max: 517nm) and CMTPX 
(ex. max: 577nm; em. max: 602nm) ‘CellTracker’ probes. Cell aggregates were scanned 
through their entire depth using a x20 objective lens employing a z-step of typically 
between 3 and 5µm to produce a stack of digitised 'optical sections'. Pellet sections were 
imaged under the confocal microscope using identical settings. 'Maximum intensity'-type 
projections were then created from the z-stacks using Leica Confocal Software and 
presented as red-green overlays with a scale bar expressed in microns. 
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5.4. Results 
 
5.4.1. Colony forming efficiencies 
 
In this preliminary study, comparing chondroprogenitors obtained from osteoarthritic and 
normal articular cartilage, colony forming efficiencies were calculated based on the initial 
seeding density (figure 5.2) and on the number of cells which initially adhered (figure 5.3). 
In the OA samples, CFEs based on the initial seeding densities were consistently below 0.1 
(no significant difference within OA group), ranging from 0.04 to 0.09 percent. In the 
normal samples, CFEs varied significantly (p<0.05), ranging between 0.04 to 0.5 percent. 
Despite the apparent range, T–tests using the averages of samples confirmed that there was 
no significant difference between CFEs of chondroprogenitors obtained from osteoarthritic 
and normal specimens, when calculated using the original method based on the initial 
seeding density. 
 
The number of colonies formed in relation to the number of cells that initially adhered is 
demonstrated in figure 5.3. The pattern of results is similar to figure 5.2 in that the OA cell 
lines produced consistently smaller CFEs and the normal cell lines varied significantly 
(p<0.05). T-tests confirmed that there was no significant difference in average CFEs 
between the two groups. In the OA cell lines, the CFEs ranged from 0.5 to 0.88 percent 
whereas the normal cell lines ranged from 0.23 to 4.93 percent. These results in both the 
OA and normal cell lines, are approximately a ten-fold increase, when compared to CFEs 
obtained using the initial seeding densities.  
 
Initial adhesion to fibronectin was mildly higher in the chondroprogenitors from OA 
articular cartilage compared to normal counterpart, however this trend was not confirmed 
statistically (p>0.05). In the OA cultures, adhesion ranged between 10.7 and 15.4 percent, 
and ANOVAs confirmed there was no significant variation within this group (p>0.05). In 
the normal cultures, initial adhesion ranged between 5.3 and 9.9 percent (figure 5.4), and 
within this group significant variation was confirmed using ANOVAs (p<0.05).  
 
Interestingly, in relation to figures 5.3 and 5.4 together it can be seen that there appears to 
be an inverse trend occurring; a higher percent of cells in the OA cultures initially adhere 
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compared to the normal cultures; but of these adhered cells, far fewer go on to form 
colonies in the OA cultures when compared to the normal cultures.  
 
5.4.2. Proliferation and senescence  
 
Cell proliferation in clonally-derived cell lines from OA and normal articular cartilage was 
assessed using a BrdU assay which incorporates BrdU into cellular DNA in place of 
thymidine during the replicative process. Three cell lines were examined per donor. 
Consistency was observed between cell lines of each donor regardless of their origin (OA 
or normal articular cartilage) (figure 5.6). In the OA category, the percent of BrdU positive 
cells ranged from 52 to 87. More specifically, the percent of BrdU incorporation in cell 
lines of the two patients showed a distinct difference; with one demonstrating a higher 
level of proliferation (mean = 85%) and the other demonstrating a lower level of 
proliferation (mean=58%). T-tests confirmed that the differences between the two patients 
were significant (p<0.05). A similar trend was observed in the normal category; the 
percent of positive cells ranged from 64 to 89 however, as mentioned, there was a divide 
seen between the cell lines of the two donors. The mean of BrdU positive cells in cell lines 
of one donor was 66 percent, whereas in cell lines from the second patient, figures were 
significantly higher with a mean of 88 percent BrdU positive cells (p<0.05). Using the data 
between the two cohorts collectively (therefore excluding patient variability), there was no 
difference between the percentage of BrdU positive cells in the OA and normal cohort 
(p<0.05). Figure 5.5 is a photomicrograph showing the differences of BrdU labelling in the 
high and low proliferating cell lines obtained from OA and normal articular cartilage.  
 
A senescence associated β-galactosidase assay was used to assess the degree of senescence 
within chondroprogenitor cell lines from OA and normal donors. A considerable degree of 
variation was evident between and within cell lineages from patients. Within the OA 
group, the variation was not significant (p>0.05) however within the normal group the 
variation between patients was significant (p<0.05). Senescence was reduced in 
osteoarthritic cell lines when compared to cell lines from normal articular cartilage, 
confirmed statistically using a T-test (p<0.05). In the OA category, the percent of SA β-gal 
positive cells ranged between 1.4 and 5.9, whereas in the normal cohort the range was 
from 5.9 to 15.7 percent. In the normal group, the range was enlarged as a result of cell 
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lines from one particular patient exhibiting high levels of senescence (mean=15.2). Figure 
5.7 is a photomicrograph demonstrating the blue precipitate formed as a result of this assay 
in each of the cell lines obtained from the OA and normal donors. It can be seen that in 
image (C) there are noticeably more labelled cells.  
 
Correlating the cell proliferation and senescence results (figures 5.6 and 5.8) it can be 
noted that in the OA category, the patient whose cell lines elicited a higher percent of 
BrdU as a result of proliferation (OA-1) presented with relatively low levels of SA β-gal 
compared to the other patient (OA-2) where higher SA β-gal is accompanied by relatively 
low levels of BrdU labelling. This pattern was also observed in the normal group –high 
proliferation was accompanied by relatively low levels of senescence.  
 
5.4.3. Biochemical analysis of pellets  
 
Following 21 days in culture, pellets were lysed using a papain digestion buffer. DNA 
content in the lysed pellets from OA and normal origins was determined using a 
PICOGREEN kit (figure 5.9). Each bar represents the mean of 5 pellets. In the OA 
samples, DNA content of the pellets varied significantly, from 38 to 91 µg per pellet 
(ANOVAs confirmed p<0.05). In the normal samples, DNA content ranged from 22 to 73 
µg (p<0.05). Due to the similarities in ranges, no trend was observed in relation to DNA 
content in pellets derived from OA or normal articular cartilage, and this was confirmed 
statistically using T-tests (p>0.05).  
 
Dimethyl methylene blue (DMMB) assays were performed to quantitatively assess GAG 
content of the pellets. Combining these data with the DNA content is was possible to 
elucidate the content of GAG relative to DNA (figure 5.10). As a whole, it was apparent 
that within both OA and normal pellets, there was very little GAG per DNA. In the OA 
cohort, GAG/DNA ranged between 0.09 to 0.19 µg/µg, and in the normal cohort the range 
was between 0.16 and 0.5 µg/µg. ANOVAs confirmed that there were significant 
differences within both the OA and normal groups (p≤0.05) and a T-test was used to 
confirm no significant difference between the OA and normal groups (p>0.05). Using this 
preliminary data it appears that there is no real difference between GAG/DNA in pellets 
derived from chondroprogenitors from OA and normal origins.   
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5.4.4. Integration study 
 
Chondroprogenitor cells were successfully labelled with CMTPX and CMFDA cell tracker 
labels. Concentration and incubation time was optimised in monolayer cultures (figure 
5.11). Optimal concentration was 5µM, incubated in a dark room on a roller for 45 
minutes. Cell viability was assessed to ascertain whether cell trackers affected cell 
viability (figure 5.12). In cultures with no tracker, 8.7 % of the cells were trypan blue 
positive, compared to the 9.9 % and 6.7 % in CMTPX and CMFDA cultures respectively. 
As such there was no significant difference between viability in cultures labelled with 
either of the cell trackers when compared to the corresponding control. This was 
confirmed using a T-test where p>0.05 in both cases (figure 5.13).  
 
Cell aggregates were formed combining clonally-derived chondroprogenitor cell lines. 
Different OA lines were combined, different normal cell lines were combined and a 
mixture of OA and normal cell lines were combined (figure 5.14). Figure 5.14.1 
demonstrates three different OA: OA cell aggregates. The results amongst the OA 
aggregates were variable in that cell integration was observed in certain aggregates 
(represented through figure 5.14.1-i); partial integration was seen in other aggregates 
(figure 5.14.1-ii) and distinct segregation was observed in others (figure 5.14.1-iii). Where 
‘partial integration’ was observed, it was evident that there were regions in the aggregate 
where cells failed to integrate, despite other areas of the aggregate showing clear 
integration. In figure 5.14.1-iii the aggregate has been categorised under ‘segregation’ as 
one population of cells can be seen to be heavily weighted on the right side (green 
CMFDA) whereas the red CMTPX labelling is localised to the left hand side. As such, no 
definitive pattern was detected when combining chondroprogenitor cell lines from OA 
articular cartilage.  
 
When two different chondroprogenitor cell lines from normal derivatives were combined, 
the trend was biased towards segregation rather than integration in the aggregates. In 
figure 5.14.2-i, there appears to be one dominant cell line (red) that has formed the 
majority of the aggregate, and cells from the other cell line (green) appear to be largely 
restricted to a small portion on the bottom left side of the aggregate. In a different 
aggregate (figure 5.14.2-ii) a similar trend was observed in that there appeared to be a 
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dominant cell line, with a concentrated area in which the other cell line predominantly 
resides. In this case however, a small increase in integration was also noted throughout the 
rest of the structure.  
 
Aggregates formed from OA and normal chondroprogenitor cells can be viewed in figure 
5.14.3. In two of the three aggregates presented, widespread integration was observed 
throughout the structure (i and ii). In the third case, clear segregation was observed 
between the two different cell lines (iii). Figure 5.14.4 is an aggregate which was formed 
in the initial optimisation stages, with a seeding density ten times larger than the optimised 
number (1.0x106 cells). As such, for analysis this structure was sectioned before being 
viewed under the confocal microscope. Despite being distinctly larger in size, clear 
integration between the two cell lines (OA: normal) was observed. 
 
Alongside the aggregates, pellets were formed which were cultured for 21 days prior to 
being subject to confocal microscopy (figure 5.15).Variation was again seen within the 
pellets with no distinct pattern of segregation and/or integration observed. In figure 5.15.1-
i, a pellet formed from two OA cell lines, segregation was evident as one cell line adopted 
the periphery (red), while the other cell line occupied the core (green). Other pellets of 
mixed OA cell lines however demonstrated greater levels of integration (figures 5.15.1-ii 
& iii). Integration with pockets of segregation as seen in the aggregates was also observed 
in the pellets (figure 5.15.1-ii).  
 
Pellets formed by normal cell lines and mixed OA and normal cell lines did not elicit any 
distinct pattern of organisation (figures 5.15.2 and 5.15.3). Again, in some instances 
integration was observed and in others clear evidence of segregation was seen. As such, no 
distinct trend could be defined within the aggregates or pellets formed from normal, OA 
and/or OA and normal cell lines. Table 5.2 summarises the results of the aggregation study 
which helps in drawing the conclusion that no defined pattern could be observed.  
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Figure 5.2. CFEs of chondroprogenitor cells isolated from OA (blue) and normal (red) 
tissue. 
CFEs based on the initial seeding density. Combined mean displayed (+/- SEM) (n=3). 
ANOVAs suggested that there was no significant difference in CFEs within the OA group 
(p>0.05), yet that there was a significant difference in CFEs within the normal group 
(p<0.05). Using the averages for each patient, t-tests suggest that there is no significant 
difference in CFEs between the two (OA and normal) groups (p>0.05).  
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Figure 5.3. CFEs of chondroprogenitor cells isolated from OA (blue) and normal (red) 
tissue.  
CFEs calculated following initial adhesion to fibronectin. Combined mean displayed (+/- 
SEM) (n=3). ANOVAs suggested that there was no significant difference in CFEs within 
the OA group (p>0.05), yet that there was a significant difference in CFEs within the 
normal group (p<0.05). Using the averages for each patient, t-tests suggest that there is no 
significant difference in CFEs between the two (OA and normal) groups (p>0.05). 
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Figure 5.4. Bar chart demonstrating the initial number of cells isolated from OA (blue) 
and normal (red) articular cartilage adhering to fibronectin within 20 minutes.  
Data illustrates the mean, displayed as a percentage of the total (+/- SEM) (n=3). 
ANOVAs suggested that there was no significant difference in percentage of adhered cells 
within the OA group (p>0.05), yet that there was a significant variability within the normal 
group (p<0.05). Using the averages for each patient, t-tests suggest that there is no 
significant difference in initial adhesion between the two (OA and normal) groups 
(p>0.05). 
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Figure 5.5. Photomicrographs of clonally derived chondroprogenitor cells isolated from 
OA (A & B) or normal (C & D) articular cartilage treated with BrdU to detect cell 
proliferation.  
Photomicrographs are representative images to demonstrate BrdU incorporation to greater 
(A & D) and lesser extents (B & C) in both cohorts. Cells were viewed under a Nikon 
Eclipse TS100 microscope and imaged using a Nikon E4500 camera. Scale bars = 200µm.  
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Figure 5.6. Graph representing mean percentage of 5-bromo-2-deoxyuridine (BrdU) positive cells in cells lines (n=3) from different patients (n=2 for OA, 
n=2 for normal).  
Blue bars represent cultures obtained from osteoarthritic patients. Red bars represent cultures obtained from normal un-diseased patients. There was a 
significant difference in BrdU labelling between patients in both the OA and normal groups, and this was confirmed statistically using t-tests (p<0.05). 
Comparing the whole OA group against the whole normal group, no difference was found and this was confirmed by a t-test (p>0.05).  
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Figure 5.7. Photomicrographs of clonally derived chondroprogenitor cells isolated from 
OA (A & B) or normal (C & D) articular cartilage stained for senescence associated β-
galactosidase (SA-β-Gal) at pH 6.0.  
Photomicrographs are representative images to demonstrate senescent cells in which a blue 
precipitate is formed following the assay. Cells were viewed under a Nikon Eclipse TS100 
microscope and imaged using a Nikon E4500 camera. Scale bars = 200µm. 
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Figure 5.8. Graph representing mean percentage of senescence associated β-galactosidase (SA-β-Gal) positive cells in cells lines (n=3) from different patients 
(n=2 for OA, n=2 for normal).  
Blue bars represent cultures obtained from osteoarthritic patients and red bars represent cultures obtained from normal un-diseased patients. SA-β-Gal 
labelling did not vary significantly within the OA group as confirmed through a student t-test (p>0.05). However, a significant difference in SA-β-Gal 
labelling within the normal group was confirmed using a t-test (p<0.05). A significant difference was observed when comparing SA-β-Gal labelling in the 
whole OA group against the SA-β-Gal labelling in the normal group, and this was confirmed using a student t-test (p<0.05).  
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Figure 5.9. Bar chart representing mean DNA content (µg) (n=5) in articular cartilage 
progenitor cell pellets derived from OA (blue) or normal (red) tissue (+/- SEM) following 
digestion using papain and DNA quantification using PICOGREEN.  
Within both the OA and normal groups, significant variation was observed in DNA 
content per pellet. This difference was confirmed statistically using ANOVAs where 
p<0.05. A t-test was used to compare DNA content between the two groups and no 
significant difference was suggested (p>0.05).  
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Figure 5.10. Bar chart representing mean glycosaminoglycan (GAG) content per µg DNA 
of articular cartilage progenitor cell pellets derived from OA (blue) or normal (red) tissue 
(+/- SEM).  
Pellets were digested using papain, DNA quantified using PICOGREEN and GAG 
quantified using a DMMB assay. Within both the OA and normal groups, significant 
variation was observed in mean GAG/DNA. This difference was confirmed statistically 
using ANOVAs where p<0.05. A t-test was used to compare GAG/DNA between the two 
groups and no significant difference was suggested (p>0.05).  
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Figure 5.11. Chondroprogenitor cell labelling using 5µM CMTPX red (A) and CMFDA 
green (B) tracker labels in monolayer cultures.  
During labelling, cells were incubated in a dark room at 37°C for 45 minutes. Cultures 
were viewed and imaged under a BX61 Olympus fluorescent microscope.  
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Figure 5.12. Trypan blue exclusion test of cell viability.  
Viable (unstained) and non-viable (stained blue) were counted using a haemocytometer. 
Cells were viewed under a Nikon Eclipse TS100 microscope and imaged using a Nikon 
E4500 camera. 
 
Figure 5.13. Bar chart demonstrating mean cell viability (n=5) after using CMTPX and 
CMFDA cell trackers in monolayer cultures.  
Mean percent of positive cells was 8.7% in control cultures, 9.9% in CMTPX cultures and 
6.7% in CMFDA cultures. T-tests confirmed that there was no significant difference in 
viability between cells labelled with either of the trackers when compared to the control 
(p>0.05).  
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Figure 5.14. Fluorescently labelled cell aggregates containing mixed populations of 
chondroprogenitors (OA:OA, normal:normal and OA:normal) cultured for 4 days in 
optimised media. 
 
Green CMFDA and red CMTPX cell trackers were used to demonstrate relative positions 
of labelled cells. Aggregates were viewed and imaged using a confocal laser scanning 
microscope.  
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Figure 5.14.1-i: OA:OA 
 
Chondroprogenitor cell aggregates of mixed cells from different OA cell lines (OA:OA) at 
a ratio of 1:1. CMFDA green and CMTPX red cell trackers distinguish between the two 
cell populations. (A & C) Position of the individually labelled cells. (B & D) Composite 
images demonstrating relative positions of cell populations. (A & B) Low power images 
and higher power images (C & D). 
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Figure 5.14.1-ii: OA:OA 
 
Chondroprogenitor cell aggregates of mixed cells from different OA cell lines (OA:OA) at 
a ratio of 1:1. CMFDA green and CMTPX red cell trackers distinguish between the two 
cell populations. (A & C) Position of the individually labelled cells. (B & D) Composite 
images demonstrating relative positions of cell populations. (A & B) Low power images 
and higher power images (C & D). 
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Figure 5.14.1-iii: OA:OA 
 
Chondroprogenitor cell aggregates of mixed cells from different OA cell lines (OA:OA) at 
a ratio of 1:1. CMFDA green and CMTPX red cell trackers distinguish between the two 
cell populations. (A) Position of the individually labelled cells. (B) Composite image 
demonstrating relative positions of cell populations. (A & B) Low power images. 
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Figure 5.14.2-i: Normal:normal 
 
Chondroprogenitor cell aggregates of mixed cells from normal cell lines (normal : normal) 
at a ratio of 1:1. CMFDA green and CMTPX red cell trackers distinguish between the two 
cell populations. (A & C) Position of the individually labelled cells. (B & D) Composite 
images demonstrating relative positions of cell populations. (A & B) Low power images 
and higher power images (C & D). 
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Figure 5.14.2-ii: Normal:normal 
 
Chondroprogenitor cell aggregates of mixed cells from normal cell lines (normal : normal) 
at a ratio of 1:1. CMFDA green and CMTPX red cell trackers distinguish between the two 
cell populations. (A & C) Position of the individually labelled cells. (B & D) Composite 
images demonstrating relative positions of cell populations. (A & B) Low power images 
and higher power images (C & D). 
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Figures 5.14.3-i -iii: OA:normal 
 
Chondroprogenitor cell aggregates of mixed cell origins (OA : normal) at a ratio of 1:1. 
CMFDA green (normal) and CMTPX red (OA) cell trackers distinguish between the two 
cell populations. (A) Position of the individually labelled cells. (B) Composite image 
demonstrating relative positions of cell populations. (A & B) Low power images. 
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Figure 5.14.4: Sectioned aggregate OA:normal 
 
Sectioned chondroprogenitor cell aggregate of mixed cell origins (OA : normal) at a ratio 
of 1:1. Initial seeding density of aggregate = 1.0x106, formed during optimisation process. 
CMFDA green (normal) and CMTPX red (OA) cell trackers distinguish between the two 
cell populations. (A & C) Position of the individually labelled cells. (B & D) Composite 
images demonstrating relative positions of cell populations. (A & B) Low power images 
and higher power images (C & D). 
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Figure 5.15. Fluorescently labelled pellets containing mixed populations of 
chondroprogenitors (OA:OA, normal:normal and OA:normal) cultured for 21 days in 
optimised media. 
 
Green CMFDA and red CMTPX cell trackers were used to demonstrate relative positions 
of labelled cells. Pellets were viewed and imaged using a confocal laser scanning 
microscope.  
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Figure 5.15.1-i: OA:OA 
 
Chondroprogenitor cell pellets of mixed cells from OA cell lines (OA : OA) at a ratio of 
1:1. CMFDA green and CMTPX red cell trackers distinguish between the two cell 
populations. (A, C & E) Position of the individually labelled cells. (B, D & F) Composite 
images demonstrating relative positions of cell populations. (A & B) Low power images 
and higher power images (C, D, E, F). 
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Figure 5.15.1-ii: OA:OA 
 
Chondroprogenitor cell pellets of mixed cells from OA cell lines (OA : OA) at a ratio of 
1:1. CMFDA green and CMTPX red cell trackers distinguish between the two cell 
populations. (A, C & E) Position of the individually labelled cells. (B, D & F) Composite 
images demonstrating relative positions of cell populations. (A & B) Low power images 
and higher power images (C, D, E, F). 
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Figure 5.15.1-iii: OA:OA 
 
Chondroprogenitor cell pellets of mixed cells from OA cell lines (OA : OA) at a ratio of 
1:1. CMFDA green and CMTPX red cell trackers distinguish between the two cell 
populations. (A & C) Position of the individually labelled cells. (B & D) Composite 
images demonstrating relative positions of cell populations. (A & B) Low power images 
and higher power images (C & D). 
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Figure 5.15.2-i: Normal:normal 
 
Chondroprogenitor cell pellets of mixed cells from normal cell lines (normal : normal) at a 
ratio of 1:1. CMFDA green and CMTPX red cell trackers distinguish between the two cell 
populations. (A,C & E) Position of the individually labelled cells. (B, D & F) Composite 
images demonstrating relative positions of cell populations. (A & B) Low power images 
anf higher power images (C, D, E & F).  
 
  
265 
 
 
Figure 5.15.2-ii: Normal:normal 
 
Chondroprogenitor cell pellets of mixed cells from normal cell lines (normal : normal) at a 
ratio of 1:1. CMFDA green and CMTPX red cell trackers distinguish between the two cell 
populations. (A & C) Position of the individually labelled cells. (B & D) Composite 
images demonstrating relative positions of cell populations. (A & B) Low power images 
anf higher power images (C & D). 
 
 
 
 
 
  
 
266 
 
Figure 5.15.3-i: OA:normal 
 
Chondroprogenitor cell pellet of mixed cell origins (OA : normal) at a ratio of 1:1. 
CMFDA green (normal) and CMTPX red (OA) cell trackers distinguish between the two 
cell populations. (A, C & E) Position of the individually labelled cells. (B, D & F) 
Composite images demonstrating relative positions of cell populations. (A & B) Low 
power images and higher power images (C, D, E, F). 
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Figure 5.15.3-ii: OA:normal 
 
Chondroprogenitor cell pellet of mixed cell origins (OA : normal) at a ratio of 1:1. 
CMFDA green (normal) and CMTPX red (OA) cell trackers distinguish between the two 
cell populations. (A & C) Position of the individually labelled cells. (B & D) Composite 
images demonstrating relative positions of cell populations. (A & B) Low power images 
anf higher power images (C & D). 
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Figure 5.15.3-iii: OA:normal 
 
Chondroprogenitor cell pellet of mixed cell origins (OA : normal) at a ratio of 1:1. 
CMFDA green (normal) and CMTPX red (OA) cell trackers distinguish between the two 
cell populations. (A & C) Position of the individually labelled cells. (B & D) Composite 
images demonstrating relative positions of cell populations. (A & B) Low power images 
anf higher power images (C & D). 
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Table 5.2. Summary results table of cell tracker study in aggregates and pellets. Colour 
code displays results in the form of green (integration), red (segregation) and yellow 
(largely integrated with distinct areas of segregation).  
 
 
 
Key 
Integration (I)  
Segregation (S)  
Integration with segregation I (S)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 OA : OA 
Normal : 
normal OA : normal 
i ii iii i ii i ii iii 
         
Aggregates I I (S) S S I (S) I I S 
   
Pellets S I (S) I S I (S) S I S 
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5.5. Discussion 
 
The aim of this chapter was to compare chondroprogenitor cells from osteoarthritic 
cartilage to those isolated from normal cartilage, in order to elucidate whether or not there 
are distinct differences between the two cell types. Results were also used as a platform to 
understand integration potentials of the two cell types.  
 
Results from this study should only be used as preliminary data due to the restricted ‘n’ 
numbers. Due to time limitations and the difficulties acquiring normal articular cartilage, 
in certain experiments it was only possible to obtain an n of 2 in the normal category. As 
such, results may be used only as suggestive data and further data acquisition would be 
required to give results from this chapter greater weight.   
 
Originally, colony forming efficiencies (CFEs) were calculated using the percentage of 
colonies formed as a proportion of the initial seeding density (Jones and Watt, 1993). 
However, depending on seeding densities, cells are known to behave very differently 
(Melero-Martin et al., 2006). As such, data were represented not only using the traditional 
method of calculation, but also as a proportion of the number of cells that initially adhered 
to the tissue culture plastic coated in fibronectin. The difference in results observed may 
appear to show similar trends, but it is important to highlight the meaning between the two 
different bar charts. Figure 5.2, demonstrates the percentage of colonies formed based on 
the initial seeding density. As such, this gives an indication of colony forming cells within 
the entire collection of cells released during the digestion of the tissue. Within both OA 
and normal categories, the total percent of colonies formed, according to the colony 
forming efficiencies was consistently below 0.5 percent. These data are agreeable to that 
of Dowthwaite et al., (2004) who reported a mean CFE of 0.27 in cells digested from 7-
day-old bovine articular cartilage. As such, this population of cells represents a small 
proportion of the whole contingent in both OA and normal cartilage. Using CFEs as an 
indicator of the presence of stem cells within the tissue is a justified proposal as these cells 
are not known to be widely abundant in mature articular cartilage; and as such, a 
proportion of less than one percent supports these data. It has previously been 
demonstrated that putative stem cell markers are upregulated in OA tissue (Grogan et al., 
2009) and thus, it would be expected that CFEs would be higher in the more diseased state. 
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Ironically, Figure 5.2 demonstrates that this was not the case; however the difference was 
not statistically significant and so must be regarded cautiously. 
 
The percentage of cells that initially adhered (within 24 hours of plating) to fibronectin 
gives an indication of the number of active α5β1 integrin receptors on the surface of the 
digested cells. The trend observed was that there was a higher proportion of cells that 
initially adhered in the OA cohort when compared to the normal group; however this 
difference was not statistically significant. This trend however, is agreeable to findings by 
other authors (Fickert et al., 2004, Grogan et al., 2009) who describe the notable increase 
in specific stem cell markers in OA tissue. Colonies formed in relation to the number of 
adherent cells (figure 5.3) therefore, demonstrates the relative proportion of cells that 
become colony forming in relation to the number cells which were initially selected due to 
receptor-integrin interactions. As there was a higher proportion of initially adhered cells in 
the OA group, it may have been hypothesised that this would consequently result in more 
colonies arising in the OA group. However, this was not the case and, in fact, it was shown 
that there was a significant decrease in colonies formed in the OA group when compared 
to colonies formed from the normal group. Consequently, it may be said that within OA, 
the progenitor cell population is elevated when compared to the normal counterpart (based 
on the number of initially adherent cells) however, the cells are not fully functioning, and 
as a result, there is a marked reduction in CFEs in the OA group. Indeed, an editorial by 
Dealy (2012) states that “the presence of disease may alter endogenous progenitor 
populations and compromise their ability to accomplish self-repair”, which in this case is 
supported by the reduced CFEs in the diseased tissue. 
 
Within all the categories; CFEs based on initial seeding density, CFEs based on initially 
adhered cells and numbers of cells that initially adhered to the fibronectin coated plates, 
significant variation was observed in the normal group. This not only highlights once again 
heterogeneity between patients, but also the need for larger ‘n’ numbers in the study. It 
could also be suggested that within the group of cells that rapidly adhere to fibronectin, 
there may be sub-groups of cells that can be further classified. As such, it is imperative 
that a greater understanding is sought not only into the differences between adherent cells, 
but also into the reasons why cells selected in a like manner form morphologically 
different colonies. Indeed, work by Barrandon and Green (1987) demonstrated that clones 
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formed by single human epidermal cells adopted one of three classes. The holoclone which 
has the greatest reproductive capacity, the paraclone which contains cells with a short 
replicative lifespan, and the meroclone which encompasses the transitional phase between 
the two. Upon further study, it may be found that a similar classification phenomenon also 
occurs in chondroprogenitor cells isolated from articular cartilage.  
 
Primary cultures of normal and OA clonal cell lines were examined for proliferation and 
senescence using BrdU and SA β-Gal respectively. Relating to the BrdU results 
specifically, no notable difference was detected between the OA and the normal cultures, 
however within both individual cohorts there was significant variation. This, therefore 
suggests, that any differences seen may not necessarily be due to the severity of tissue 
from which the chondroprogenitor cell is excised, and more so the variation between 
individual patients.  
 
Proliferation is often assessed using sectioned tissue and immunohistochemistry (as 
covered in the previous chapter) as a means of detection. It is accepted that chondrocyte 
proliferation is a characteristic feature typically considered to be part of the OA pathology 
(Dealy, 2012). However, within this study we are looking specifically into the 
chondroprogenitors and not the whole chondrocyte population. It could be that this is the 
reason why the usual discrepancies between proliferation in normal and OA articular 
cartilage were not observed in this study. As such, one may hypothesise that the 
chondrocyte clusters as a result of cell proliferation may not be instigated by the residing 
progenitor cells themselves, but instead, the transient amplifying cells. This hypothesis 
could explain the failure in self-repair that articular tissue is renowned for –perhaps the 
chondroprogenitor cells lack the signal necessary for activation. Indeed, a recent study by 
Pretzel et al., (2011) found that the relative content of superficial and mid-zone progenitors 
was similar in normal and OA cartilage. As such, it may be suggested that the increased 
metabolism evident in OA cartilage is not necessarily indicative of increased 
chondroprogenitor cell activity. Further work would be needed to test this hypothesis.  
 
Clonal cell cultures in both OA and normal categories tested positive for SA β-Gal despite 
showing continued proliferation. Interestingly it was found that senescence was higher in 
the normal group when compared to the OA group, although again significant variation 
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was observed. Clonal cell lines from ‘Normal-1’ demonstrated particularly high levels of 
senescence, with a mean of approximately 15 percent labelling positively. If cell lines 
from this patient were omitted and a comparison was made purely between ‘OA-2’ and 
‘Normal-2’, no significant difference would have been found. As such, this highlights the 
issue and need for analysing greater numbers in order to give more statistical validity. As 
mentioned previously, differences seen may be purely a result of individual patient 
variation rather than a consequence of disease, however this will not be known until 
additional numbers are analysed. This issue of low ‘n’ numbers also applies to the BrdU 
results obtained through this study and further analysis is imperative in order for solid 
conclusions to be drawn.   
 
Rate of proliferation may also be a reason for differences observed in senescence results 
from this study. Unpublished results from our laboratory have shown that some OA cell 
lines match the proliferation rate of normal cell lines when measured using population 
doublings, however, other cell lines are far slower. As this experiment was carried out at 
the same point in time rather than same PD, it may be that the normal cell lines, in this 
particular instance, proliferated at a faster rate than the OA cell lines and as such were 
farther along the proliferation timeline when compared to the OA counterpart. This may 
justify the reason for increased senescence in the normal clonal cell lines. Furthermore, it 
was also noted in the previous chapter that some cell lines had the tendency to almost 
suddenly stop proliferating, and so at this stage it is unknown whether or not the cell lines 
used for this study would have fallen into that category or not.   
 
Potentially affecting both the BrdU and SA β-Gal results in this study, compared to many 
studies in the literature that rely on histological sections for analysis, are the issues that 
accompany in vitro culturing of cells. Not only are the cells initially stripped from their 
3-D environment having adverse effects, the cells are also prone to dedifferentiation 
(Schnabel et al., 2002). Having said that, this factor does not influence the relative 
differences observed between chondroprogenitor cells isolated from normal and OA tissue.  
 
Following 21 days in culture, 3-D pellets were digested and analysed for DNA and GAG 
content as there was no clear morphological difference between the pellets originating 
from normal or OA articular cartilage. Similar to other findings throughout this chapter, 
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there was no distinct trend observed between normal and OA pellets it terms of 
biochemical composition. What was reiterated again however, was the variation between 
patients within the same cohort. A study conducted by Temple-Wong et al., (2009) 
demonstrated that GAG levels were also variable in articular cartilage samples which were 
characteristically normal or showing signs of OA. In this study the variation seen was vast 
throughout different areas of a specific joint, highlighting the ease of which disparities 
may arise, when studying human articular cartilage.  
 
Data from this study suggest that GAG content per DNA is very low in both categories, 
however it is should be noted that in comparison, DNA levels within the pellets of this 
study appear to be significantly higher than levels reported in other studies. A study by 
Giovanni et al., (2010) reported less that 10µg DNA per pellet whereas in this study DNA 
content per pellet exceeded 90µg. Differences in methods used, therefore, hinders the 
ability to compare results of this study to previous findings. Perhaps the difference in the 
way that the pellet cultures were formed and maintained affected the DNA content within 
the pellet. It may also be that the instruments used in DNA detection in this study was 
more sensitive or vice versa, raising discrepancies.  
 
It does appear that within this study, levels of GAG are low; particularly in the OA pellets 
despite there being no statistical significance. Interestingly, it appears that pellets with a 
higher DNA content do not reciprocate with a higher GAG/DNA content, suggesting that 
GAG production is hindered in these pellets. This occurred in pellets from both OA and 
normal origins. The normal pellet which is shown to have the greatest GAG/DNA content 
is consistent with the pellet with the least DNA content. In this case, it appears that 
regardless of the low levels of DNA, the pellets were able to produce greater amounts of 
GAG. As such, the need to further expand this study is emphasized so that definitive 
trends can be noted. Is this increased GAG production a result of ‘normal’ 
chondroprogenitor cells being superior to chondroprogenitor cells isolated from OA 
tissue? Or is it simply a case of patient variation regardless of OA grade? These are 
questions that remain to be answered and are essential in the pursuit to understand 
similarities and differences between chondroprogenitor cells present in normal and OA 
tissue, so that the true potential of cells in OA tissue can be elucidated.     
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Aggregation and integration 
 
The integration study of this chapter was carried out in order to determine whether 
chondroprogenitor cells isolated from OA articular cartilage differ behaviourally from 
those isolated from normal cartilage; and if so, whether local signals from the normal 
chondroprogenitor cells would improve cartilage formation in mixed co-cultures. There 
are many recent studies that look into the effect of combining MSCs to articular cartilage 
chondrocytes, suggesting that the co-culture system yields a more favourable cartilage 
phenotype to MSCs alone (Tsuchiya, 2004, Acharya et al., 2011, Bian et al., 2011). 
Relating back to this study, it was thought that perhaps if the cells showed distinct 
segregation, indicating two different cohorts of cells, paracrine factors from the normal 
cells may relay a beneficial effect onto the OA chondroprogenitor cells. 
 
As such, results from the integration study yielded very inconsistent and inconclusive data. 
It was hypothesised that co-cultures of different OA chondroprogenitors would integrate 
and show no behavioural differences, however this was not always the case. In both the 
pellets and aggregates, integration was seen in some cultures and segregation in others. 
This supports the previous suggestion that within OA articular cartilage, 
chondroprogenitor cells may be further classified into behaviourally different groups. The 
pellets, which were cultured for 21 days were given more time to structurally reorganise, 
however within the OA: OA group, no distinct change in structural conformation could be 
detected.  
 
The underlying attraction in understanding chondroprogenitor cells in OA tissue is to 
elucidate whether or not these cells, given the right conditions, have the potential to repair 
into a hyaline cartilage like tissue. This may be through in vivo stimulation or through in 
vitro culture in a laboratory prior to being reinserted into the tissue of interest. Either way 
it is imperative that the tissue integrates efficiently to produce a decent repair tissue; an 
issue that is widely discussed in the literature [reviewed by Khan et al., (2008)]. Although 
further investigations are necessary in order to definitively report this result due to the 
small ‘n’ numbers used in this study, these preliminary data suggest that all 
chondroprogenitor cells isolated from OA tissue using the fibronectin adhesion assay, will 
not necessarily integrate effortlessly with neighbouring cells. As a result, further work 
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would need to be carried out in order to determine whether or not, given the right 
conditions, these cells could be directed into successful integration.  
 
Co-culturing chondroprogenitors from normal origins (normal: normal), and normal with 
OA (normal: OA) in aggregates and pellets, similarly demonstrated inconsistent data. As 
such, it appears that the phenomenon of ‘good and bad’ cell lines that was apparent in the 
OA group, may also be evident in cells isolated from normal tissue. In the OA: normal 
group, certain pellets and aggregates were beautifully integrated while others showed 
pockets of segregation. It may, therefore, be suggested that part of what determines a cell 
line as a ‘good’ cell line is its integrative capacity. Circulating paracrine factors from 
neighbouring cells are involved in improving chondrocyte integration with progenitor cells 
(Ahmed et al., 2007) and so it would be interesting to investigate these in the cultures used 
for this study, and identify whether or not paracrine factors are stimulated at differing 
levels between cell lines. This may reveal information relating to why some cell lines 
integrate efficiently while others do not.  
 
The protocol used for this co-culture study was adapted from Moscona et al., (1961), 
however there are currently many intricate scaffolds that have been developed to support 
3-D structure formation [recently reviewed by Vinatier et al., (2009)] (Vinatier et al., 
2009). As such, it would be beneficial to repeat a similar integration study using a scaffold 
to support the cells to see if the increased integrity allows scope for better integration 
between the cells.  
 
In this chapter, mixed cell populations were co-cultured and results demonstrated the 
compatibility of the different cell types. Testing the integrative capacities of the 
chondroprogenitor cells to whole cartilage explants would further enhance this work and 
give a true indication of the integrative capacity of the tissue engineered from 
chondroprogenitor cells isolated from normal and OA tissue. Additionally, quantitative 
methods of assessment would then be able to be used to test the adhesive strength of the 
integration surface using push-out mechanical tests. This work could be coupled with the 
introduction of scaffolds as mentioned above to achieve greater consistencies and better 
integrated tissue.  
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As a whole, this chapter has shown that there is not only great patient variation, but also 
variation between clonally derived cells lines, which may supersede changes occurring as 
a result of osteoarthritis. It is also imperative, however, that these results are only regarded 
as preliminary as ‘n’ numbers used in this study were restricted. As such a study of a 
greater magnitude is essential to confirm these results. If, however, these results are shown 
to be true, it could be positively assumed that chondroprogenitors isolated from OA tissue 
are not necessarily compromised when compared to normal cells. Instead, it highlights the 
importance to understand why cells isolated using a single technique are so variable. 
Understanding this will undoubtedly help with achieving the goal of obtaining a reliable 
cell type to be used in cartilage repair and regeneration.  
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Chapter 6: 
General Discussion 
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6. General discussion 
 
A Scottish anatomist and physician, William Hunter, wrote his first paper to the Royal 
Society in 1743 on articular cartilage and its diseases. In this paper he wrote “If we consult 
the standard Chirurgical Writers from Hippocrates down to the present age, we shall find, 
that an ulcerated cartilage is universally allowed to be a very troublesome disease; that it 
admits of a Cure with more Difficulty than carious Bone; and that, when destroyed, it is 
never recovered” (Hunter, 1743). Despite the age of this quote, the poor intrinsic capacity 
for articular cartilage to repair itself continues to be a challenge to scientists and clinicians 
alike.  
 
The inherently poor repair capacity of articular cartilage is due to the avascular, 
alymphatic and aneural nature of the tissue, combined with low cellularity and the absence 
of a germinal layer. The structural and biochemical composition of articular cartilage, 
however, gives the tissue its characteristic features including resilience, ability to bear high 
tensile forces and ability to withstand and restore itself after compression (Benjamin, 
1999). In health, metabolism and mitotic activity are low resulting in a stable tissue that 
can be regarded as ‘low maintenance’ however, this asset in a healthy state exacerbates the 
problem when diseased.  
 
Osteoarthritis is one of many diseases that affects articular cartilage. Despite the 
involvement of many surrounding tissues including the subchondral bone, synovium and 
meniscus; the hyaline cartilage has traditionally been the prime target when investigating 
the morbid disease (Martel-Pelletier and Pelletier, 2010). 
  
Congruent to the work of others, within this study, the main focus was directed towards 
evaluating the potential for hyaline cartilage repair using progenitor cells resident in the 
diseased tissue. However a subset of the work was also directed towards exposing the 
relationship of neighbouring bone and the clinical implications that this could lead 
towards.  
 
Figure 6.1 is a summary flow chart which outlines the development of work carried out 
within this study.  
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Figure 6.1. Summary flow chart outlining briefly the topic of work (green), the 
development of work carried out within the study (black) and indications of future benefits 
which may arise from the work (blue).  
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As a means of histologically assessing the severity of OA, many scoring systems have 
been devised; however, the focus of these established scoring systems, as previously 
mentioned, is the hyaline cartilage (Mainil-Varlet et al., 2003, Mankin et al., 1971, 
O'Driscoll et al., 1988, Roberts et al., 2003). With the increase in literature highlighting the 
involvement of bone in the osteoarthritic process, a novel scoring system was devised 
within the study which incorporates this neighbouring tissue.  
 
An observation that was evident and consistent throughout the study was the degree of 
variation. It is accepted that cartilage changes occur alongside bony changes (Lajeunesse 
and Reboul, 2003). However, as disease progression varies so significantly from patient to 
patient, the involvement of the bone in the development of the disease may also differ. 
Therefore, bone changes should not be eliminated from the histological assessment 
process. As such, the new scoring method is more encompassing and consequently 
provides a more accurate representation of the severity of disease in the histological 
specimens. 
 
Upon analysis of the scoring system by comparing individual parameters, it was seen that 
bone changes may precede the degenerative change that occurs in the cartilage. This is a 
significant finding which needs to be further addressed as it could lead to major 
repercussions. Is it that metabolic changes occur more quickly in bone and, as such, the 
bone starts to be symptomatic earlier than the cartilage? Or is it, in fact, a signal that 
initiates in the bone? Not only does this finding draw upon the “chicken or egg” analogy of 
which comes first, which in turn could affect targeted treatments, but this also has major 
clinical implications with regards to diagnostic tools. Indeed, understanding the correlation 
of bone changes in relation to other changes in OA, if developed properly, could provide a 
means for diagnosis at early stages of disease, using a minimally invasive bone-based 
method. Hypothetically, this early diagnosis could translate into early attenuation of the 
disease, perhaps reducing the need for cartilage repair and regeneration which is currently 
so critical. 
 
In order for this to be achievable, however, a study of a significantly larger scale would be 
essential, so that the entire range of scores are covered. This information is vital, ensuring 
that each stage of progression can be accounted for. A study of a larger scale would also 
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allow for a better indication of patient variability, as well as inter- and intra-observer 
variability which will ultimately affect the validity of the new scoring system.  
 
Within this study, the newly devised scoring system was used to correlate disease severity 
with the expression of matrix markers, chondrocyte proliferation & putative stem cell 
markers so that progressive changes could be mapped out. The scoring system yielded 
scores ranging from a possible 0 to 17, where lower scores were representative of a more 
normal state and high scores were suggestive of thick, eburnated bone. As scores greater 
than 10 contained little exposed cartilage, it is important to put into context what is meant 
by a ‘high’ score, when referring to immunolabelling in the articular cartilage. For 
instance, immunolabelling in the articular cartilage of OCPs scored between 11 and 17 
would not have demonstrated vast amounts of labelling, if any, due to the mere absence of 
cartilage. As such, the discussion of immunolabelling in the cartilage is only inclusive of 
OCPs that actually contained a layer of articular cartilage over the subchondral bone.  
 
The presence of type I collagen and procollagen type IIA was confirmed in the early stages 
of tissue degeneration, suggesting that early remodelling was occurring in an attempt to 
repair the tissue whilst it was still recoverable. Dissimilar to many articles in the literature, 
type X collagen expression remained in the deep and calcified cartilage regions, without 
spreading into other regions of the tissue, upon disease progression. Results of this study 
demonstrated the difficulty in extrapolating likely trends, and again, highlights the need for 
a clear understanding in the changes that occur throughout OA to be sought.  
 
Within the small scale of this study, an anomalous OCP was clearly distinct from others. It 
would be of use to elucidate whether or not OA, as a disease, does in fact rear these 
different histological specimens or, if perhaps, patients’ symptoms are being 
misdiagnosed. As OA is a multifactoral disease that affects patients to different extents, it 
seems plausible that this may happen; however, moving on it is essential that patients 
receive the right diagnosis so that they can receive optimum treatment.  
 
Together with the matrix markers, the scoring system was used to quantify the presence of 
putative stem cell markers Stro-1 and Notch-1 in tissue of varying severities. Although 
some data in the literature suggest that these markers can be used as stem cell markers 
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(Dennis et al., 2002, Dowthwaite et al., 2004), others have reported a surprisingly high 
number of these cells in OA tissue, questioning their validity as a stem cell marker whilst 
confirming their involvement in the abnormal cell activation and differentiation process 
that occurs in OA (Grogan et al., 2009). Results from this study confirmed the suggestion 
of Grogan et al., (2009) in that over 40 percent of cells in the surface zone labelled 
positively for both Stro-1 and Notch-1.  
 
The difficulty in identifying stem cells of mesenchymal origin is that, unlike hematopoietic 
stem cells, there is no single marker that can be used, and the identified markers are not 
exclusively restricted to the cohort of specialised stem cells. Despite this difficulty, they 
may however be indicative of stem cell interaction. Previous work from our laboratory has 
identified a method that relies on α5β1 interactions to isolate a progenitor cell population 
from normal articular cartilage of several different species (Dowthwaite et al., 2004, 
Williams et al., 2010, McCarthy et al., 2011). 
 
Within this study, the question was asked ‘Are the chondroprogenitor cells that are present 
in normal articular cartilage also present in diseased osteoarthritic cartilage, and can they 
be isolated and expanded?’ The answer to this question was ‘yes’ and it was shown for the 
first time that these cells could be isolated, and did have capacity to proliferate beyond the 
potential of chondrocytes, whilst maintaining the chondrogenic phenotype. That said, this 
result requires further investigation as not all of the cells behaved in the same manner and, 
as such, the heterogeneity observed between the cells has left many unanswered questions.  
 
Heterogeneity was observed throughout all stages of experimentation; colony morphology, 
proliferation potential, rate of proliferation and chondrogenic capabilities were all factors 
which, in some cases, yielded very positive results and, in other cases, raised concern over 
the potential of these cells. Plasticity into osteogenic and adipogenic lineages was also 
achieved however, the time required for osteogenic induction varied between cells. This 
leads to the proposition that perhaps the chondroprogenitors isolated using this method can 
still be further refined so that the deranged cells are excluded. Indeed, the long-term 
outlook of these cells is that they would be used for repair and, thus, it is imperative that 
the cells behave accordingly and homogeneously so that the desired output can be 
achieved.  
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Interestingly, unpublished work from our laboratory has investigated telomere length in 
chondroprogenitors isolated from normal and OA tissue. Telomeres are terminal regions of 
linear chromosomes that function to allow chromosomal replication and prevent 
chromosomal fusion and rearrangements (Blackburn, 1991). Telomeres shorten with each 
cycle of genomic replication, resulting in the cell eventually reaching replicative 
senescence (Hastie et al., 1990). There is strong evidence to suggest that telomere length is 
maintained in stem cell populations to facilitate and maintain the cell division required for 
tissue homeostasis (Allen and Baird, 2009). Results from co-workers have shown that 
within the normal group of chondroprogenitors, there is a high average telomere length, 
whereas in the group of chondroprogenitors isolated from OA tissue, there is a distinct 
division whereby 60 percent of the cells display lower telomere lengths. Telomere length 
of the remaining 40 percent is slightly lower, yet comparable, to that of the normal group. 
As such, these findings support the results of this study in that the heterogeneity observed 
may in fact be due to different groups of cells exhibiting behavioural discrepancies. 
 
In a continued attempt to decipher whether or not chondroprogenitor cells isolated from 
OA tissue was similar or dissimilar to chondroprogenitors of normal origin, a preliminary 
study was carried out to initially compare the two populations of cells. Contradictory to 
previous work from our laboratory, heterogeneity was also observed within the normal 
cohort. As such, no significant difference between the OA and normal groups was 
observed when comparing colony forming efficiencies of cell lines, BrdU incorporation of 
cells, and biochemical composition of pellets. Senescence associated β- galactosidase was 
surprisingly higher in the normal group, however, this may be due to the cells being at a 
later population doubling as a result of faster proliferation rates. This would need to be 
further investigated in order to make a solid conclusion. 
 
An integration study was carried out to see whether any structural reorganisation would 
occur upon mixing different populations of cells, as local circulating paracrine factors are 
known to influence cell interactions (Ahmed et al., 2007). Integration between normal and 
OA cells could be indicative of a positive effect of the normal chondroprogenitor cells on 
the OA cells, and/or, suggestive of the fact that perhaps the cells are indeed similar with 
comparable behavioural responses therefore resulting in no segregation between the cells.  
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Unfortunately, within this study it was not possible to extrapolate any conclusions, and 
these results must be used merely as a springboard for more experimentation. It is 
necessary to undertake this study on a much larger scale in order to elucidate conclusively 
the similarities or differences between chondroprogenitor cells isolated from normal and 
OA articular cartilage.  
 
As a whole, it can be said that osteoarthritic tissue does contain a group of 
chondroprogenitor cells, and it has been shown that some of these cells do have the 
potential to repair articular cartilage. This is a pivotal finding as many characteristics seen 
within this study reflect those of other stem cells, highlighting their capability potentials 
which can be further exploited to aid the field of regenerative medicine. 
 
That said, this study has also highlighted the importance of carrying out further work in 
order to establish sufficient groundwork to be able to consider these cells as suitable 
candidates for translational use in the future.   
 
6.1. Further work 
 
Referring back to the early work on the scoring system and the correlation between bone 
and cartilage, it would be interesting to determine conclusively whether the trend of the 
bone changes preceding the cartilage changes in humans, is in fact true, as this could offer 
clinical implications. On a similar note, it would be of interest to further this study by 
assessing the correlation between the degree of pain experienced by the patient, and scores 
obtained using this new scoring system. If pain was directly related to the score, and the 
score tied-in with degree of bone change, then this could further enhance the case for 
developing a method for a bone-based diagnostic tool.   
   
One of the major challenges faced in part of this study was the issue of auto-fluorescence 
in the osteochondral plugs. Many failed attempts were carried out to reduce this hindrance 
during this study and, as such, the less sensitive method of peroxidise labelling as used 
rather than fluorescent labelling. Background labelling is a well known issue particularly 
in aged, human tissue; however, it may also be exacerbated by tissue preparation and 
fixation techniques. As such, although seemingly basic, it would be of use to methodically 
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try different fixation, decalcification, and auto-fluorescence reducing techniques in order 
to establish a method that can be used successfully using immunofluorescence. Similarly, 
epitope unmasking and antigen retrieval techniques can also contribute to the problem, so 
it would be of use to include these in the study.   
 
With regards to the in vitro work, heterogeneity was a distinguishable recurring factor 
throughout this study. As such, it would be of use to know whether additional factors 
affected the results of this study or if the cells are inherently enigmatic. As such, it would 
be interesting to determine whether expansion time affected the composition of the 
engineered pellets. In other words, do the growth kinetics of particular cell lines affect the 
chondrogenicity and integrity of a pellet? Similarly, it would be of use to further 
investigate the underlying reason behind the different colonies which initially form, so that 
the colony selection process need not be at random. Equally, this may result in reduced 
heterogeneity and more consistent data.    
 
Additionally, it would be interesting to investigate whether maturity, or age of patient 
affects the structural integrity and composition of the chondrogenic pellets. This is 
difficult, however, due to the lack of availability of osteoarthritic tissue in patients of a 
young age.  
 
The in vitro section of this study relied heavily on the Dowthwaite et al., (2004) method of 
isolating chondroprogenitors cells from articular cartilage. In his study, he identifies the 
progenitor cells in the surface zone of the tissue. Due to the lack of uniform tissue acquired 
from total knee replacements in patients with OA, it is difficult to definitively separate 
cells from the surface from the remaining regions. As such, cells from regions other than 
the surface were included in this study and this may have been another cause for the 
heterogeneity in this study. Indeed, a study by Siczkowski and Watt (1990) have 
demonstrated that cells from the upper zone of articular cartilage adhere and proliferate 
more slowly than cells from the lower zones when cultured in vitro. As such, as it was not 
only the surface zone that was being digested for cell isolation, could it be that during the 
20 minute adhesion period, chondroprogenitors were adhering together with deep zone 
chondrocytes purely because they have a tendency to adhere quickly? It would be 
interesting to investigate this further, as it may again, be a contributing factor to the 
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heterogeneity observed within this study. Perhaps the isolation procedure in osteoarthritic 
cartilage needs to be further refined in order to obtain a more specific cohort of cells.  
 
Linking the work on histological sections with the in vitro findings, it would also be 
interesting to determine whether there is a correlation between the cells which labelled 
positively for Stro-1 and Notch-1, and the cells that adhere during the fibronectin adhesion 
assay. As such, a fluorescently activated cell sorter could be used to sort and replate 
positively immunolabelled cells, and subsequently, colony forming efficiencies and 
percentage of initial adhesion to fibronectin following the ‘Dowthwaite method’ could be 
investigated. This would give us an indication as to whether or not it is in fact the same 
cells which label positively for Stro-1 and/or Notch-1 that are involved in the α5β1 
interactions. Not only would this enable us to decipher a more specific means of 
chondroprogenitor cell selection, but it will also unveil more crucial information regarding 
stem cells in osteoarthritic tissue.    
 
Lastly, with regards to the final chapter which addressed similarities and differences 
between chondroprogenitors from OA and normal tissue, as well as their integrative 
capacities; it would be necessary to repeat this study on a larger scale. A solid conclusion 
to that study would reveal information that could be critical, when considering taking this 
work forward into translational science.  
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8: Appendix 
 
Massons trichrome stain: 
 
Stain in Celestine blue B (10 minutes) 
Wash in running tap water until clear 
Stain in Mayer’s Haematoxylin (10 minutes) 
Wash in running tap water (10 minutes) 
Stain in Ponceau/acid fuchin (5 minutes) 
Wash in running tap water (1 minute) 
Differentiate in 1% phosphomolydic acid (5 minutes) 
Transfer to light green stain (3 minutes) 
Wash in running tap water (1 minute) 
Wash in 1% acetic acid (1 minute) 
Rinse in running tap water (30 seconds) 
Dehydrate in alcohols  
Clear in xylene 
Mount in DPX 
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